How Pharmacy Benefit Managers Make Money and What To Do About It [Free Webinar]

Name: TransparentRx
Address: 10845 Griffith Peak Dr, Las Vegas, NV, 89135, US
Telephone: (866) 499-1940
How many businesses do you know want to cut their revenues in half? That’s why traditional pharmacy benefit managers, and their stakeholders, don’t offer a fiduciary standard and instead opt for hidden cash flow opportunities such as rebate masking. Want to learn more?
Here is what some participants have said about the webinar.
“Thank you Tyrone. Nice job, good information.” David Stoots, AVP
“Thank you! Awesome presentation.” Mallory Nelson, PharmD
“Thank you Tyrone for this informative meeting.” David Wachtel, VP
“…Great presentation! I had our two partners on the presentation as well. Very informative.” Nolan Waterfall, Agent/Benefits Specialist
A snapshot of what you will learn during this 30-minute webinar:
Hidden cash flows in the PBM Industry
Basic to intermediate level PBM terminologies
Specialty pharmacy cost-containment strategies
Examples of drugs that you might be covering that are costing you
The #1 metric to measure when evaluating PBM proposals
See you Tuesday, 02/08/22 at 2 PM ET!
Sincerely,
TransparentRx
Tyrone D. Squires, MBA
10845 Griffith Peak Drive, Suite 200
Las Vegas, NV 89135
Office: (866) 499-1940
Mobile: (702) 803-4154
P.S. Yes, it’s recorded. I know you’re busy … so register now and we’ll send you the link to the session recording as soon as it’s ready.
Post author:Tyrone Squires, MBA, CPBS
Post published:February 1, 2022
Post comments:0 Comments
ABOUT THE AUTHOR

Tyrone Squires, CPBS is author of The Employer’s Guide Blog to Overseeing PBMs. Mr. Squires is Founder and Managing Director of TransparentRx , the first fiduciary model PBM, and lead lecturer for the Certified Pharmacy Benefits Specialist (CPBS) program. A course which offers, SHRM, HRCI, pharmacists and L&H licensees up to 20 hours of continuing education. Read More.
collapsArch options:
Array
(
    [title] => VIEW POSTS BY DATE
    [noTitle] => 
    [inExcludeCat] => exclude
    [inExcludeCats] => 
    [inExcludeYear] => exclude
    [inExcludeYears] => 
    [showPages] => 
    [sort] => DESC
    [linkToArch] => 1
    [showYearCount] => 1
    [expandCurrentYear] => 1
    [expandMonths] => 1
    [expandYears] => 1
    [expandCurrentMonth] => 1
    [showMonthCount] => 1
    [showPostTitle] => 1
    [expand] => 0
    [showPostDate] => 1
    [debug] => 1
    [postDateFormat] => m/d
    [postDateAppend] => after
    [accordion] => 1
    [useCookies] => 1
    [post_type] => post
    [taxoncmy] => category
    [postTitleLength] => 
    [showPostCount] => 1
    [style] => custom
    [archSortOrder] => DESC
    [showPosts] => 
    [customExpand] => 
    [customCollapse] => 
    [taxonomy] => both
    [number] => 2
)
POST QUERY:
 SELECT trx_terms.slug, trx_posts.ID,
    trx_posts.post_name, trx_posts.post_title, trx_posts.post_author,
    trx_posts.post_date, YEAR(trx_posts.post_date) AS 'year',
    MONTH(trx_posts.post_date) AS 'month' ,
    trx_posts.post_type
    FROM trx_posts LEFT JOIN trx_term_relationships ON trx_posts.ID =
    trx_term_relationships.object_id 
		LEFT JOIN trx_term_taxonomy ON trx_term_taxonomy.term_taxonomy_id =
																			trx_term_relationships.term_taxonomy_id
		LEFT JOIN trx_terms ON trx_terms.term_id = 
		                          trx_term_taxonomy.term_id 
  WHERE post_status='publish' AND trx_posts.post_type='post'   
  GROUP BY trx_posts.ID 
  ORDER BY trx_posts.post_date DESC

POST QUERY RESULTS
Array
(
    [0] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14935
            [post_name] => fda-approves-3-5-million-gene-therapy-to-treat-adults-with-hemophilia-b
            [post_title] => FDA Approves $3.5 Million Gene Therapy to Treat Adults with Hemophilia B
            [post_author] => 2
            [post_date] => 2022-11-23 16:05:45
            [year] => 2022
            [month] => 11
            [post_type] => post
        )

    [1] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14874
            [post_name] => what-do-ticketmaster-and-pharmacy-benefit-managers-have-in-common
            [post_title] => What do Ticketmaster and Pharmacy Benefit Managers have in common? [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-11-19 16:01:20
            [year] => 2022
            [month] => 11
            [post_type] => post
        )

    [2] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14913
            [post_name] => ftc-reaffirms-commitment-to-unfair-business-practices
            [post_title] => FTC reaffirms commitment to unfair business practices
            [post_author] => 2
            [post_date] => 2022-11-16 14:15:52
            [year] => 2022
            [month] => 11
            [post_type] => post
        )

    [3] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14872
            [post_name] => consolidated-appropriations-act-shifts-more-responsibility-to-employers-next-year
            [post_title] => Consolidated Appropriations Act shifts more responsibility to employers next year [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-11-14 00:43:12
            [year] => 2022
            [month] => 11
            [post_type] => post
        )

    [4] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14900
            [post_name] => pbm-revenue-streams-that-are-bad-for-customers
            [post_title] => PBM Revenue Streams that are Bad for Customers
            [post_author] => 2
            [post_date] => 2022-11-12 22:01:05
            [year] => 2022
            [month] => 11
            [post_type] => post
        )

    [5] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14879
            [post_name] => how-pbms-make-money-and-what-to-do-about-it-free-webinar-2
            [post_title] => How PBMs Make Money and What to Do About It [Free Webinar]
            [post_author] => 2
            [post_date] => 2022-11-05 15:51:01
            [year] => 2022
            [month] => 11
            [post_type] => post
        )

    [6] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14876
            [post_name] => get-ready-for-hemophilia-gene-therapies-at-2m-3m
            [post_title] => Get ready for hemophilia gene therapies at $2M-$3M [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-11-04 19:07:02
            [year] => 2022
            [month] => 11
            [post_type] => post
        )

    [7] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14866
            [post_name] => 6-things-every-transparent-pbm-should-do
            [post_title] => 6 Things Every Transparent PBM Should Do for Clients
            [post_author] => 2
            [post_date] => 2022-10-31 21:52:07
            [year] => 2022
            [month] => 10
            [post_type] => post
        )

    [8] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14863
            [post_name] => how-the-10-largest-pbms-hold-huge-sway-in-health-care-marketplace
            [post_title] => How the 10 largest PBMs hold huge sway in health care marketplace [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-10-31 01:07:13
            [year] => 2022
            [month] => 10
            [post_type] => post
        )

    [9] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14858
            [post_name] => new-report-clears-up-misunderstandings-about-drug-pricing-benchmarks
            [post_title] => New Report Clears Up Misunderstandings About Drug Pricing Benchmarks
            [post_author] => 2
            [post_date] => 2022-10-29 19:17:38
            [year] => 2022
            [month] => 10
            [post_type] => post
        )

    [10] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14854
            [post_name] => learn-how-pbms-make-money
            [post_title] => Learn How PBMs Make Money
            [post_author] => 2
            [post_date] => 2022-10-19 14:53:08
            [year] => 2022
            [month] => 10
            [post_type] => post
        )

    [11] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14807
            [post_name] => new-inflation-linked-drug-rebates-have-gone-into-effect
            [post_title] => New inflation-linked drug rebates have gone into effect [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-10-16 13:25:34
            [year] => 2022
            [month] => 10
            [post_type] => post
        )

    [12] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14772
            [post_name] => 4-questions-to-ask-before-signing-your-next-pbm-service-agreement
            [post_title] => 4 questions to ask before signing your next PBM service agreement [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-10-01 21:02:13
            [year] => 2022
            [month] => 10
            [post_type] => post
        )

    [13] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14778
            [post_name] => three-reasons-for-micromanaging-pharmacy-benefits
            [post_title] => Three Underappreciated Reasons for Micromanaging Pharmacy Benefits
            [post_author] => 2
            [post_date] => 2022-09-29 16:13:54
            [year] => 2022
            [month] => 9
            [post_type] => post
        )

    [14] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14774
            [post_name] => how-pbms-make-money-and-what-to-do-about-it-free-webinar
            [post_title] => How PBMs Make Money and What to Do About It [Free Webinar]
            [post_author] => 2
            [post_date] => 2022-09-27 17:04:47
            [year] => 2022
            [month] => 9
            [post_type] => post
        )

    [15] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14762
            [post_name] => 2023-large-employers-health-care-strategy-and-plan-design-survey
            [post_title] => 2023 Large Employers’ Health Care Strategy and Plan Design Survey [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-09-24 15:12:53
            [year] => 2022
            [month] => 9
            [post_type] => post
        )

    [16] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14753
            [post_name] => conventional-pbm-rfp-process-is-flawed
            [post_title] => The Conventional PBM RFP Process Is Flawed – Here’s the #1 Way to Fix It
            [post_author] => 2
            [post_date] => 2022-09-20 18:22:59
            [year] => 2022
            [month] => 9
            [post_type] => post
        )

    [17] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14751
            [post_name] => pbm-ordered-to-pay-american-healthcare-foundation-ahf-23-million
            [post_title] => PBM Ordered to Pay Aids Healthcare Foundation (AHF) $23 million [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-09-18 20:15:23
            [year] => 2022
            [month] => 9
            [post_type] => post
        )

    [18] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 14737
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-428
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 428)
            [post_author] => 2
            [post_date] => 2022-09-08 11:59:05
            [year] => 2022
            [month] => 9
            [post_type] => post
        )

    [19] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14728
            [post_name] => 6-indicators-your-pbm-is-hoarding-rebates
            [post_title] => 6 Indicators Your PBM is Hoarding Rebates
            [post_author] => 2
            [post_date] => 2022-09-07 15:17:09
            [year] => 2022
            [month] => 9
            [post_type] => post
        )

    [20] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14638
            [post_name] => 4-pbm-trends-to-watch-transparency-is-one-of-them
            [post_title] => 4 PBM Trends to Watch — And, Yes, Transparency is One of Them [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-09-04 20:38:05
            [year] => 2022
            [month] => 9
            [post_type] => post
        )

    [21] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 14628
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-427
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 427)
            [post_author] => 2
            [post_date] => 2022-09-01 11:03:34
            [year] => 2022
            [month] => 9
            [post_type] => post
        )

    [22] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14330
            [post_name] => solution-to-growing-medical-and-prescription-drug-costs
            [post_title] => Is self-funding the solution to growing medical and drug costs? [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-08-27 20:21:11
            [year] => 2022
            [month] => 8
            [post_type] => post
        )

    [23] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 14440
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-426
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 426)
            [post_author] => 2
            [post_date] => 2022-08-25 10:09:58
            [year] => 2022
            [month] => 8
            [post_type] => post
        )

    [24] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14314
            [post_name] => newly-launched-u-s-drugs-head-toward-record-high-prices-weekly-roundup
            [post_title] => Newly launched U.S. drugs head toward record-high prices [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-08-19 14:48:22
            [year] => 2022
            [month] => 8
            [post_type] => post
        )

    [25] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 14264
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-425
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 425)
            [post_author] => 2
            [post_date] => 2022-08-18 11:48:40
            [year] => 2022
            [month] => 8
            [post_type] => post
        )

    [26] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 14107
            [post_name] => pharmacy-benefit-managers-falsely-use-daw-codes-reduce-number-rebate-eligible-claims
            [post_title] => Pharmacy Benefit Managers Falsely Use DAW Codes
            [post_author] => 2
            [post_date] => 2022-08-16 17:45:10
            [year] => 2022
            [month] => 8
            [post_type] => post
        )

    [27] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 14020
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-424-2
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 424)
            [post_author] => 2
            [post_date] => 2022-08-11 13:34:18
            [year] => 2022
            [month] => 8
            [post_type] => post
        )

    [28] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 13961
            [post_name] => biosimilars-shake-up-us-drug-market
            [post_title] => Biosimilars shake up US drug market in 2023 and beyond [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-08-08 18:12:13
            [year] => 2022
            [month] => 8
            [post_type] => post
        )

    [29] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 13914
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-424
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 423)
            [post_author] => 2
            [post_date] => 2022-08-05 13:58:46
            [year] => 2022
            [month] => 8
            [post_type] => post
        )

    [30] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 13851
            [post_name] => how-pharmacy-benefit-managers-make-money-and-what-to-do-about-it-free-webinar-5
            [post_title] => How Pharmacy Benefit Managers Make Money and What to Do About It [Free Webinar]
            [post_author] => 2
            [post_date] => 2022-08-02 18:41:03
            [year] => 2022
            [month] => 8
            [post_type] => post
        )

    [31] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 13656
            [post_name] => pharmacogenomics-is-increasingly-relevant
            [post_title] => Pharmacogenomics is Increasingly Relevant [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-07-29 16:55:41
            [year] => 2022
            [month] => 7
            [post_type] => post
        )

    [32] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 13755
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-422
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 422)
            [post_author] => 2
            [post_date] => 2022-07-28 12:37:32
            [year] => 2022
            [month] => 7
            [post_type] => post
        )

    [33] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 13713
            [post_name] => drug-importation-a-valid-prescription
            [post_title] => Is Drug Importation a Valid Prescription?
            [post_author] => 2
            [post_date] => 2022-07-26 15:55:23
            [year] => 2022
            [month] => 7
            [post_type] => post
        )

    [34] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 13654
            [post_name] => doctors-use-more-brand-drugs-when-on-the-pharma-dole
            [post_title] => Doctors use more brand drugs when on the pharma dole [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-07-24 13:20:00
            [year] => 2022
            [month] => 7
            [post_type] => post
        )

    [35] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 13577
            [post_name] => simplifying-medical-benefit-drug-management-complexities
            [post_title] => Simplifying Medical Benefit Drug Management Complexities [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-07-24 11:51:55
            [year] => 2022
            [month] => 7
            [post_type] => post
        )

    [36] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 13619
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-421
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 421)
            [post_author] => 2
            [post_date] => 2022-07-21 15:06:34
            [year] => 2022
            [month] => 7
            [post_type] => post
        )

    [37] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 13560
            [post_name] => drivers-of-pharmacy-costs
            [post_title] => 5 Things To Do Immediately About Drivers Of Pharmacy Costs
            [post_author] => 2
            [post_date] => 2022-07-19 21:48:46
            [year] => 2022
            [month] => 7
            [post_type] => post
        )

    [38] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 13456
            [post_name] => specialty-drug-solution-stacking
            [post_title] => How specialty drug ‘solution stacking’ can rein in pharmacy benefit costs [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-07-17 18:37:44
            [year] => 2022
            [month] => 7
            [post_type] => post
        )

    [39] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 13485
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-420
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 420)
            [post_author] => 2
            [post_date] => 2022-07-14 13:24:43
            [year] => 2022
            [month] => 7
            [post_type] => post
        )

    [40] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 13450
            [post_name] => three-reasons-why-the-pbm-transparency-act-wont-reduce-drug-costs
            [post_title] => Three Reasons Why the PBM Transparency Act Won’t Reduce Drug Costs
            [post_author] => 2
            [post_date] => 2022-07-13 18:19:59
            [year] => 2022
            [month] => 7
            [post_type] => post
        )

    [41] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 13409
            [post_name] => florida-takes-additional-actions-to-lower-prescription-drug-prices
            [post_title] => Florida Takes Additional Actions to Lower Prescription Drug Prices [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-07-11 00:21:01
            [year] => 2022
            [month] => 7
            [post_type] => post
        )

    [42] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 13382
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-419
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 419)
            [post_author] => 2
            [post_date] => 2022-07-07 11:09:53
            [year] => 2022
            [month] => 7
            [post_type] => post
        )

    [43] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 13346
            [post_name] => big-three-pbm-and-nacds-part-ways
            [post_title] => “Big Three” PBM and National Association of Chain Drug Stores (NACDS) Part Ways
            [post_author] => 2
            [post_date] => 2022-07-06 13:27:23
            [year] => 2022
            [month] => 7
            [post_type] => post
        )

    [44] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 13314
            [post_name] => 300-drugs-now-in-generic-cartel-probe
            [post_title] => 300 drugs now in generic 'cartel' probe [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-07-02 20:56:14
            [year] => 2022
            [month] => 7
            [post_type] => post
        )

    [45] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 13282
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-417-2
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 418)
            [post_author] => 2
            [post_date] => 2022-06-30 12:05:51
            [year] => 2022
            [month] => 6
            [post_type] => post
        )

    [46] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 13244
            [post_name] => prescription-drug-pricing-isnt-the-problem
            [post_title] => Prescription Drug Pricing Isn’t The Problem. Bloomberg Law Has It Wrong.
            [post_author] => 2
            [post_date] => 2022-06-28 19:48:16
            [year] => 2022
            [month] => 6
            [post_type] => post
        )

    [47] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12959
            [post_name] => formulary-steering-prevents-members-from-accessing-generics
            [post_title] => Formulary Steering Prevents Members from Accessing Generics [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-06-24 12:29:56
            [year] => 2022
            [month] => 6
            [post_type] => post
        )

    [48] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 13157
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-417
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 417)
            [post_author] => 2
            [post_date] => 2022-06-23 12:02:24
            [year] => 2022
            [month] => 6
            [post_type] => post
        )

    [49] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 13067
            [post_name] => how-pharmacy-benefit-managers-pbm-make-money
            [post_title] => How Pharmacy Benefit Managers (PBM) Make Money
            [post_author] => 2
            [post_date] => 2022-06-21 19:42:27
            [year] => 2022
            [month] => 6
            [post_type] => post
        )

    [50] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12985
            [post_name] => the-future-of-employer-sponsored-healthcare-plans-is-cost-management
            [post_title] => The Future of Employer Sponsored Healthcare Plans Is Cost Management [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-06-19 16:22:34
            [year] => 2022
            [month] => 6
            [post_type] => post
        )

    [51] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 13000
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-416
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 416)
            [post_author] => 2
            [post_date] => 2022-06-16 11:35:27
            [year] => 2022
            [month] => 6
            [post_type] => post
        )

    [52] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12991
            [post_name] => pbm-formulary-management-tips-three-that-are-meaningful-rerun
            [post_title] => PBM Formulary Management Tips: Three That Are Meaningful [Rerun]
            [post_author] => 2
            [post_date] => 2022-06-14 13:05:09
            [year] => 2022
            [month] => 6
            [post_type] => post
        )

    [53] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12821
            [post_name] => 6-payor-tactics-to-control-drug-spending-weekly-roundup
            [post_title] => 6 Payor Tactics to Control Drug Spending [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-06-10 14:37:34
            [year] => 2022
            [month] => 6
            [post_type] => post
        )

    [54] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 12872
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-415
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 415)
            [post_author] => 2
            [post_date] => 2022-06-09 13:35:43
            [year] => 2022
            [month] => 6
            [post_type] => post
        )

    [55] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12853
            [post_name] => benefits-of-working-with-a-fiduciary-model-pbm-free-webinar
            [post_title] => Benefits of Working with a Fiduciary Model PBM [Free Webinar]
            [post_author] => 2
            [post_date] => 2022-06-08 13:12:38
            [year] => 2022
            [month] => 6
            [post_type] => post
        )

    [56] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12819
            [post_name] => payor-tactics-to-control-drug-spending
            [post_title] => 6 Payor Tactics to Control Drug Spending [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-06-03 20:57:25
            [year] => 2022
            [month] => 6
            [post_type] => post
        )

    [57] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 12780
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-414
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 414)
            [post_author] => 2
            [post_date] => 2022-06-02 08:09:18
            [year] => 2022
            [month] => 6
            [post_type] => post
        )

    [58] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12751
            [post_name] => how-to-calculate-how-much-money-pbms-make
            [post_title] => How Pharmacy Benefit Managers Make Money and What to Do About It [Free Webinar]
            [post_author] => 2
            [post_date] => 2022-05-30 17:36:36
            [year] => 2022
            [month] => 5
            [post_type] => post
        )

    [59] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12711
            [post_name] => anti-competitive-pbm-practices
            [post_title] => Anti-competitive PBM Practices Harming Patients, Payers, and Pharmacies, APCI Tells FTC [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-05-28 15:59:24
            [year] => 2022
            [month] => 5
            [post_type] => post
        )

    [60] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 12706
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-413
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 413)
            [post_author] => 2
            [post_date] => 2022-05-26 13:06:29
            [year] => 2022
            [month] => 5
            [post_type] => post
        )

    [61] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12679
            [post_name] => 6-pbm-performance-metrics-to-hang-your-hat-on
            [post_title] => 6 PBM Performance Metrics to Hang Your Hat On
            [post_author] => 2
            [post_date] => 2022-05-25 14:27:08
            [year] => 2022
            [month] => 5
            [post_type] => post
        )

    [62] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12602
            [post_name] => federal-judge-strikes-down-cms-medicaid-copay-rule
            [post_title] => CMS Medicaid Copay Rule Struck Down by Federal Judge, Handing Drugmakers Major Win [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-05-20 14:49:34
            [year] => 2022
            [month] => 5
            [post_type] => post
        )

    [63] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 12536
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-412
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 412)
            [post_author] => 2
            [post_date] => 2022-05-19 03:29:47
            [year] => 2022
            [month] => 5
            [post_type] => post
        )

    [64] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12505
            [post_name] => 5-questions-to-ask-pbm-finalists-before-announcing-the-winner-of-a-competitive-bidding-process
            [post_title] => 5 Questions to Ask PBM Finalists Before Announcing the Winner of a Competitive Bidding Process
            [post_author] => 2
            [post_date] => 2022-05-17 15:13:49
            [year] => 2022
            [month] => 5
            [post_type] => post
        )

    [65] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12398
            [post_name] => trends-in-specialty-benefit-design
            [post_title] => Trends in Specialty Benefit Design Report Published by PSG [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-05-15 15:47:04
            [year] => 2022
            [month] => 5
            [post_type] => post
        )

    [66] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12446
            [post_name] => generic-substitution-rate-employer-sponsored-prescription-drug-costs
            [post_title] => Generic Substitution Rate (GSR) and Employer-Sponsored Prescription Drug Costs
            [post_author] => 2
            [post_date] => 2022-05-13 14:47:12
            [year] => 2022
            [month] => 5
            [post_type] => post
        )

    [67] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 12422
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-411
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 411)
            [post_author] => 2
            [post_date] => 2022-05-12 12:57:07
            [year] => 2022
            [month] => 5
            [post_type] => post
        )

    [68] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12394
            [post_name] => johnson-and-johnson-sues-saveonsp-for-allegedly-overusing-drug-cost-assistance-program-weekly-roundup
            [post_title] => Johnson and Johnson sues SaveOnSP for allegedly overusing drug cost assistance program [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-05-06 16:39:40
            [year] => 2022
            [month] => 5
            [post_type] => post
        )

    [69] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 12380
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-410
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 410)
            [post_author] => 2
            [post_date] => 2022-05-05 12:32:53
            [year] => 2022
            [month] => 5
            [post_type] => post
        )

    [70] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12370
            [post_name] => how-pbms-make-money-and-what-to-do-about-it-on-demand-video
            [post_title] => How PBMs Make Money and What To Do About It [On-Demand Video]
            [post_author] => 2
            [post_date] => 2022-05-03 18:46:12
            [year] => 2022
            [month] => 5
            [post_type] => post
        )

    [71] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12364
            [post_name] => how-pharmacy-benefit-managers-make-money-and-what-to-do-about-it-free-webinar-4
            [post_title] => How Pharmacy Benefit Managers Make Money and What to Do About It [Free Webinar]
            [post_author] => 2
            [post_date] => 2022-05-01 14:18:05
            [year] => 2022
            [month] => 5
            [post_type] => post
        )

    [72] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12354
            [post_name] => are-drug-copay-coupons-a-form-of-charity-or-a-bribe
            [post_title] => Copay Coupons Charity or a Bribe? [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-04-29 22:50:17
            [year] => 2022
            [month] => 4
            [post_type] => post
        )

    [73] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 12356
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-409
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 409)
            [post_author] => 2
            [post_date] => 2022-04-28 14:49:00
            [year] => 2022
            [month] => 4
            [post_type] => post
        )

    [74] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12349
            [post_name] => pbm-formulary-management-tips
            [post_title] => PBM Formulary Management Tips: Three That Are Meaningful
            [post_author] => 2
            [post_date] => 2022-04-26 20:10:52
            [year] => 2022
            [month] => 4
            [post_type] => post
        )

    [75] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12071
            [post_name] => court-rules-in-favor-of-cigna-over-anthem-in-14-8b-pbm-drug-overcharge-claim-2
            [post_title] => Court Rules in Favor of Cigna Over Anthem in $14.8B PBM Drug Overcharge Claim [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-04-22 13:38:51
            [year] => 2022
            [month] => 4
            [post_type] => post
        )

    [76] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 12339
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-408
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 408)
            [post_author] => 2
            [post_date] => 2022-04-21 11:30:54
            [year] => 2022
            [month] => 4
            [post_type] => post
        )

    [77] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12335
            [post_name] => prior-authorization-for-prescription-drugs-what-you-should-now
            [post_title] => Prior Authorization for Prescription Drugs What You Should Now
            [post_author] => 2
            [post_date] => 2022-04-20 15:52:32
            [year] => 2022
            [month] => 4
            [post_type] => post
        )

    [78] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 12330
            [post_name] => average-wholesale-price-awp-3-reasons-why-it-is-misunderstood
            [post_title] => Average Wholesale Price (AWP) 3 Reasons Why It is Misunderstood
            [post_author] => 2
            [post_date] => 2022-04-14 16:03:57
            [year] => 2022
            [month] => 4
            [post_type] => post
        )

    [79] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 12326
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-407
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 407)
            [post_author] => 2
            [post_date] => 2022-04-14 12:14:46
            [year] => 2022
            [month] => 4
            [post_type] => post
        )

    [80] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 11882
            [post_name] => court-rules-in-favor-of-cigna-over-anthem-in-14-8b-pbm-drug-overcharge-claim
            [post_title] => Court Rules in Favor of Cigna Over Anthem in $14.8B PBM Drug Overcharge Claim
            [post_author] => 2
            [post_date] => 2022-04-08 14:22:06
            [year] => 2022
            [month] => 4
            [post_type] => post
        )

    [81] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 12050
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-406
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 406)
            [post_author] => 2
            [post_date] => 2022-04-07 11:26:47
            [year] => 2022
            [month] => 4
            [post_type] => post
        )

    [82] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 11885
            [post_name] => pbm-performance-guarantees-are-meaningless-unless-constituent-elements-are-spelled-out-tip-of-the-week
            [post_title] => PBM Performance Guarantees are Meaningless Unless Constituent Elements are Spelled Out [Tip of the Week]
            [post_author] => 2
            [post_date] => 2022-04-04 13:57:40
            [year] => 2022
            [month] => 4
            [post_type] => post
        )

    [83] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 11875
            [post_name] => key-differences-between-fiduciary-and-traditional-pbm-business-models-weekly-roundup
            [post_title] => Key Differences Between Fiduciary and Traditional PBM Business Models [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-04-01 20:33:32
            [year] => 2022
            [month] => 4
            [post_type] => post
        )

    [84] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 11787
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-405
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 405)
            [post_author] => 2
            [post_date] => 2022-03-31 12:07:51
            [year] => 2022
            [month] => 3
            [post_type] => post
        )

    [85] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 11715
            [post_name] => how-pharmacy-benefit-managers-make-money-and-what-to-do-about-it-free-webinar-3
            [post_title] => How Pharmacy Benefit Managers Make Money and What To Do About It [Free Webinar]
            [post_author] => 2
            [post_date] => 2022-03-29 20:17:09
            [year] => 2022
            [month] => 3
            [post_type] => post
        )

    [86] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 11706
            [post_name] => 5-best-methods-to-counter-fraud-waste-and-abuse-in-pharmacy-benefits
            [post_title] => 5 Best Methods to Counter Fraud, Waste and Abuse in Pharmacy Benefits
            [post_author] => 2
            [post_date] => 2022-03-28 15:47:55
            [year] => 2022
            [month] => 3
            [post_type] => post
        )

    [87] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 11149
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-404
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 404)
            [post_author] => 2
            [post_date] => 2022-03-12 09:51:17
            [year] => 2022
            [month] => 3
            [post_type] => post
        )

    [88] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9718
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-403
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 403)
            [post_author] => 1
            [post_date] => 2022-03-03 13:33:00
            [year] => 2022
            [month] => 3
            [post_type] => post
        )

    [89] => stdClass Object
        (
            [slug] => transparentrx-tips
            [ID] => 9719
            [post_name] => copayment-coupons-are-adding-to-pharmacy-costs-tip-of-the-week
            [post_title] => Copayment coupons are adding to pharmacy costs [Tip of the Week]
            [post_author] => 2
            [post_date] => 2022-03-01 15:06:00
            [year] => 2022
            [month] => 3
            [post_type] => post
        )

    [90] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9720
            [post_name] => new-study-claims-hospitals-charge-double-for-specialty-drugs-compared-to-pharmacies-weekly-roundup
            [post_title] => New study claims hospitals charge double for specialty drugs compared to pharmacies [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-02-25 14:19:00
            [year] => 2022
            [month] => 2
            [post_type] => post
        )

    [91] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9721
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-402
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 402)
            [post_author] => 1
            [post_date] => 2022-02-24 13:44:00
            [year] => 2022
            [month] => 2
            [post_type] => post
        )

    [92] => stdClass Object
        (
            [slug] => transparentrx-tips
            [ID] => 9722
            [post_name] => every-health-care-plan-sponsor-must-have-a-system-in-place-to-make-sure-drugs-work-tip-of-the-week
            [post_title] => Every Health Care Plan Sponsor Must Have a System in Place to Make Sure Drugs Work [Tip of the Week]
            [post_author] => 2
            [post_date] => 2022-02-23 19:33:00
            [year] => 2022
            [month] => 2
            [post_type] => post
        )

    [93] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9723
            [post_name] => how-pharmacy-benefit-managers-make-money-and-what-to-do-about-it-free-webinar
            [post_title] => How Pharmacy Benefit Managers Make Money and What To Do About It [Free Webinar]
            [post_author] => 2
            [post_date] => 2022-02-21 12:16:00
            [year] => 2022
            [month] => 2
            [post_type] => post
        )

    [94] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9726
            [post_name] => new-expose-reveals-pharmacy-benefit-manager-tactics-that-hurt-patients-providers-employers-and-taxpayers-weekly-roundup
            [post_title] => New Exposé Reveals Pharmacy Benefit Manager Tactics That Hurt Patients, Providers, Employers, and Taxpayers [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-02-20 16:15:00
            [year] => 2022
            [month] => 2
            [post_type] => post
        )

    [95] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9727
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-401
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 401)
            [post_author] => 1
            [post_date] => 2022-02-17 11:11:00
            [year] => 2022
            [month] => 2
            [post_type] => post
        )

    [96] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9728
            [post_name] => pbms-ranked-by-market-share-cvs-caremark-is-no-1-weekly-roundup
            [post_title] => PBMs ranked by market share: CVS Caremark is No. 1 [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-02-12 14:00:00
            [year] => 2022
            [month] => 2
            [post_type] => post
        )

    [97] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9729
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-400
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 400)
            [post_author] => 1
            [post_date] => 2022-02-10 12:10:00
            [year] => 2022
            [month] => 2
            [post_type] => post
        )

    [98] => stdClass Object
        (
            [slug] => transparentrx-tips
            [ID] => 9730
            [post_name] => 4-little-known-ways-to-optimize-drug-spend-tip-of-the-week
            [post_title] => 4 Little Known Ways to Optimize Drug Spend [Tip of the Week]
            [post_author] => 2
            [post_date] => 2022-02-07 21:53:00
            [year] => 2022
            [month] => 2
            [post_type] => post
        )

    [99] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9731
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-399
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 399)
            [post_author] => 1
            [post_date] => 2022-02-03 12:03:00
            [year] => 2022
            [month] => 2
            [post_type] => post
        )

    [100] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9732
            [post_name] => how-pharmacy-benefit-managers-make-money-and-what-to-do-about-it-free-webinar-2
            [post_title] => How Pharmacy Benefit Managers Make Money and What To Do About It [Free Webinar]
            [post_author] => 2
            [post_date] => 2022-02-01 00:20:00
            [year] => 2022
            [month] => 2
            [post_type] => post
        )

    [101] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9733
            [post_name] => billionaire-mark-cuban-steps-up-assault-on-us-prescription-drug-prices-or-is-he-just-another-player-in-the-mail-order-pharmacy-market-weekly-roundup
            [post_title] => Billionaire Mark Cuban steps up assault on US prescription drug prices, or is he just another player in the mail-order pharmacy market? [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-01-29 20:38:00
            [year] => 2022
            [month] => 1
            [post_type] => post
        )

    [102] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9734
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-398
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 398)
            [post_author] => 1
            [post_date] => 2022-01-27 13:16:00
            [year] => 2022
            [month] => 1
            [post_type] => post
        )

    [103] => stdClass Object
        (
            [slug] => benefit-design
            [ID] => 9735
            [post_name] => tip-of-the-week-evouchers-help-circumvent-health-plan-sponsor-benefit-designs-to-get-high-cost-brand-drugs-dispensed
            [post_title] => Tip of the Week: eVouchers help circumvent health plan sponsor benefit designs to get high-cost brand drugs dispensed
            [post_author] => 2
            [post_date] => 2022-01-27 00:56:00
            [year] => 2022
            [month] => 1
            [post_type] => post
        )

    [104] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9736
            [post_name] => issues-arise-as-health-plans-begin-covering-at-home-covid-19-tests-weekly-roundup
            [post_title] => Issues Arise as Health Plans Begin Covering At-Home COVID-19 Tests [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-01-22 22:00:00
            [year] => 2022
            [month] => 1
            [post_type] => post
        )

    [105] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9737
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-397
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 397)
            [post_author] => 1
            [post_date] => 2022-01-20 11:29:00
            [year] => 2022
            [month] => 1
            [post_type] => post
        )

    [106] => stdClass Object
        (
            [slug] => procurement
            [ID] => 9738
            [post_name] => tip-of-the-week-why-ignoring-small-pbms-will-cost-self-insured-employers-time-and-money
            [post_title] => Tip of the Week:  Why Ignoring Small PBMs Will Cost Self-Insured Employers Time and Money
            [post_author] => 2
            [post_date] => 2022-01-18 21:09:00
            [year] => 2022
            [month] => 1
            [post_type] => post
        )

    [107] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9740
            [post_name] => the-case-against-excluding-specialty-drug-coverage-weekly-roundup
            [post_title] => The Case Against Excluding Specialty Drug Coverage [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-01-14 22:05:00
            [year] => 2022
            [month] => 1
            [post_type] => post
        )

    [108] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9741
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-396
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 396)
            [post_author] => 1
            [post_date] => 2022-01-13 12:42:00
            [year] => 2022
            [month] => 1
            [post_type] => post
        )

    [109] => stdClass Object
        (
            [slug] => medical-benefit
            [ID] => 9742
            [post_name] => the-chief-medical-officer-for-cvs-caremark-said-what
            [post_title] => The Chief Medical Officer for CVS Caremark Said What?!
            [post_author] => 2
            [post_date] => 2022-01-11 17:48:00
            [year] => 2022
            [month] => 1
            [post_type] => post
        )

    [110] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9743
            [post_name] => cms-plans-to-regulate-pharmacy-benefit-manager-dir-fees-weekly-roundup
            [post_title] => CMS Plans to Regulate Pharmacy Benefit Manager DIR Fees [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2022-01-07 23:02:00
            [year] => 2022
            [month] => 1
            [post_type] => post
        )

    [111] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9744
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-395
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 395)
            [post_author] => 1
            [post_date] => 2022-01-06 13:32:00
            [year] => 2022
            [month] => 1
            [post_type] => post
        )

    [112] => stdClass Object
        (
            [slug] => copay-accumulator
            [ID] => 9745
            [post_name] => tip-of-the-week-copay-accumulator-programs-are-bad-for-business
            [post_title] => Tip of the Week:  Copay Accumulator Programs are Bad for Business
            [post_author] => 2
            [post_date] => 2022-01-04 15:43:00
            [year] => 2022
            [month] => 1
            [post_type] => post
        )

    [113] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9746
            [post_name] => dir-fees-from-pbms-increased-by-91500-in-just-9-years-weekly-roundup
            [post_title] => DIR fees from PBMs increased by 91,500% in just 9 years [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2021-12-30 22:44:00
            [year] => 2021
            [month] => 12
            [post_type] => post
        )

    [114] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9747
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-394
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 394)
            [post_author] => 1
            [post_date] => 2021-12-30 12:46:00
            [year] => 2021
            [month] => 12
            [post_type] => post
        )

    [115] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9748
            [post_name] => the-untold-truth-how-pharmacy-benefit-managers-make-money-free-webinar
            [post_title] => The Untold Truth: How Pharmacy Benefit Managers Make Money [Free Webinar]
            [post_author] => 2
            [post_date] => 2021-12-27 17:47:00
            [year] => 2021
            [month] => 12
            [post_type] => post
        )

    [116] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9749
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-393
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 393)
            [post_author] => 1
            [post_date] => 2021-12-23 14:17:00
            [year] => 2021
            [month] => 12
            [post_type] => post
        )

    [117] => stdClass Object
        (
            [slug] => radical-transparency
            [ID] => 9750
            [post_name] => the-consolidated-appropriations-act-caa-introduces-broker-compensation-transparency-weekly-roundup
            [post_title] => The Consolidated Appropriations Act (CAA) Introduces Broker Compensation Transparency [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2021-12-17 20:39:00
            [year] => 2021
            [month] => 12
            [post_type] => post
        )

    [118] => stdClass Object
        (
            [slug] => coalitions
            [ID] => 9751
            [post_name] => tip-of-the-week-think-twice-before-joining-a-pbm-drug-pricing-coalition-rerun
            [post_title] => Tip of the Week: Think Twice Before Joining a PBM Drug Pricing Coalition (rerun)
            [post_author] => 2
            [post_date] => 2021-12-14 16:30:00
            [year] => 2021
            [month] => 12
            [post_type] => post
        )

    [119] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9752
            [post_name] => understanding-the-evolving-business-models-and-revenue-of-pharmacy-benefit-managers-weekly-roundup
            [post_title] => Understanding the Evolving Business Models and Revenue of Pharmacy Benefit Managers [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2021-12-11 13:14:00
            [year] => 2021
            [month] => 12
            [post_type] => post
        )

    [120] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9753
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-392
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 392)
            [post_author] => 1
            [post_date] => 2021-12-09 12:33:00
            [year] => 2021
            [month] => 12
            [post_type] => post
        )

    [121] => stdClass Object
        (
            [slug] => information-asymmetry
            [ID] => 9754
            [post_name] => tip-of-the-week-think-twice-before-joining-a-pbm-drug-pricing-coalition
            [post_title] => Tip of the Week:  Think Twice Before Joining a PBM Drug Pricing Coalition
            [post_author] => 2
            [post_date] => 2021-12-07 16:08:00
            [year] => 2021
            [month] => 12
            [post_type] => post
        )

    [122] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9755
            [post_name] => pharmacy-benefit-managers-are-outwitting-attempts-at-accountability-tougher-rules-weekly-roundup
            [post_title] => Pharmacy Benefit Managers are Outwitting Attempts at Accountability, Tougher Rules [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2021-12-03 21:23:00
            [year] => 2021
            [month] => 12
            [post_type] => post
        )

    [123] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9756
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-391
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 391)
            [post_author] => 1
            [post_date] => 2021-12-02 13:55:00
            [year] => 2021
            [month] => 12
            [post_type] => post
        )

    [124] => stdClass Object
        (
            [slug] => dum
            [ID] => 9757
            [post_name] => tip-of-the-week-dont-opt-out-of-step-therapy-programs
            [post_title] => Tip of the Week: Don't Opt-Out of Step Therapy Programs
            [post_author] => 2
            [post_date] => 2021-11-30 18:08:00
            [year] => 2021
            [month] => 11
            [post_type] => post
        )

    [125] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9758
            [post_name] => pharmacy-and-pbm-leader-deloitte-consulting-specialty-drugs-rely-on-personalization-for-optimal-outcomes-weekly-roundup
            [post_title] => Pharmacy and PBM Leader Deloitte Consulting: Specialty Drugs Rely on Personalization for Optimal Outcomes [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2021-11-27 22:42:00
            [year] => 2021
            [month] => 11
            [post_type] => post
        )

    [126] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9759
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-390
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 390)
            [post_author] => 1
            [post_date] => 2021-11-25 13:44:00
            [year] => 2021
            [month] => 11
            [post_type] => post
        )

    [127] => stdClass Object
        (
            [slug] => 340b
            [ID] => 9760
            [post_name] => tip-of-the-week-how-hospitals-and-specialty-pharmacies-get-paid-the-340b-math
            [post_title] => Tip of the Week:  How Hospitals and Specialty Pharmacies Get Paid - The 340B Math
            [post_author] => 2
            [post_date] => 2021-11-23 22:13:00
            [year] => 2021
            [month] => 11
            [post_type] => post
        )

    [128] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9761
            [post_name] => medicaid-specialty-drug-trend-finally-surpasses-50-of-pharmacy-spend-in-most-recent-pharmacy-trend-report-weekly-roundup
            [post_title] => Medicaid Specialty Drug Trend Finally Surpasses 50% of Pharmacy Spend in Most Recent Pharmacy Trend Report [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2021-11-21 14:08:00
            [year] => 2021
            [month] => 11
            [post_type] => post
        )

    [129] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9762
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-389
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 389)
            [post_author] => 1
            [post_date] => 2021-11-18 16:42:00
            [year] => 2021
            [month] => 11
            [post_type] => post
        )

    [130] => stdClass Object
        (
            [slug] => hidden-cash-flows
            [ID] => 9763
            [post_name] => tip-of-the-week-pbms-that-make-money-through-hidden-cash-flows-do-so-at-the-expense-of-client-savings-and-health-of-members
            [post_title] => Tip of the Week: PBMs that make money through hidden cash flows do so at the expense of client savings and health of members
            [post_author] => 2
            [post_date] => 2021-11-16 21:28:00
            [year] => 2021
            [month] => 11
            [post_type] => post
        )

    [131] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9764
            [post_name] => private-insurers-pay-steep-markups-for-hospital-drugs-weekly-roundup
            [post_title] => Private insurers pay steep markups for hospital drugs [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2021-11-12 19:00:00
            [year] => 2021
            [month] => 11
            [post_type] => post
        )

    [132] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9765
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-388
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 388)
            [post_author] => 1
            [post_date] => 2021-11-11 17:21:00
            [year] => 2021
            [month] => 11
            [post_type] => post
        )

    [133] => stdClass Object
        (
            [slug] => transparentrx-tips
            [ID] => 9766
            [post_name] => tip-of-the-week-three-undervalued-pbm-performance-metrics
            [post_title] => Tip of the Week:  Three Undervalued PBM Performance Metrics
            [post_author] => 2
            [post_date] => 2021-11-09 22:27:00
            [year] => 2021
            [month] => 11
            [post_type] => post
        )

    [134] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9767
            [post_name] => employer-strategies-to-manage-costs-for-rare-diseases-weekly-roundup
            [post_title] => Employer strategies to manage costs for rare diseases [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2021-11-07 13:25:00
            [year] => 2021
            [month] => 11
            [post_type] => post
        )

    [135] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9768
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-387
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 387)
            [post_author] => 1
            [post_date] => 2021-11-07 01:26:00
            [year] => 2021
            [month] => 11
            [post_type] => post
        )

    [136] => stdClass Object
        (
            [slug] => switch
            [ID] => 9769
            [post_name] => tip-of-the-week-how-drugmakers-circumvent-benefit-designs-to-get-high-cost-brand-drugs-dispensed-rerun
            [post_title] => Tip of the Week: How drugmakers circumvent benefit designs to get high-cost brand drugs dispensed [Rerun]
            [post_author] => 2
            [post_date] => 2021-11-02 18:14:00
            [year] => 2021
            [month] => 11
            [post_type] => post
        )

    [137] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9770
            [post_name] => the-untold-truth-how-pharmacy-benefit-managers-make-money-free-webinar-2
            [post_title] => The Untold Truth: How Pharmacy Benefit Managers Make Money [Free Webinar]
            [post_author] => 2
            [post_date] => 2021-11-01 22:03:00
            [year] => 2021
            [month] => 11
            [post_type] => post
        )

    [138] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9771
            [post_name] => just-because-a-drug-is-approved-by-the-fda-does-not-mean-it-has-proof-of-efficacy-weekly-roundup
            [post_title] => Just because a drug is approved by the FDA, does not mean it has proof of efficacy [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2021-10-29 18:56:00
            [year] => 2021
            [month] => 10
            [post_type] => post
        )

    [139] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9772
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-386
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 386)
            [post_author] => 1
            [post_date] => 2021-10-28 13:11:00
            [year] => 2021
            [month] => 10
            [post_type] => post
        )

    [140] => stdClass Object
        (
            [slug] => pbm-contracts
            [ID] => 9773
            [post_name] => three-surefire-ways-to-know-if-your-pbm-is-overcharging-you
            [post_title] => Three surefire ways to know if your PBM is overcharging you
            [post_author] => 2
            [post_date] => 2021-10-27 01:51:00
            [year] => 2021
            [month] => 10
            [post_type] => post
        )

    [141] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9774
            [post_name] => an-attorney-shares-the-warning-signs-of-self-serving-pbms-weekly-roundup
            [post_title] => An attorney shares the warning signs of ‘self-serving’ PBMs [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2021-10-22 18:17:00
            [year] => 2021
            [month] => 10
            [post_type] => post
        )

    [142] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9775
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-385
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 385)
            [post_author] => 1
            [post_date] => 2021-10-21 13:45:00
            [year] => 2021
            [month] => 10
            [post_type] => post
        )

    [143] => stdClass Object
        (
            [slug] => mac-list
            [ID] => 9776
            [post_name] => self-funded-employers-have-a-corporate-responsibility-to-understand-mac-lists
            [post_title] => Self-funded employers have a corporate responsibility to understand MAC lists
            [post_author] => 2
            [post_date] => 2021-10-19 16:12:00
            [year] => 2021
            [month] => 10
            [post_type] => post
        )

    [144] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9777
            [post_name] => average-specialty-drug-price-reached-84442-in-2020-rising-more-than-three-times-faster-than-the-prices-of-other-goods-and-services-weekly-roundup
            [post_title] => Average Specialty Drug Price Reached $84,442 in 2020, Rising More Than Three Times Faster Than the Prices of Other Goods and Services [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2021-10-16 16:59:00
            [year] => 2021
            [month] => 10
            [post_type] => post
        )

    [145] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9778
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-384
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 384)
            [post_author] => 1
            [post_date] => 2021-10-14 13:36:00
            [year] => 2021
            [month] => 10
            [post_type] => post
        )

    [146] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9779
            [post_name] => tip-of-the-week-how-pharmacy-benefit-managers-make-money-on-demand-video
            [post_title] => Tip of the Week: How Pharmacy Benefit Managers Make Money [On-Demand Video]
            [post_author] => 2
            [post_date] => 2021-10-12 20:22:00
            [year] => 2021
            [month] => 10
            [post_type] => post
        )

    [147] => stdClass Object
        (
            [slug] => weekly-roundup
            [ID] => 9780
            [post_name] => kansas-audited-its-80-million-prescription-plan-but-its-still-shrouded-in-mystery-weekly-roundup
            [post_title] => Kansas audited its $80 million prescription plan, but it's still shrouded in mystery [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2021-10-10 18:14:00
            [year] => 2021
            [month] => 10
            [post_type] => post
        )

    [148] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9781
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-383
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 383)
            [post_author] => 1
            [post_date] => 2021-10-07 12:11:00
            [year] => 2021
            [month] => 10
            [post_type] => post
        )

    [149] => stdClass Object
        (
            [slug] => pbm-contracts
            [ID] => 9782
            [post_name] => tip-of-the-week-claims-repricings-as-the-primary-tool-in-evaluating-pbm-proposals-is-like-buying-a-used-car-without-ever-looking-under-the-hood-rerun
            [post_title] => Tip of the Week:  Claims Repricings as the Primary Tool in Evaluating PBM Proposals is Like Buying a Used Car Without Ever Looking Under the Hood [Rerun]
            [post_author] => 2
            [post_date] => 2021-10-06 16:59:00
            [year] => 2021
            [month] => 10
            [post_type] => post
        )

    [150] => stdClass Object
        (
            [slug] => hidden-cash-flows
            [ID] => 9783
            [post_name] => how-pbm-rebate-walls-impact-drug-spending-patient-care-and-competition-weekly-roundup
            [post_title] => How PBM “rebate walls” impact drug spending, patient care and competition [Weekly Roundup]
            [post_author] => 2
            [post_date] => 2021-10-02 14:58:00
            [year] => 2021
            [month] => 10
            [post_type] => post
        )

    [151] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9784
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-382
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 382)
            [post_author] => 1
            [post_date] => 2021-09-30 12:29:00
            [year] => 2021
            [month] => 9
            [post_type] => post
        )

    [152] => stdClass Object
        (
            [slug] => specialty-drugs
            [ID] => 9785
            [post_name] => tip-of-the-week-specialty-drugs-have-taken-over-rerun
            [post_title] => Tip of the Week:  Specialty Drugs Have Taken Over (Rerun)
            [post_author] => 2
            [post_date] => 2021-09-28 17:24:00
            [year] => 2021
            [month] => 9
            [post_type] => post
        )

    [153] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9786
            [post_name] => the-untold-truth-how-pharmacy-benefit-managers-make-money-free-webinar-3
            [post_title] => The Untold Truth: How Pharmacy Benefit Managers Make Money [Free Webinar]
            [post_author] => 2
            [post_date] => 2021-09-27 12:50:00
            [year] => 2021
            [month] => 9
            [post_type] => post
        )

    [154] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9787
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-381
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 381)
            [post_author] => 1
            [post_date] => 2021-09-23 11:52:00
            [year] => 2021
            [month] => 9
            [post_type] => post
        )

    [155] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9789
            [post_name] => tip-of-the-week-what-is-spread-pricing-and-how-does-it-affect-a-pbms-revenues
            [post_title] => Tip of the Week:  What is spread pricing, and how does it affect a PBM’s revenues?
            [post_author] => 2
            [post_date] => 2021-09-21 16:08:00
            [year] => 2021
            [month] => 9
            [post_type] => post
        )

    [156] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9791
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-380
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 380)
            [post_author] => 1
            [post_date] => 2021-09-16 14:23:00
            [year] => 2021
            [month] => 9
            [post_type] => post
        )

    [157] => stdClass Object
        (
            [slug] => pbm-services
            [ID] => 9792
            [post_name] => tip-of-the-week-how-pbms-help-rein-in-drug-spending
            [post_title] => Tip of the Week: How PBMs Help Rein in Drug Spending
            [post_author] => 2
            [post_date] => 2021-09-14 14:50:00
            [year] => 2021
            [month] => 9
            [post_type] => post
        )

    [158] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9794
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-379
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 379)
            [post_author] => 1
            [post_date] => 2021-09-09 10:59:00
            [year] => 2021
            [month] => 9
            [post_type] => post
        )

    [159] => stdClass Object
        (
            [slug] => formulary
            [ID] => 9795
            [post_name] => tip-of-the-week-a-good-formulary-is-the-backbone-of-an-efficient-pharmacy-benefit-program
            [post_title] => Tip of the Week: A Good Formulary is the Backbone of an Efficient Pharmacy Benefit Program
            [post_author] => 2
            [post_date] => 2021-09-07 15:23:00
            [year] => 2021
            [month] => 9
            [post_type] => post
        )

    [160] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9797
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-379-2
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 379)
            [post_author] => 1
            [post_date] => 2021-09-02 12:27:00
            [year] => 2021
            [month] => 9
            [post_type] => post
        )

    [161] => stdClass Object
        (
            [slug] => management-fee
            [ID] => 9798
            [post_name] => tip-of-the-week-how-to-eliminate-huge-pbm-markups-and-reduce-pharmacy-costs-by-50
            [post_title] => Tip of the Week: How to Eliminate Huge PBM Markups and Reduce Pharmacy Costs by 50%
            [post_author] => 2
            [post_date] => 2021-08-31 16:19:00
            [year] => 2021
            [month] => 8
            [post_type] => post
        )

    [162] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9799
            [post_name] => the-untold-truth-how-pharmacy-benefit-managers-make-money-free-webinar-4
            [post_title] => The Untold Truth: How Pharmacy Benefit Managers Make Money [Free Webinar]
            [post_author] => 2
            [post_date] => 2021-08-29 23:27:00
            [year] => 2021
            [month] => 8
            [post_type] => post
        )

    [163] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9801
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-378
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 378)
            [post_author] => 1
            [post_date] => 2021-08-25 14:29:00
            [year] => 2021
            [month] => 8
            [post_type] => post
        )

    [164] => stdClass Object
        (
            [slug] => switch
            [ID] => 9802
            [post_name] => tip-of-the-week-drugmakers-circumvent-health-plan-sponsor-benefit-designs-at-the-switch-to-get-high-cost-brand-drugs-dispensed
            [post_title] => Tip of the Week: Drugmakers circumvent health plan sponsor benefit designs, at the switch, to get high-cost brand drugs dispensed
            [post_author] => 2
            [post_date] => 2021-08-24 18:42:00
            [year] => 2021
            [month] => 8
            [post_type] => post
        )

    [165] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9803
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-377
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 377)
            [post_author] => 1
            [post_date] => 2021-08-18 16:59:00
            [year] => 2021
            [month] => 8
            [post_type] => post
        )

    [166] => stdClass Object
        (
            [slug] => fwa
            [ID] => 9804
            [post_name] => ohio-awards-contract-worth-billions-to-the-same-company-it-accused-of-fraud-and-was-later-paid-88-million-as-a-result
            [post_title] => Ohio awards contract worth billions to the same company it accused of fraud and was later paid $88 million as a result
            [post_author] => 2
            [post_date] => 2021-08-18 16:05:00
            [year] => 2021
            [month] => 8
            [post_type] => post
        )

    [167] => stdClass Object
        (
            [slug] => pricing
            [ID] => 9805
            [post_name] => 10-definitions-related-to-prescription-drug-prices-all-purchasers-of-pbm-services-should-know
            [post_title] => 10 Definitions, Related to Prescription Drug Prices, All Purchasers of PBM Services Should Know
            [post_author] => 2
            [post_date] => 2021-08-17 13:53:00
            [year] => 2021
            [month] => 8
            [post_type] => post
        )

    [168] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9806
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-376
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 376)
            [post_author] => 1
            [post_date] => 2021-08-12 12:03:00
            [year] => 2021
            [month] => 8
            [post_type] => post
        )

    [169] => stdClass Object
        (
            [slug] => wasteful-spending
            [ID] => 9808
            [post_name] => tip-of-the-week-the-health-plan-sponsor-hiring-a-pbm-always-has-the-final-say-on-contract-terms
            [post_title] => Tip of the Week: The health plan sponsor hiring a PBM always has the final say on contract terms
            [post_author] => 2
            [post_date] => 2021-08-10 20:57:00
            [year] => 2021
            [month] => 8
            [post_type] => post
        )

    [170] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9810
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-375
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 375)
            [post_author] => 1
            [post_date] => 2021-08-05 11:16:00
            [year] => 2021
            [month] => 8
            [post_type] => post
        )

    [171] => stdClass Object
        (
            [slug] => quiz
            [ID] => 9811
            [post_name] => tip-of-the-week-education-is-the-most-logical-and-effective-foundation-for-achieving-maximum-value-in-pharmacy-benefit-management-pbm-services
            [post_title] => Tip of the Week: Education is the most logical and effective foundation for achieving maximum value in pharmacy benefit management (PBM) services.
            [post_author] => 2
            [post_date] => 2021-08-03 16:25:00
            [year] => 2021
            [month] => 8
            [post_type] => post
        )

    [172] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9812
            [post_name] => the-untold-truth-how-pharmacy-benefit-managers-make-money-free-webinar-5
            [post_title] => The Untold Truth: How Pharmacy Benefit Managers Make Money [Free Webinar]
            [post_author] => 2
            [post_date] => 2021-07-30 20:18:00
            [year] => 2021
            [month] => 7
            [post_type] => post
        )

    [173] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9814
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-374
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 374)
            [post_author] => 1
            [post_date] => 2021-07-29 13:06:00
            [year] => 2021
            [month] => 7
            [post_type] => post
        )

    [174] => stdClass Object
        (
            [slug] => strategy
            [ID] => 9816
            [post_name] => tip-of-the-week-non-fiduciary-pbms-hedge-against-their-legacy-business-models
            [post_title] => Tip of the Week: Non-Fiduciary PBMs Hedge Against Their Legacy Business Models
            [post_author] => 2
            [post_date] => 2021-07-27 12:50:00
            [year] => 2021
            [month] => 7
            [post_type] => post
        )

    [175] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9817
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-374-2
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 374)
            [post_author] => 1
            [post_date] => 2021-07-22 13:59:00
            [year] => 2021
            [month] => 7
            [post_type] => post
        )

    [176] => stdClass Object
        (
            [slug] => specialty-drugs
            [ID] => 9818
            [post_name] => tip-of-the-week-the-specialty-drug-pipeline-will-make-you-rethink-your-pharmacy-benefits-management-strategy
            [post_title] => Tip of the Week:  The Specialty Drug Pipeline Will Make You Rethink Your Pharmacy Benefits Management Strategy
            [post_author] => 2
            [post_date] => 2021-07-20 19:56:00
            [year] => 2021
            [month] => 7
            [post_type] => post
        )

    [177] => stdClass Object
        (
            [slug] => hidden-cash-flows
            [ID] => 9819
            [post_name] => costco-approach-could-have-saved-medicare-2-6-billion-in-drug-spending-analysis-shows
            [post_title] => Costco approach could have saved Medicare $2.6 billion in drug spending, analysis shows
            [post_author] => 2
            [post_date] => 2021-07-16 16:46:00
            [year] => 2021
            [month] => 7
            [post_type] => post
        )

    [178] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9820
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-373
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 373)
            [post_author] => 1
            [post_date] => 2021-07-15 13:16:00
            [year] => 2021
            [month] => 7
            [post_type] => post
        )

    [179] => stdClass Object
        (
            [slug] => fiduciary-pbm
            [ID] => 9822
            [post_name] => tip-of-the-week-fiduciary-model-pharmacy-benefit-managers-pbm-are-a-thing
            [post_title] => Tip of the Week:  Fiduciary Model Pharmacy Benefit Managers (PBM) are a Thing
            [post_author] => 2
            [post_date] => 2021-07-13 15:30:00
            [year] => 2021
            [month] => 7
            [post_type] => post
        )

    [180] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9823
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-373-2
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 373)
            [post_author] => 1
            [post_date] => 2021-07-08 12:10:00
            [year] => 2021
            [month] => 7
            [post_type] => post
        )

    [181] => stdClass Object
        (
            [slug] => specialty-drugs
            [ID] => 9824
            [post_name] => tip-of-the-week-pharmaceutical-manufacturers-are-light-years-ahead-of-commercial-and-public-sector-employers-unions-health-plans-and-health-systems
            [post_title] => Tip of the Week: Pharmaceutical Manufacturers are Light Years Ahead of Commercial and Public Sector Employers, Unions, Health Plans and Health Systems
            [post_author] => 2
            [post_date] => 2021-07-06 13:34:00
            [year] => 2021
            [month] => 7
            [post_type] => post
        )

    [182] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9825
            [post_name] => free-webinar-the-untold-truth-how-pharmacy-benefit-managers-make-money
            [post_title] => [Free Webinar] The Untold Truth: How Pharmacy Benefit Managers Make Money
            [post_author] => 2
            [post_date] => 2021-07-02 15:15:00
            [year] => 2021
            [month] => 7
            [post_type] => post
        )

    [183] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9827
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-372
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 372)
            [post_author] => 1
            [post_date] => 2021-06-30 23:08:00
            [year] => 2021
            [month] => 6
            [post_type] => post
        )

    [184] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9829
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-371
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 371)
            [post_author] => 1
            [post_date] => 2021-06-24 11:50:00
            [year] => 2021
            [month] => 6
            [post_type] => post
        )

    [185] => stdClass Object
        (
            [slug] => pharmacy-network
            [ID] => 9831
            [post_name] => aids-healthcare-foundation-ahf-files-federal-antitrust-lawsuit-against-buca-pbm
            [post_title] => AIDS Healthcare Foundation (AHF) Files Federal Antitrust Lawsuit Against BUCA PBM
            [post_author] => 2
            [post_date] => 2021-06-22 14:34:00
            [year] => 2021
            [month] => 6
            [post_type] => post
        )

    [186] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9832
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-370
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 370)
            [post_author] => 1
            [post_date] => 2021-06-17 10:55:00
            [year] => 2021
            [month] => 6
            [post_type] => post
        )

    [187] => stdClass Object
        (
            [slug] => fiduciary-pbm
            [ID] => 9833
            [post_name] => mississippi-ag-files-lawsuit-against-insulin-manufacturers-and-pbms-over-insulin-pricing-scheme
            [post_title] => Mississippi AG Files Lawsuit Against Insulin Manufacturers and PBMs over Insulin Pricing Scheme
            [post_author] => 2
            [post_date] => 2021-06-16 17:12:00
            [year] => 2021
            [month] => 6
            [post_type] => post
        )

    [188] => stdClass Object
        (
            [slug] => spread-pricing
            [ID] => 9834
            [post_name] => pbm-agrees-to-pay-a-record-88-3-million-to-settle-ohio-case
            [post_title] => PBM Agrees to Pay a Record $88.3 Million to Settle Ohio Case
            [post_author] => 2
            [post_date] => 2021-06-15 17:57:00
            [year] => 2021
            [month] => 6
            [post_type] => post
        )

    [189] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9835
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-369
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 369)
            [post_author] => 1
            [post_date] => 2021-06-10 12:32:00
            [year] => 2021
            [month] => 6
            [post_type] => post
        )

    [190] => stdClass Object
        (
            [slug] => specialty-drugs
            [ID] => 9837
            [post_name] => tuesday-tip-of-the-week-specialty-drugs-have-taken-over
            [post_title] => Tuesday Tip of the Week:  Specialty Drugs Have Taken Over
            [post_author] => 2
            [post_date] => 2021-06-08 15:32:00
            [year] => 2021
            [month] => 6
            [post_type] => post
        )

    [191] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9840
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-368
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 368)
            [post_author] => 1
            [post_date] => 2021-06-03 13:23:00
            [year] => 2021
            [month] => 6
            [post_type] => post
        )

    [192] => stdClass Object
        (
            [slug] => customer-satisfaction
            [ID] => 9841
            [post_name] => tip-of-the-week-smaller-pbms-grade-higher-on-customer-satisfaction
            [post_title] => Tip of the Week: Smaller PBMs Grade Higher on Customer Satisfaction
            [post_author] => 2
            [post_date] => 2021-06-02 20:28:00
            [year] => 2021
            [month] => 6
            [post_type] => post
        )

    [193] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9844
            [post_name] => the-untold-truth-how-pharmacy-benefit-managers-make-money-free-webinar-6
            [post_title] => The Untold Truth: How Pharmacy Benefit Managers Make Money [Free Webinar]
            [post_author] => 2
            [post_date] => 2021-05-31 16:22:00
            [year] => 2021
            [month] => 5
            [post_type] => post
        )

    [194] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9846
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-367
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 367)
            [post_author] => 1
            [post_date] => 2021-05-27 11:45:00
            [year] => 2021
            [month] => 5
            [post_type] => post
        )

    [195] => stdClass Object
        (
            [slug] => claims-repricing
            [ID] => 9847
            [post_name] => tip-of-the-week-claims-repricings-should-not-be-your-most-important-tool-in-evaluating-pbm-proposals
            [post_title] => Tip of the Week: Claims Repricings Should Not Be Your Most Important Tool in Evaluating PBM Proposals
            [post_author] => 2
            [post_date] => 2021-05-25 11:31:00
            [year] => 2021
            [month] => 5
            [post_type] => post
        )

    [196] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9850
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-366
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 366)
            [post_author] => 1
            [post_date] => 2021-05-20 13:39:00
            [year] => 2021
            [month] => 5
            [post_type] => post
        )

    [197] => stdClass Object
        (
            [slug] => evaluate-pbm-performance
            [ID] => 9852
            [post_name] => tip-of-the-week-money-is-good-information-is-better-rerun
            [post_title] => Tip of the Week:  Money is good, Information is better [rerun]
            [post_author] => 2
            [post_date] => 2021-05-18 21:56:00
            [year] => 2021
            [month] => 5
            [post_type] => post
        )

    [198] => stdClass Object
        (
            [slug] => pbm-business-models
            [ID] => 9853
            [post_name] => large-pbm-under-fire-for-not-accurately-disclosing-the-true-cost-of-its-pbm-services
            [post_title] => Large PBM Under Fire for Not Accurately Disclosing the True Cost of its PBM Services
            [post_author] => 2
            [post_date] => 2021-05-17 15:06:00
            [year] => 2021
            [month] => 5
            [post_type] => post
        )

    [199] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9854
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-365
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 365)
            [post_author] => 1
            [post_date] => 2021-05-13 12:33:00
            [year] => 2021
            [month] => 5
            [post_type] => post
        )

    [200] => stdClass Object
        (
            [slug] => fiduciary-pbm
            [ID] => 9855
            [post_name] => whats-worse-than-overpaying-for-pharmacy-benefits-believing-you-arent
            [post_title] => What's Worse Than Overpaying for Pharmacy Benefits? Believing You Aren't.
            [post_author] => 2
            [post_date] => 2021-05-12 21:04:00
            [year] => 2021
            [month] => 5
            [post_type] => post
        )

    [201] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9856
            [post_name] => tuesday-tip-of-the-week-how-pharmacy-benefit-managers-make-money-video
            [post_title] => Tuesday Tip of the Week: How Pharmacy Benefit Managers Make Money [Video]
            [post_author] => 2
            [post_date] => 2021-05-11 20:13:00
            [year] => 2021
            [month] => 5
            [post_type] => post
        )

    [202] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9858
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-364
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 364)
            [post_author] => 1
            [post_date] => 2021-05-06 12:18:00
            [year] => 2021
            [month] => 5
            [post_type] => post
        )

    [203] => stdClass Object
        (
            [slug] => management-fee
            [ID] => 9859
            [post_name] => tuesday-tip-of-the-week-dig-deeper-into-your-non-fiduciary-pbms-financial-shenanigans
            [post_title] => Tuesday Tip of the Week: Dig Deeper into Your Non-Fiduciary PBM's Financial Shenanigans
            [post_author] => 2
            [post_date] => 2021-05-04 20:56:00
            [year] => 2021
            [month] => 5
            [post_type] => post
        )

    [204] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9860
            [post_name] => free-webinar-the-untold-truth-how-pharmacy-benefit-managers-make-money-2
            [post_title] => [Free Webinar] The Untold Truth: How Pharmacy Benefit Managers Make Money
            [post_author] => 2
            [post_date] => 2021-05-03 12:23:00
            [year] => 2021
            [month] => 5
            [post_type] => post
        )

    [205] => stdClass Object
        (
            [slug] => fiduciary-pbm
            [ID] => 9861
            [post_name] => aids-healthcare-foundation-taking-tough-stance-on-pbms-pharmacy-benefit-manipulators-really
            [post_title] => AIDS Healthcare Foundation Taking Tough Stance on PBMs - Pharmacy Benefit Manipulators, Really?
            [post_author] => 2
            [post_date] => 2021-04-30 21:55:00
            [year] => 2021
            [month] => 4
            [post_type] => post
        )

    [206] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9862
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-363
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 363)
            [post_author] => 1
            [post_date] => 2021-04-29 11:54:00
            [year] => 2021
            [month] => 4
            [post_type] => post
        )

    [207] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9863
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-362
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 362)
            [post_author] => 1
            [post_date] => 2021-04-22 12:05:00
            [year] => 2021
            [month] => 4
            [post_type] => post
        )

    [208] => stdClass Object
        (
            [slug] => transparentrx-tips
            [ID] => 9864
            [post_name] => tuesday-tip-of-the-week-8-considerations-during-annual-pbm-reviews
            [post_title] => Tuesday Tip of the Week: 8 Considerations During Annual PBM Reviews
            [post_author] => 2
            [post_date] => 2021-04-20 12:42:00
            [year] => 2021
            [month] => 4
            [post_type] => post
        )

    [209] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9866
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-361
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 361)
            [post_author] => 1
            [post_date] => 2021-04-15 13:20:00
            [year] => 2021
            [month] => 4
            [post_type] => post
        )

    [210] => stdClass Object
        (
            [slug] => drug-trend-report
            [ID] => 9867
            [post_name] => tuesday-tip-of-the-week-pbms-are-under-attack-but-commercial-employers-get-little-help
            [post_title] => Tuesday Tip of the Week:  PBMs are Under Attack But Commercial Employers Get Little Help
            [post_author] => 2
            [post_date] => 2021-04-13 23:29:00
            [year] => 2021
            [month] => 4
            [post_type] => post
        )

    [211] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9869
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-360
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 360)
            [post_author] => 1
            [post_date] => 2021-04-08 12:31:00
            [year] => 2021
            [month] => 4
            [post_type] => post
        )

    [212] => stdClass Object
        (
            [slug] => radical-pbm-transparency
            [ID] => 9870
            [post_name] => tuesday-tip-of-the-week-benefits-of-working-with-a-fiduciary-model-pbm
            [post_title] => Tuesday Tip of the Week:  Benefits of Working with a Fiduciary-Model PBM
            [post_author] => 2
            [post_date] => 2021-04-06 15:51:00
            [year] => 2021
            [month] => 4
            [post_type] => post
        )

    [213] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9873
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-359
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 359)
            [post_author] => 1
            [post_date] => 2021-04-01 12:08:00
            [year] => 2021
            [month] => 4
            [post_type] => post
        )

    [214] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 9875
            [post_name] => tip-of-the-week-pass-through-and-transparent-pbm-business-models-are-small-ideas-re-run
            [post_title] => Tip of the Week: Pass-Through and Transparent PBM Business Models are Small Ideas (Re-run)
            [post_author] => 2
            [post_date] => 2021-03-31 13:53:00
            [year] => 2021
            [month] => 3
            [post_type] => post
        )

    [215] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9878
            [post_name] => free-webinar-the-untold-truth-how-pharmacy-benefit-managers-make-money-3
            [post_title] => [Free Webinar] The Untold Truth: How Pharmacy Benefit Managers Make Money
            [post_author] => 2
            [post_date] => 2021-03-26 21:42:00
            [year] => 2021
            [month] => 3
            [post_type] => post
        )

    [216] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9879
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-358
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 358)
            [post_author] => 1
            [post_date] => 2021-03-25 12:30:00
            [year] => 2021
            [month] => 3
            [post_type] => post
        )

    [217] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 9880
            [post_name] => tuesday-tip-of-the-week-it-is-a-myth-that-any-pharmacy-benefit-manager-offers-better-price-savings-because-of-their-size-rerun
            [post_title] => Tuesday Tip of the Week:  It is a Myth That Any Pharmacy Benefit Manager Offers Better Price Savings Because of Their Size (Rerun)
            [post_author] => 2
            [post_date] => 2021-03-23 23:46:00
            [year] => 2021
            [month] => 3
            [post_type] => post
        )

    [218] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9881
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-357
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 357)
            [post_author] => 1
            [post_date] => 2021-03-18 12:48:00
            [year] => 2021
            [month] => 3
            [post_type] => post
        )

    [219] => stdClass Object
        (
            [slug] => admin-fees
            [ID] => 9882
            [post_name] => tuesday-tip-of-the-week-dont-turn-a-blind-eye-to-pbm-management-fees
            [post_title] => Tuesday Tip of the Week:  Don't Turn a Blind Eye to PBM Management Fees
            [post_author] => 2
            [post_date] => 2021-03-16 20:26:00
            [year] => 2021
            [month] => 3
            [post_type] => post
        )

    [220] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9883
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-356
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 356)
            [post_author] => 1
            [post_date] => 2021-03-11 12:18:00
            [year] => 2021
            [month] => 3
            [post_type] => post
        )

    [221] => stdClass Object
        (
            [slug] => evaluate-pbm-performance
            [ID] => 9884
            [post_name] => tuesday-tip-of-the-week-pbms-are-the-only-check-on-drug-manufacturers-ability-to-increase-drug-costs
            [post_title] => Tuesday Tip of the Week: PBM’s are the Only Check on Drug Manufacturers’ Ability to Increase Drug Costs
            [post_author] => 2
            [post_date] => 2021-03-09 13:36:00
            [year] => 2021
            [month] => 3
            [post_type] => post
        )

    [222] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9885
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-355
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 355)
            [post_author] => 1
            [post_date] => 2021-03-04 12:33:00
            [year] => 2021
            [month] => 3
            [post_type] => post
        )

    [223] => stdClass Object
        (
            [slug] => rebates
            [ID] => 9886
            [post_name] => tuesday-tip-of-the-week-vertically-integrated-insurers-pivot-to-protect-drug-manufacturer-revenue
            [post_title] => Tuesday Tip of the Week: Vertically Integrated Insurers Pivot to Protect Drug Manufacturer Revenue
            [post_author] => 2
            [post_date] => 2021-03-02 14:49:00
            [year] => 2021
            [month] => 3
            [post_type] => post
        )

    [224] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9887
            [post_name] => free-webinar-the-untold-truth-how-pharmacy-benefit-managers-make-money-4
            [post_title] => [Free Webinar] The Untold Truth: How Pharmacy Benefit Managers Make Money
            [post_author] => 2
            [post_date] => 2021-03-01 17:41:00
            [year] => 2021
            [month] => 3
            [post_type] => post
        )

    [225] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9888
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-354
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 354)
            [post_author] => 1
            [post_date] => 2021-02-25 12:49:00
            [year] => 2021
            [month] => 2
            [post_type] => post
        )

    [226] => stdClass Object
        (
            [slug] => benefit-design
            [ID] => 9889
            [post_name] => tuesday-tip-of-the-week-3-ways-savings-could-be-achieved-by-improving-pharmacy-benefit-design-and-management-rerun
            [post_title] => Tuesday Tip of the Week:  3 Ways Savings Could be Achieved by Improving Pharmacy Benefit Design and Management (Rerun)
            [post_author] => 2
            [post_date] => 2021-02-24 02:10:00
            [year] => 2021
            [month] => 2
            [post_type] => post
        )

    [227] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9890
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-353
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 353)
            [post_author] => 1
            [post_date] => 2021-02-18 13:05:00
            [year] => 2021
            [month] => 2
            [post_type] => post
        )

    [228] => stdClass Object
        (
            [slug] => specialty-drugs
            [ID] => 9891
            [post_name] => tuesday-tip-of-the-week-optimize-specialty-contracting-to-control-costs-and-improve-patient-outcomes
            [post_title] => Tuesday Tip of the Week: Optimize Specialty Contracting to Control Costs and Improve Patient Outcomes
            [post_author] => 2
            [post_date] => 2021-02-16 15:43:00
            [year] => 2021
            [month] => 2
            [post_type] => post
        )

    [229] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9892
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-352
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 352)
            [post_author] => 1
            [post_date] => 2021-02-11 13:15:00
            [year] => 2021
            [month] => 2
            [post_type] => post
        )

    [230] => stdClass Object
        (
            [slug] => information-asymmetry
            [ID] => 9893
            [post_name] => tuesday-tip-of-the-week-money-is-good-information-is-better
            [post_title] => Tuesday Tip of the Week:  Money is Good, Information is Better
            [post_author] => 2
            [post_date] => 2021-02-09 16:06:00
            [year] => 2021
            [month] => 2
            [post_type] => post
        )

    [231] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9895
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-351
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 351)
            [post_author] => 1
            [post_date] => 2021-02-04 12:48:00
            [year] => 2021
            [month] => 2
            [post_type] => post
        )

    [232] => stdClass Object
        (
            [slug] => rebates
            [ID] => 9896
            [post_name] => auditor-claims-non-fiduciary-pharmacy-benefit-manager-hiked-drug-prices-by-1-6-million-with-rebate-credit-program
            [post_title] => Auditor Claims Non-Fiduciary Pharmacy Benefit Manager Hiked Drug Prices by $1.6 million with Rebate Credit Program
            [post_author] => 2
            [post_date] => 2021-02-03 18:25:00
            [year] => 2021
            [month] => 2
            [post_type] => post
        )

    [233] => stdClass Object
        (
            [slug] => rebates
            [ID] => 9897
            [post_name] => tuesday-tip-of-the-week-drug-manufacturer-rebates-have-never-been-the-problem
            [post_title] => Tuesday Tip of the Week:  Drug Manufacturer Rebates Have Never Been the Problem
            [post_author] => 2
            [post_date] => 2021-02-02 14:28:00
            [year] => 2021
            [month] => 2
            [post_type] => post
        )

    [234] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9898
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-350
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 350)
            [post_author] => 1
            [post_date] => 2021-01-28 12:34:00
            [year] => 2021
            [month] => 1
            [post_type] => post
        )

    [235] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9899
            [post_name] => free-webinar-the-untold-truth-how-pharmacy-benefit-managers-make-money-5
            [post_title] => [Free Webinar] The Untold Truth: How Pharmacy Benefit Managers Make Money
            [post_author] => 2
            [post_date] => 2021-01-26 23:26:00
            [year] => 2021
            [month] => 1
            [post_type] => post
        )

    [236] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9900
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-349
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 349)
            [post_author] => 1
            [post_date] => 2021-01-21 12:45:00
            [year] => 2021
            [month] => 1
            [post_type] => post
        )

    [237] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9901
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-348
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 348)
            [post_author] => 1
            [post_date] => 2021-01-14 12:34:00
            [year] => 2021
            [month] => 1
            [post_type] => post
        )

    [238] => stdClass Object
        (
            [slug] => pbm-contracts
            [ID] => 9902
            [post_name] => tuesday-tip-of-the-week-it-is-a-myth-that-any-pharmacy-benefit-manager-offers-better-price-savings-because-of-their-size
            [post_title] => Tuesday Tip of the Week:  It is a Myth That Any Pharmacy Benefit Manager Offers Better Price Savings Because of Their Size
            [post_author] => 2
            [post_date] => 2021-01-13 00:13:00
            [year] => 2021
            [month] => 1
            [post_type] => post
        )

    [239] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9903
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-347
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 347)
            [post_author] => 1
            [post_date] => 2021-01-07 12:07:00
            [year] => 2021
            [month] => 1
            [post_type] => post
        )

    [240] => stdClass Object
        (
            [slug] => benefit-design
            [ID] => 9904
            [post_name] => tuesday-tip-of-the-week-expanded-drug-lists-are-an-excessive-pharmacy-cost-driver
            [post_title] => Tuesday Tip of the Week:  Expanded Drug Lists are an Excessive Pharmacy Cost Driver
            [post_author] => 2
            [post_date] => 2021-01-06 04:03:00
            [year] => 2021
            [month] => 1
            [post_type] => post
        )

    [241] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9906
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-346
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 346)
            [post_author] => 1
            [post_date] => 2020-12-31 12:53:00
            [year] => 2020
            [month] => 12
            [post_type] => post
        )

    [242] => stdClass Object
        (
            [slug] => hidden-cash-flows
            [ID] => 9907
            [post_name] => study-finds-non-fiduciary-pbms-are-draining-floridas-medicaid-funds
            [post_title] => Study Finds Non-Fiduciary PBMs are Draining Florida’s Medicaid Funds
            [post_author] => 2
            [post_date] => 2020-12-30 16:25:00
            [year] => 2020
            [month] => 12
            [post_type] => post
        )

    [243] => stdClass Object
        (
            [slug] => how-to-reduce-prescription-drug-costs
            [ID] => 9909
            [post_name] => internal-email-shows-big-three-pbm-was-overcharging-and-knew-it
            [post_title] => Internal Email Shows Big Three PBM Was Overcharging – And Knew It
            [post_author] => 2
            [post_date] => 2020-12-29 14:00:00
            [year] => 2020
            [month] => 12
            [post_type] => post
        )

    [244] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9910
            [post_name] => free-webinar-the-untold-truth-how-pharmacy-benefit-managers-make-money-6
            [post_title] => [Free Webinar] The Untold Truth: How Pharmacy Benefit Managers Make Money
            [post_author] => 2
            [post_date] => 2020-12-28 22:36:00
            [year] => 2020
            [month] => 12
            [post_type] => post
        )

    [245] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9913
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-345
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 345)
            [post_author] => 1
            [post_date] => 2020-12-24 13:19:00
            [year] => 2020
            [month] => 12
            [post_type] => post
        )

    [246] => stdClass Object
        (
            [slug] => spread-pricing
            [ID] => 9914
            [post_name] => tuesday-tip-of-the-week-commercial-employers-pay-more-than-public-sector-employers-in-spread-pricing
            [post_title] => Tuesday Tip of the Week:  Commercial Employers Pay More Than Public Sector Employers in Spread Pricing
            [post_author] => 2
            [post_date] => 2020-12-22 23:41:00
            [year] => 2020
            [month] => 12
            [post_type] => post
        )

    [247] => stdClass Object
        (
            [slug] => generic-drugs
            [ID] => 9916
            [post_name] => self-funded-employers-your-generic-dispense-rate-gdr-should-be-90-or-higher
            [post_title] => Self-Funded Employers:  Your Generic Dispense Rate (GDR) Should be 90% or Higher
            [post_author] => 2
            [post_date] => 2020-12-18 18:39:00
            [year] => 2020
            [month] => 12
            [post_type] => post
        )

    [248] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9917
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-344
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 344)
            [post_author] => 1
            [post_date] => 2020-12-17 13:19:00
            [year] => 2020
            [month] => 12
            [post_type] => post
        )

    [249] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9918
            [post_name] => tuesday-tip-of-the-week-the-untold-truth-how-non-fiduciary-pbms-make-money-volume-153
            [post_title] => Tuesday Tip of the Week: The Untold Truth How Non-Fiduciary PBMs Make Money [Volume 153]
            [post_author] => 2
            [post_date] => 2020-12-16 00:27:00
            [year] => 2020
            [month] => 12
            [post_type] => post
        )

    [250] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9919
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-343
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 343)
            [post_author] => 2
            [post_date] => 2020-12-10 13:48:00
            [year] => 2020
            [month] => 12
            [post_type] => post
        )

    [251] => stdClass Object
        (
            [slug] => cost-sharing
            [ID] => 9920
            [post_name] => what-is-a-copay-accumulator-program-and-how-does-it-work
            [post_title] => What is a Copay Accumulator Program and How Does It Work?
            [post_author] => 2
            [post_date] => 2020-12-09 16:38:00
            [year] => 2020
            [month] => 12
            [post_type] => post
        )

    [252] => stdClass Object
        (
            [slug] => rfp
            [ID] => 9921
            [post_name] => tip-of-the-week-dos-and-donts-of-pbm-rfps
            [post_title] => Tip of the Week:  Do's and Don'ts of PBM RFPs
            [post_author] => 2
            [post_date] => 2020-12-09 03:17:00
            [year] => 2020
            [month] => 12
            [post_type] => post
        )

    [253] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9922
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-342
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 342)
            [post_author] => 2
            [post_date] => 2020-12-03 13:13:00
            [year] => 2020
            [month] => 12
            [post_type] => post
        )

    [254] => stdClass Object
        (
            [slug] => good-stewardship
            [ID] => 9923
            [post_name] => tuesday-tip-of-the-week-3-ways-for-employers-and-hr-pros-to-know-if-they-have-selected-the-right-insurance-broker-for-pharmacy-benefits
            [post_title] => Tuesday Tip of the Week:  3 Ways for Employers and HR Pros to Know If They Have Selected the Right Insurance Broker for Pharmacy Benefits
            [post_author] => 2
            [post_date] => 2020-12-01 20:11:00
            [year] => 2020
            [month] => 12
            [post_type] => post
        )

    [255] => stdClass Object
        (
            [slug] => hidden-cash-flows
            [ID] => 9924
            [post_name] => ohio-requesting-bids-for-administrator-to-oversee-its-pharmacy-benefit-program
            [post_title] => Ohio Requesting Bids for Administrator to Oversee its Pharmacy Benefit Program
            [post_author] => 2
            [post_date] => 2020-11-30 16:59:00
            [year] => 2020
            [month] => 11
            [post_type] => post
        )

    [256] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9925
            [post_name] => free-webinar-the-untold-truth-how-pharmacy-benefit-managers-make-money-7
            [post_title] => [Free Webinar] The Untold Truth: How Pharmacy Benefit Managers Make Money
            [post_author] => 2
            [post_date] => 2020-11-28 14:03:00
            [year] => 2020
            [month] => 11
            [post_type] => post
        )

    [257] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9926
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-341
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 341)
            [post_author] => 2
            [post_date] => 2020-11-27 17:58:00
            [year] => 2020
            [month] => 11
            [post_type] => post
        )

    [258] => stdClass Object
        (
            [slug] => hidden-cash-flows
            [ID] => 9927
            [post_name] => tuesday-tip-of-the-week-non-fiduciary-pbm-rent-seeking-behavior-eliminates-their-price-advantage
            [post_title] => Tuesday Tip of the Week:  Non-Fiduciary PBM Rent-Seeking Behavior Eliminates Their Price Advantage
            [post_author] => 2
            [post_date] => 2020-11-24 23:03:00
            [year] => 2020
            [month] => 11
            [post_type] => post
        )

    [259] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9928
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-340
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 340)
            [post_author] => 2
            [post_date] => 2020-11-20 15:12:00
            [year] => 2020
            [month] => 11
            [post_type] => post
        )

    [260] => stdClass Object
        (
            [slug] => strategy
            [ID] => 9929
            [post_name] => tuesday-tip-of-the-week-6-reasons-a-small-pbm-is-as-good-as-a-big-pbm-rerun
            [post_title] => Tuesday Tip of the Week:  6 Reasons a Small PBM is as Good as a Big PBM [Rerun]
            [post_author] => 2
            [post_date] => 2020-11-17 02:56:00
            [year] => 2020
            [month] => 11
            [post_type] => post
        )

    [261] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9930
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-339
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 339)
            [post_author] => 2
            [post_date] => 2020-11-12 12:26:00
            [year] => 2020
            [month] => 11
            [post_type] => post
        )

    [262] => stdClass Object
        (
            [slug] => specialty-drugs
            [ID] => 9931
            [post_name] => tuesday-tip-of-the-week-specialty-drug-utilization-management-three-things-to-know
            [post_title] => Tuesday Tip of the Week:  Specialty Drug Utilization Management Three Things to Know
            [post_author] => 2
            [post_date] => 2020-11-10 16:17:00
            [year] => 2020
            [month] => 11
            [post_type] => post
        )

    [263] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9934
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-338
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 338)
            [post_author] => 2
            [post_date] => 2020-11-05 16:59:00
            [year] => 2020
            [month] => 11
            [post_type] => post
        )

    [264] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 9935
            [post_name] => tuesday-tip-of-the-week-three-myths-about-pbm-pricing-every-employer-sponsored-plan-should-know
            [post_title] => Tuesday Tip of the Week:  Three Myths about PBM Pricing Every Employer-Sponsored Plan Should Know
            [post_author] => 2
            [post_date] => 2020-11-03 13:30:00
            [year] => 2020
            [month] => 11
            [post_type] => post
        )

    [265] => stdClass Object
        (
            [slug] => rbp-for-prescription-drugs
            [ID] => 9937
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-337
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 337)
            [post_author] => 2
            [post_date] => 2020-10-29 21:43:00
            [year] => 2020
            [month] => 10
            [post_type] => post
        )

    [266] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9938
            [post_name] => webinar-the-untold-truth-how-pharmacy-benefit-managers-make-money
            [post_title] => [Webinar] The Untold Truth: How Pharmacy Benefit Managers Make Money
            [post_author] => 2
            [post_date] => 2020-10-28 13:00:00
            [year] => 2020
            [month] => 10
            [post_type] => post
        )

    [267] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 9939
            [post_name] => tuesday-tip-of-the-week-factor-benefit-design-into-your-pbm-scorecard-rerun
            [post_title] => Tuesday Tip of the Week:  Factor Benefit Design into your PBM Scorecard (Rerun)
            [post_author] => 2
            [post_date] => 2020-10-27 21:24:00
            [year] => 2020
            [month] => 10
            [post_type] => post
        )

    [268] => stdClass Object
        (
            [slug] => wasteful-spending
            [ID] => 9940
            [post_name] => bling-loving-postal-boss-asked-to-step-down-over-12000-worth-of-cartier-watches
            [post_title] => Bling-Loving Postal Boss Asked to Step Down Over $12,000 Worth of Cartier Watches
            [post_author] => 2
            [post_date] => 2020-10-26 13:35:00
            [year] => 2020
            [month] => 10
            [post_type] => post
        )

    [269] => stdClass Object
        (
            [slug] => carve-out-pbm-arrangement
            [ID] => 9942
            [post_name] => dean-foods-carves-out-specialty-pharmacy-and-saves-big
            [post_title] => Dean Foods Carves Out Specialty Pharmacy and Saves Big
            [post_author] => 2
            [post_date] => 2020-10-23 20:08:00
            [year] => 2020
            [month] => 10
            [post_type] => post
        )

    [270] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9943
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-336
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 336)
            [post_author] => 2
            [post_date] => 2020-10-22 21:45:00
            [year] => 2020
            [month] => 10
            [post_type] => post
        )

    [271] => stdClass Object
        (
            [slug] => pbm-transparency
            [ID] => 9944
            [post_name] => tip-of-the-week-self-insured-employers-must-draw-a-line-in-the-sand-between-them-and-non-fiduciary-pharmacy-benefit-managers
            [post_title] => Tip of the Week:  Self-insured Employers Must Draw a Line in the Sand between them and Non-fiduciary Pharmacy Benefit Managers
            [post_author] => 2
            [post_date] => 2020-10-20 15:34:00
            [year] => 2020
            [month] => 10
            [post_type] => post
        )

    [272] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9945
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-335
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 335)
            [post_author] => 2
            [post_date] => 2020-10-16 14:55:00
            [year] => 2020
            [month] => 10
            [post_type] => post
        )

    [273] => stdClass Object
        (
            [slug] => spread-pricing
            [ID] => 9946
            [post_name] => tuesday-tip-of-the-week-institute-new-contract-terms-that-do-not-permit-spread-pricing
            [post_title] => Tuesday Tip of the Week:  Institute new contract terms that do not permit spread pricing
            [post_author] => 2
            [post_date] => 2020-10-13 20:24:00
            [year] => 2020
            [month] => 10
            [post_type] => post
        )

    [274] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9947
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-334
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 334)
            [post_author] => 2
            [post_date] => 2020-10-09 13:04:00
            [year] => 2020
            [month] => 10
            [post_type] => post
        )

    [275] => stdClass Object
        (
            [slug] => benefit-design
            [ID] => 9948
            [post_name] => tuesday-tip-of-the-week-3-ways-savings-could-be-achieved-by-improving-pharmacy-benefit-design-and-management
            [post_title] => Tuesday Tip of the Week:  3 Ways Savings Could be Achieved by Improving Pharmacy Benefit Design and Management
            [post_author] => 2
            [post_date] => 2020-10-06 15:15:00
            [year] => 2020
            [month] => 10
            [post_type] => post
        )

    [276] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9949
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-333
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 333)
            [post_author] => 2
            [post_date] => 2020-10-01 20:25:00
            [year] => 2020
            [month] => 10
            [post_type] => post
        )

    [277] => stdClass Object
        (
            [slug] => fiduciary-pbm
            [ID] => 9950
            [post_name] => tuesday-tip-of-the-week-pbms-can-be-fiduciaries
            [post_title] => Tuesday Tip of the Week:  PBMs can be Fiduciaries
            [post_author] => 2
            [post_date] => 2020-09-30 00:08:00
            [year] => 2020
            [month] => 9
            [post_type] => post
        )

    [278] => stdClass Object
        (
            [slug] => 340b
            [ID] => 9951
            [post_name] => drugmakers-push-back-on-the-use-of-contract-pharmacies-by-340b-covered-entities
            [post_title] => Drugmakers Push Back on the Use of Contract Pharmacies by 340B Covered Entities
            [post_author] => 2
            [post_date] => 2020-09-28 12:58:00
            [year] => 2020
            [month] => 9
            [post_type] => post
        )

    [279] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9953
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-332
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 332)
            [post_author] => 2
            [post_date] => 2020-09-24 13:56:00
            [year] => 2020
            [month] => 9
            [post_type] => post
        )

    [280] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9954
            [post_name] => free-webinar-the-untold-truth-how-pharmacy-benefit-managers-make-money-8
            [post_title] => Free Webinar | The Untold Truth: How Pharmacy Benefit Managers Make Money
            [post_author] => 2
            [post_date] => 2020-09-24 01:16:00
            [year] => 2020
            [month] => 9
            [post_type] => post
        )

    [281] => stdClass Object
        (
            [slug] => how-to-reduce-prescription-drug-costs
            [ID] => 9955
            [post_name] => tuesday-tip-of-the-week-focus-on-lowest-net-cost-drugs
            [post_title] => Tuesday Tip of the Week:  Focus on Lowest Net Cost Drugs
            [post_author] => 2
            [post_date] => 2020-09-22 14:20:00
            [year] => 2020
            [month] => 9
            [post_type] => post
        )

    [282] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9956
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-331
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 331)
            [post_author] => 2
            [post_date] => 2020-09-17 19:40:00
            [year] => 2020
            [month] => 9
            [post_type] => post
        )

    [283] => stdClass Object
        (
            [slug] => benefit-design
            [ID] => 9957
            [post_name] => tuesday-tip-of-the-week-increase-out-of-pocket-oop-spending-for-specialty-drugs
            [post_title] => Tuesday Tip of the Week:  Increase out-of-pocket (OOP) spending for specialty drugs
            [post_author] => 2
            [post_date] => 2020-09-15 13:43:00
            [year] => 2020
            [month] => 9
            [post_type] => post
        )

    [284] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9958
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-330
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 330)
            [post_author] => 2
            [post_date] => 2020-09-10 23:30:00
            [year] => 2020
            [month] => 9
            [post_type] => post
        )

    [285] => stdClass Object
        (
            [slug] => rerun
            [ID] => 9959
            [post_name] => tuesday-tip-of-the-week-when-the-carrier-pbm-and-aso-all-share-the-same-parent-company-you-are-fully-insured-rerun
            [post_title] => Tuesday Tip of the Week:  When the carrier, PBM and ASO all share the same parent company you are fully insured (Rerun)
            [post_author] => 2
            [post_date] => 2020-09-08 15:56:00
            [year] => 2020
            [month] => 9
            [post_type] => post
        )

    [286] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9960
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-329
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 329)
            [post_author] => 2
            [post_date] => 2020-09-04 12:47:00
            [year] => 2020
            [month] => 9
            [post_type] => post
        )

    [287] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 9961
            [post_name] => tuesday-tip-of-the-week-6-reasons-a-small-pbm-is-as-good-as-a-big-pbm
            [post_title] => Tuesday Tip of the Week:  6 Reasons a Small PBM is as Good as a Big PBM
            [post_author] => 2
            [post_date] => 2020-09-02 03:19:00
            [year] => 2020
            [month] => 9
            [post_type] => post
        )

    [288] => stdClass Object
        (
            [slug] => rbp-for-prescription-drugs
            [ID] => 9962
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-328
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 328)
            [post_author] => 2
            [post_date] => 2020-08-27 12:30:00
            [year] => 2020
            [month] => 8
            [post_type] => post
        )

    [289] => stdClass Object
        (
            [slug] => benefit-design
            [ID] => 9963
            [post_name] => tuesday-tip-of-the-week-out-of-pocket-caps-dont-lead-to-increased-health-plan-spending-or-reduced-affordability-for-all-enrollees
            [post_title] => Tuesday Tip of the Week:  Out-of-pocket caps don't lead to increased health plan spending or reduced affordability for all enrollees
            [post_author] => 2
            [post_date] => 2020-08-25 15:59:00
            [year] => 2020
            [month] => 8
            [post_type] => post
        )

    [290] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9965
            [post_name] => free-webinar-the-untold-truth-how-pharmacy-benefit-managers-make-money-9
            [post_title] => Free Webinar | The Untold Truth: How Pharmacy Benefit Managers Make Money
            [post_author] => 2
            [post_date] => 2020-08-24 14:55:00
            [year] => 2020
            [month] => 8
            [post_type] => post
        )

    [291] => stdClass Object
        (
            [slug] => rbp-for-prescription-drugs
            [ID] => 9966
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-327
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 327)
            [post_author] => 2
            [post_date] => 2020-08-20 22:19:00
            [year] => 2020
            [month] => 8
            [post_type] => post
        )

    [292] => stdClass Object
        (
            [slug] => benefit-design
            [ID] => 9967
            [post_name] => tuesday-tip-of-the-week-factor-benefit-design-into-your-pbm-scorecard
            [post_title] => Tuesday Tip of the Week:  Factor Benefit Design into your PBM Scorecard
            [post_author] => 2
            [post_date] => 2020-08-18 16:51:00
            [year] => 2020
            [month] => 8
            [post_type] => post
        )

    [293] => stdClass Object
        (
            [slug] => pharmacy-audit
            [ID] => 9968
            [post_name] => pharmacy-ceo-pleads-guilty-to-50m-reimbursement-fraud
            [post_title] => Pharmacy CEO pleads guilty to $50M reimbursement fraud
            [post_author] => 2
            [post_date] => 2020-08-14 16:13:00
            [year] => 2020
            [month] => 8
            [post_type] => post
        )

    [294] => stdClass Object
        (
            [slug] => rbp-for-prescription-drugs
            [ID] => 9969
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-326
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 326)
            [post_author] => 2
            [post_date] => 2020-08-13 15:01:00
            [year] => 2020
            [month] => 8
            [post_type] => post
        )

    [295] => stdClass Object
        (
            [slug] => pbm-contracts
            [ID] => 9970
            [post_name] => tuesday-tip-of-the-week-if-i-were-a-plan-sponsor-here-are-the-seven-things-i-would-be-asking-of-pbms-during-an-rfp
            [post_title] => Tuesday Tip of the Week:  If I were a plan sponsor here are the seven things I would be asking of PBMs during an RFP
            [post_author] => 2
            [post_date] => 2020-08-11 19:47:00
            [year] => 2020
            [month] => 8
            [post_type] => post
        )

    [296] => stdClass Object
        (
            [slug] => rbp-for-prescription-drugs
            [ID] => 9972
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-325
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 325)
            [post_author] => 2
            [post_date] => 2020-08-06 16:34:00
            [year] => 2020
            [month] => 8
            [post_type] => post
        )

    [297] => stdClass Object
        (
            [slug] => webinar
            [ID] => 9973
            [post_name] => free-webinar-the-untold-truth-how-pharmacy-benefit-managers-make-money-10
            [post_title] => Free Webinar | The Untold Truth: How Pharmacy Benefit Managers Make Money
            [post_author] => 2
            [post_date] => 2020-08-05 22:48:00
            [year] => 2020
            [month] => 8
            [post_type] => post
        )

    [298] => stdClass Object
        (
            [slug] => transparentrx-tips
            [ID] => 9975
            [post_name] => tuesday-tip-of-the-week-put-a-stake-in-vampiric-pbm-management-fees
            [post_title] => Tuesday Tip of the Week: Put a Stake in Vampiric PBM Management Fees
            [post_author] => 2
            [post_date] => 2020-08-04 12:15:00
            [year] => 2020
            [month] => 8
            [post_type] => post
        )

    [299] => stdClass Object
        (
            [slug] => rbp-for-prescription-drugs
            [ID] => 9976
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-324
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 324)
            [post_author] => 2
            [post_date] => 2020-07-30 21:24:00
            [year] => 2020
            [month] => 7
            [post_type] => post
        )

    [300] => stdClass Object
        (
            [slug] => pbm-contracts
            [ID] => 9977
            [post_name] => tuesday-tip-of-the-week-deadlines-get-deals-done
            [post_title] => Tuesday Tip of the Week:  Deadlines get deals done
            [post_author] => 2
            [post_date] => 2020-07-28 16:50:00
            [year] => 2020
            [month] => 7
            [post_type] => post
        )

    [301] => stdClass Object
        (
            [slug] => rbp-for-prescription-drugs
            [ID] => 9980
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-323
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 323)
            [post_author] => 2
            [post_date] => 2020-07-23 12:21:00
            [year] => 2020
            [month] => 7
            [post_type] => post
        )

    [302] => stdClass Object
        (
            [slug] => specialty-drugs
            [ID] => 9981
            [post_name] => tuesday-tip-of-the-week-dose-optimization-interventions-yield-significant-specialty-drug-cost-savings
            [post_title] => Tuesday Tip of the Week:  Dose Optimization Interventions Yield Significant Specialty Drug Cost Savings
            [post_author] => 2
            [post_date] => 2020-07-22 03:26:00
            [year] => 2020
            [month] => 7
            [post_type] => post
        )

    [303] => stdClass Object
        (
            [slug] => medical-benefit
            [ID] => 9982
            [post_name] => channel-management-for-specialty-challenges-with-medical-benefit-or-pharmacy-benefit
            [post_title] => Channel Management for Specialty: Challenges with Medical Benefit or Pharmacy Benefit
            [post_author] => 2
            [post_date] => 2020-07-20 16:54:00
            [year] => 2020
            [month] => 7
            [post_type] => post
        )

    [304] => stdClass Object
        (
            [slug] => rbp-for-prescription-drugs
            [ID] => 9983
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-322
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 322)
            [post_author] => 2
            [post_date] => 2020-07-16 13:36:00
            [year] => 2020
            [month] => 7
            [post_type] => post
        )

    [305] => stdClass Object
        (
            [slug] => self-funding
            [ID] => 9984
            [post_name] => tuesday-tip-of-the-week-when-the-carrier-pbm-and-aso-all-share-the-same-parent-company-you-are-fully-insured
            [post_title] => Tuesday Tip of the Week:  When the carrier, PBM and ASO all share the same parent company you are fully insured
            [post_author] => 2
            [post_date] => 2020-07-14 23:28:00
            [year] => 2020
            [month] => 7
            [post_type] => post
        )

    [306] => stdClass Object
        (
            [slug] => specialty-drugs
            [ID] => 9985
            [post_name] => potential-specialty-generic-drugs-2020
            [post_title] => Potential Specialty Generic Drugs 2020
            [post_author] => 2
            [post_date] => 2020-07-13 13:17:00
            [year] => 2020
            [month] => 7
            [post_type] => post
        )

    [307] => stdClass Object
        (
            [slug] => rbp-for-prescription-drugs
            [ID] => 9986
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-321
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 321)
            [post_author] => 2
            [post_date] => 2020-07-09 18:04:00
            [year] => 2020
            [month] => 7
            [post_type] => post
        )

    [308] => stdClass Object
        (
            [slug] => pbm-business-models
            [ID] => 9987
            [post_name] => tip-of-the-week-pass-through-and-transparent-pbm-business-models-are-small-ideas
            [post_title] => Tip of the Week: Pass-Through and Transparent PBM Business Models are Small Ideas
            [post_author] => 2
            [post_date] => 2020-07-07 14:50:00
            [year] => 2020
            [month] => 7
            [post_type] => post
        )

    [309] => stdClass Object
        (
            [slug] => rbp-for-prescription-drugs
            [ID] => 9989
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-320
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 320)
            [post_author] => 2
            [post_date] => 2020-07-02 21:14:00
            [year] => 2020
            [month] => 7
            [post_type] => post
        )

    [310] => stdClass Object
        (
            [slug] => transparentrx-tips
            [ID] => 9991
            [post_name] => tuesday-tip-of-the-week-3-ways-to-prepare-for-the-inevitable-rise-in-pharmacy-benefit-costs
            [post_title] => Tuesday Tip of the Week: 3 Ways to Prepare for the Inevitable Rise in Pharmacy Benefit Costs
            [post_author] => 2
            [post_date] => 2020-07-01 00:36:00
            [year] => 2020
            [month] => 7
            [post_type] => post
        )

    [311] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 9994
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-319
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 319)
            [post_author] => 2
            [post_date] => 2020-06-25 12:10:00
            [year] => 2020
            [month] => 6
            [post_type] => post
        )

    [312] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 9995
            [post_name] => the-untold-truth-how-pharmacy-benefit-managers-make-money-free-webinar-7
            [post_title] => The Untold Truth: How Pharmacy Benefit Managers Make Money [Free Webinar]
            [post_author] => 2
            [post_date] => 2020-06-24 15:36:00
            [year] => 2020
            [month] => 6
            [post_type] => post
        )

    [313] => stdClass Object
        (
            [slug] => pbm-contracts
            [ID] => 9996
            [post_name] => tuesday-tip-of-the-week-3-common-places-pbm-overcharges-occur
            [post_title] => Tuesday Tip of the Week:  3 Common Places PBM Overcharges Occur
            [post_author] => 2
            [post_date] => 2020-06-23 13:10:00
            [year] => 2020
            [month] => 6
            [post_type] => post
        )

    [314] => stdClass Object
        (
            [slug] => rbp-for-prescription-drugs
            [ID] => 9997
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-318
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 318)
            [post_author] => 2
            [post_date] => 2020-06-18 13:38:00
            [year] => 2020
            [month] => 6
            [post_type] => post
        )

    [315] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 9999
            [post_name] => specialty-drugs-a-five-pillar-approach-to-managing-cost
            [post_title] => Specialty Drugs:  A Five Pillar Approach to Managing Cost
            [post_author] => 2
            [post_date] => 2020-06-17 12:49:00
            [year] => 2020
            [month] => 6
            [post_type] => post
        )

    [316] => stdClass Object
        (
            [slug] => pbm-contracts
            [ID] => 10000
            [post_name] => tuesday-tip-of-the-week-spreadsheets-as-the-primary-tool-in-evaluating-pbm-proposals-is-like-buying-a-used-car-without-ever-looking-under-the-hood
            [post_title] => Tuesday Tip of the Week:  Spreadsheets as the Primary Tool in Evaluating PBM Proposals is Like Buying a Used Car Without Ever Looking Under the Hood
            [post_author] => 2
            [post_date] => 2020-06-16 17:39:00
            [year] => 2020
            [month] => 6
            [post_type] => post
        )

    [317] => stdClass Object
        (
            [slug] => rbp-for-prescription-drugs
            [ID] => 10003
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-317
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 317)
            [post_author] => 2
            [post_date] => 2020-06-11 11:50:00
            [year] => 2020
            [month] => 6
            [post_type] => post
        )

    [318] => stdClass Object
        (
            [slug] => pbm-transparency
            [ID] => 10004
            [post_name] => tuesday-tip-of-the-week-lead-with-transparency-or-a-non-fiduciary-pbms-pricing-analyst-will-exploit-your-lack-of-sophistication
            [post_title] => Tuesday Tip of the Week:  Lead with Transparency or a Non-Fiduciary PBM's Pricing Analyst will Exploit Your Lack of Sophistication
            [post_author] => 2
            [post_date] => 2020-06-09 16:13:00
            [year] => 2020
            [month] => 6
            [post_type] => post
        )

    [319] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10007
            [post_name] => bcbs-insurers-in-six-states-sue-cvs-health-over-an-alleged-scheme-to-overcharge-them-for-generic-drugs
            [post_title] => BCBS Insurers in Six States Sue CVS Health Over an Alleged Scheme to Overcharge Them for Generic Drugs
            [post_author] => 2
            [post_date] => 2020-06-05 14:34:00
            [year] => 2020
            [month] => 6
            [post_type] => post
        )

    [320] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 10008
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-316
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 316)
            [post_author] => 2
            [post_date] => 2020-06-04 13:01:00
            [year] => 2020
            [month] => 6
            [post_type] => post
        )

    [321] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10009
            [post_name] => tuesday-tip-of-the-week-large-non-fiduciary-pbms-hire-members-of-the-big-four-consulting-firms-to-help-them-identify-ways-to-generate-hidden-cash-flows
            [post_title] => Tuesday Tip of the Week:  Large non-fiduciary PBMs hire members of the Big Four consulting firms to help them identify ways to generate hidden cash flows
            [post_author] => 2
            [post_date] => 2020-06-02 22:16:00
            [year] => 2020
            [month] => 6
            [post_type] => post
        )

    [322] => stdClass Object
        (
            [slug] => webinar
            [ID] => 10010
            [post_name] => the-untold-truth-how-pharmacy-benefit-managers-make-money-free-webinar-8
            [post_title] => The Untold Truth: How Pharmacy Benefit Managers Make Money [Free Webinar]
            [post_author] => 2
            [post_date] => 2020-05-29 12:46:00
            [year] => 2020
            [month] => 5
            [post_type] => post
        )

    [323] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10012
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-315
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 315)
            [post_author] => 2
            [post_date] => 2020-05-28 13:37:00
            [year] => 2020
            [month] => 5
            [post_type] => post
        )

    [324] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10013
            [post_name] => tuesday-tip-of-the-week-there-are-no-problems-associated-with-pharmacy-costs-a-pbm-consultant-can-solve-that-a-pbm-if-it-so-chooses-cant-itself-solve-for-self-funded-employers
            [post_title] => Tuesday Tip of the Week: There are no problems associated with pharmacy costs a PBM consultant can solve that a PBM, if it so chooses, can't itself solve for self-funded employers
            [post_author] => 2
            [post_date] => 2020-05-26 14:46:00
            [year] => 2020
            [month] => 5
            [post_type] => post
        )

    [325] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 10014
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-314
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 314)
            [post_author] => 2
            [post_date] => 2020-05-21 14:44:00
            [year] => 2020
            [month] => 5
            [post_type] => post
        )

    [326] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10015
            [post_name] => 6-pillars-of-pharmacy-benefit-plan-design-rerun
            [post_title] => 6 Pillars of Pharmacy Benefit Plan Design (Rerun)
            [post_author] => 2
            [post_date] => 2020-05-20 23:12:00
            [year] => 2020
            [month] => 5
            [post_type] => post
        )

    [327] => stdClass Object
        (
            [slug] => transparentrx-tips
            [ID] => 10016
            [post_name] => tuesday-tip-of-the-week-price-isnt-the-only-driver-of-pharmacy-costs
            [post_title] => Tuesday Tip of the Week:  Price Isn't the Only Driver of Pharmacy Costs
            [post_author] => 2
            [post_date] => 2020-05-19 19:21:00
            [year] => 2020
            [month] => 5
            [post_type] => post
        )

    [328] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 10017
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-313
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 313)
            [post_author] => 2
            [post_date] => 2020-05-14 12:55:00
            [year] => 2020
            [month] => 5
            [post_type] => post
        )

    [329] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10018
            [post_name] => tuesday-tip-of-the-week-take-daw-9-off-the-table-for-non-fiduciary-pbms
            [post_title] => Tuesday Tip of the Week:  Take DAW 9 Off the Table for Non-Fiduciary PBMs
            [post_author] => 2
            [post_date] => 2020-05-12 14:47:00
            [year] => 2020
            [month] => 5
            [post_type] => post
        )

    [330] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10019
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-312
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 312)
            [post_author] => 2
            [post_date] => 2020-05-07 12:09:00
            [year] => 2020
            [month] => 5
            [post_type] => post
        )

    [331] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10020
            [post_name] => tuesday-tip-of-the-week-pbms-must-be-fiduciaries
            [post_title] => Tuesday Tip of the Week:  PBMs Must be Fiduciaries
            [post_author] => 2
            [post_date] => 2020-05-05 22:51:00
            [year] => 2020
            [month] => 5
            [post_type] => post
        )

    [332] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10021
            [post_name] => the-untold-truth-how-pharmacy-benefit-managers-make-money-free-webinar-9
            [post_title] => The Untold Truth: How Pharmacy Benefit Managers Make Money [Free Webinar]
            [post_author] => 2
            [post_date] => 2020-05-01 13:29:00
            [year] => 2020
            [month] => 5
            [post_type] => post
        )

    [333] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10023
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-311
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 311)
            [post_author] => 2
            [post_date] => 2020-04-30 12:35:00
            [year] => 2020
            [month] => 4
            [post_type] => post
        )

    [334] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10025
            [post_name] => formulary-exclusions-are-gaining-popularity
            [post_title] => Formulary Exclusions are Gaining Popularity
            [post_author] => 2
            [post_date] => 2020-04-29 13:40:00
            [year] => 2020
            [month] => 4
            [post_type] => post
        )

    [335] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10026
            [post_name] => tuesday-tip-of-the-week-you-should-not-pay-a-pbm-for-your-own-claims-data
            [post_title] => Tuesday Tip of the Week: You Should Not Pay a PBM for Your Own Claims Data
            [post_author] => 2
            [post_date] => 2020-04-28 18:18:00
            [year] => 2020
            [month] => 4
            [post_type] => post
        )

    [336] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10028
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-310
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 310)
            [post_author] => 2
            [post_date] => 2020-04-23 12:42:00
            [year] => 2020
            [month] => 4
            [post_type] => post
        )

    [337] => stdClass Object
        (
            [slug] => transparentrx-tips
            [ID] => 10029
            [post_name] => tuesday-tip-of-the-week-a-pbm-proposing-anything-short-of-full-disclosure-is-a-non-starter
            [post_title] => Tuesday Tip of the Week: A PBM Proposing Anything Short of Full Disclosure is a Non-Starter
            [post_author] => 2
            [post_date] => 2020-04-21 20:49:00
            [year] => 2020
            [month] => 4
            [post_type] => post
        )

    [338] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10034
            [post_name] => what-is-the-cpbs-credential-a-podcast-with-dr-erin-l-albert
            [post_title] => What is the CPBS credential? A Podcast with Dr. Erin L. Albert
            [post_author] => 2
            [post_date] => 2020-04-17 13:15:00
            [year] => 2020
            [month] => 4
            [post_type] => post
        )

    [339] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10035
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-309
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 309)
            [post_author] => 2
            [post_date] => 2020-04-16 14:08:00
            [year] => 2020
            [month] => 4
            [post_type] => post
        )

    [340] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10036
            [post_name] => tuesday-tip-of-the-week-who-is-watching-the-watcher
            [post_title] => Tuesday Tip of the Week: Who is Watching the Watcher?
            [post_author] => 2
            [post_date] => 2020-04-14 16:41:00
            [year] => 2020
            [month] => 4
            [post_type] => post
        )

    [341] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10037
            [post_name] => how-the-pharmacy-benefit-management-industry-is-reacting-to-covid-19
            [post_title] => How the Pharmacy Benefit Management Industry is Reacting to COVID-19
            [post_author] => 2
            [post_date] => 2020-04-13 12:15:00
            [year] => 2020
            [month] => 4
            [post_type] => post
        )

    [342] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10039
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-308
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 308)
            [post_author] => 2
            [post_date] => 2020-04-09 13:21:00
            [year] => 2020
            [month] => 4
            [post_type] => post
        )

    [343] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10041
            [post_name] => tuesday-tip-of-the-week-one-year-pbm-service-agreements-are-not-a-fail-safe
            [post_title] => Tuesday Tip of the Week: One Year PBM Service Agreements are not a Fail-Safe
            [post_author] => 2
            [post_date] => 2020-04-07 14:58:00
            [year] => 2020
            [month] => 4
            [post_type] => post
        )

    [344] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10043
            [post_name] => reference-pricing-gross-invoice-cost-vs-awp-for-popular-generic-and-brand-prescription-drugs-volume-307
            [post_title] => Reference Pricing: "Gross" Invoice Cost vs. AWP for Popular Generic and Brand Prescription Drugs (Volume 307)
            [post_author] => 2
            [post_date] => 2020-04-02 15:27:00
            [year] => 2020
            [month] => 4
            [post_type] => post
        )

    [345] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10044
            [post_name] => tuesday-tip-of-the-week-avoid-bargain-basement-pbm-administration-fees
            [post_title] => Tuesday Tip of the Week:  Avoid "Bargain Basement" PBM Administration fees
            [post_author] => 2
            [post_date] => 2020-03-31 15:12:00
            [year] => 2020
            [month] => 3
            [post_type] => post
        )

    [346] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10045
            [post_name] => pbm-evaluation-process-is-yours-up-to-par
            [post_title] => PBM Evaluation Process: Is Yours Up to Par?
            [post_author] => 2
            [post_date] => 2020-03-30 16:50:00
            [year] => 2020
            [month] => 3
            [post_type] => post
        )

    [347] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10046
            [post_name] => gross-to-net-bubble-brand-drug-list-prices-increase-159-and-net-prices-60-from-2007-to-2018
            [post_title] => Gross-to-Net Bubble: Brand Drug List Prices Increase 159% and Net Prices 60% from 2007 to 2018
            [post_author] => 2
            [post_date] => 2020-03-27 15:16:00
            [year] => 2020
            [month] => 3
            [post_type] => post
        )

    [348] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10047
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-306
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 306)
            [post_author] => 2
            [post_date] => 2020-03-26 12:58:00
            [year] => 2020
            [month] => 3
            [post_type] => post
        )

    [349] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10048
            [post_name] => tuesday-tip-of-the-week-maximize-dum-programs-to-manage-costs-of-specialty-pharmaceuticals
            [post_title] => Tuesday Tip of the Week: Maximize DUM Programs to Manage Costs of Specialty Pharmaceuticals
            [post_author] => 2
            [post_date] => 2020-03-24 17:49:00
            [year] => 2020
            [month] => 3
            [post_type] => post
        )

    [350] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10049
            [post_name] => american-pharmacist-association-apha-issues-prescription-drug-supply-guidance-for-patients-and-caregivers
            [post_title] => American Pharmacist Association (APhA) Issues Prescription Drug Supply Guidance for Patients and Caregivers
            [post_author] => 2
            [post_date] => 2020-03-20 15:17:00
            [year] => 2020
            [month] => 3
            [post_type] => post
        )

    [351] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10050
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-305
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 305)
            [post_author] => 2
            [post_date] => 2020-03-19 19:03:00
            [year] => 2020
            [month] => 3
            [post_type] => post
        )

    [352] => stdClass Object
        (
            [slug] => transparentrx-tips
            [ID] => 10051
            [post_name] => tuesday-tip-of-the-week-get-your-contract-definitions-in-order
            [post_title] => Tuesday Tip of the Week: Get Your Contract Definitions in Order
            [post_author] => 2
            [post_date] => 2020-03-17 15:58:00
            [year] => 2020
            [month] => 3
            [post_type] => post
        )

    [353] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10052
            [post_name] => non-fiduciary-pbms-arbitrarily-designate-certain-drugs-as-specialty-medications
            [post_title] => Non-Fiduciary PBMs Arbitrarily Designate Certain Drugs as “Specialty” Medications
            [post_author] => 2
            [post_date] => 2020-03-16 15:12:00
            [year] => 2020
            [month] => 3
            [post_type] => post
        )

    [354] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10053
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-304
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 304)
            [post_author] => 2
            [post_date] => 2020-03-12 20:16:00
            [year] => 2020
            [month] => 3
            [post_type] => post
        )

    [355] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10054
            [post_name] => large-employer-groups-push-back-on-non-fiduciary-pbms-and-win-big
            [post_title] => Large Employer Groups Push Back on Non-Fiduciary PBMs and Win Big!
            [post_author] => 2
            [post_date] => 2020-03-09 14:50:00
            [year] => 2020
            [month] => 3
            [post_type] => post
        )

    [356] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10055
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-fees-up-to-50-without-reducing-benefits-or-shifting-costs-to-employees
            [post_title] => Don't Miss Webinar: How to Slash PBM Service Fees, up to 50%, Without Reducing Benefits or Shifting Costs to Employees
            [post_author] => 2
            [post_date] => 2020-03-03 18:02:00
            [year] => 2020
            [month] => 3
            [post_type] => post
        )

    [357] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10056
            [post_name] => patient-assistance-programs-a-shield-from-high-cost-or-trampoline-for-abuse
            [post_title] => Patient Assistance Programs: A Shield from High Cost or Trampoline for Abuse?
            [post_author] => 2
            [post_date] => 2020-03-02 22:02:00
            [year] => 2020
            [month] => 3
            [post_type] => post
        )

    [358] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10057
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-303
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 303)
            [post_author] => 2
            [post_date] => 2020-02-28 18:10:00
            [year] => 2020
            [month] => 2
            [post_type] => post
        )

    [359] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10058
            [post_name] => the-roi-on-pharmacy-benefit-management-services-new-study-from-pcma
            [post_title] => The ROI on Pharmacy Benefit Management Services; New Study from PCMA
            [post_author] => 2
            [post_date] => 2020-02-27 00:13:00
            [year] => 2020
            [month] => 2
            [post_type] => post
        )

    [360] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10059
            [post_name] => tip-of-the-week-for-your-next-pbm-request-for-proposal-ditch-email-and-paper
            [post_title] => Tip of the Week: For your next PBM request for proposal ditch email and paper
            [post_author] => 2
            [post_date] => 2020-02-25 15:45:00
            [year] => 2020
            [month] => 2
            [post_type] => post
        )

    [361] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10060
            [post_name] => value-based-contracts-slowly-picking-up-steam
            [post_title] => Value-Based Contracts Slowly Picking Up Steam
            [post_author] => 2
            [post_date] => 2020-02-24 19:09:00
            [year] => 2020
            [month] => 2
            [post_type] => post
        )

    [362] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10061
            [post_name] => 3-ways-pbms-can-team-up-with-employers-to-save-on-specialty-drugs
            [post_title] => 3 ways PBMs can team up with employers to save on specialty drugs
            [post_author] => 2
            [post_date] => 2020-02-23 16:31:00
            [year] => 2020
            [month] => 2
            [post_type] => post
        )

    [363] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10062
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-302
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 302)
            [post_author] => 2
            [post_date] => 2020-02-21 18:28:00
            [year] => 2020
            [month] => 2
            [post_type] => post
        )

    [364] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10063
            [post_name] => tip-of-the-week-dont-give-up-leverage-to-pbms
            [post_title] => Tip of the Week: Don't Give Up Leverage to PBMs
            [post_author] => 2
            [post_date] => 2020-02-14 15:16:00
            [year] => 2020
            [month] => 2
            [post_type] => post
        )

    [365] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10064
            [post_name] => new-report-alleges-that-pharmacy-benefit-managers-pbms-in-florida-are-favoring-their-own-affiliated-pharmacies
            [post_title] => New report alleges that pharmacy benefit managers (PBMs) in Florida are favoring their own affiliated pharmacies
            [post_author] => 2
            [post_date] => 2020-02-06 18:25:00
            [year] => 2020
            [month] => 2
            [post_type] => post
        )

    [366] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10065
            [post_name] => new-report-health-plans-pbms-employers-and-health-systems-keep-166b-in-rebates-and-discounts-provided-by-drugmakers
            [post_title] => New Report: Health Plans, PBMs, Employers, and Health Systems Keep $166B in Rebates and Discounts Provided by Drugmakers
            [post_author] => 2
            [post_date] => 2020-01-31 14:53:00
            [year] => 2020
            [month] => 1
            [post_type] => post
        )

    [367] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10066
            [post_name] => physician-practices-must-create-a-system-to-deal-with-pbm-drug-denials
            [post_title] => Physician Practices Must Create a System to Deal with PBM Drug Denials
            [post_author] => 2
            [post_date] => 2020-01-29 18:11:00
            [year] => 2020
            [month] => 1
            [post_type] => post
        )

    [368] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10067
            [post_name] => pbm-101-webinar-how-to-slash-pbm-service-fees-up-to-50-without-reducing-benefits-or-shifting-costs-to-employees
            [post_title] => PBM 101 Webinar: How to Slash PBM Service Fees, up to 50%, Without Reducing Benefits or Shifting Costs to Employees
            [post_author] => 2
            [post_date] => 2020-01-28 19:55:00
            [year] => 2020
            [month] => 1
            [post_type] => post
        )

    [369] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10069
            [post_name] => self-insured-employers-turning-to-pbms-to-fight-prescription-drug-abuse
            [post_title] => Self-Insured Employers Turning to PBMs to Fight Prescription Drug Abuse
            [post_author] => 2
            [post_date] => 2020-01-24 14:43:00
            [year] => 2020
            [month] => 1
            [post_type] => post
        )

    [370] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10070
            [post_name] => infographic-6-reasons-a-small-pbm-is-as-good-as-a-big-pbm
            [post_title] => Infographic: 6 Reasons a Small PBM is as Good as a Big PBM
            [post_author] => 2
            [post_date] => 2020-01-21 17:32:00
            [year] => 2020
            [month] => 1
            [post_type] => post
        )

    [371] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10073
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-301
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 301)
            [post_author] => 2
            [post_date] => 2020-01-16 15:19:00
            [year] => 2020
            [month] => 1
            [post_type] => post
        )

    [372] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10074
            [post_name] => u-s-supreme-court-to-hear-case-on-states-right-to-regulate-pharmacy-benefit-managers-pbm
            [post_title] => U.S. Supreme Court to hear case on States’ Right to Regulate Pharmacy Benefit Managers (PBM)
            [post_author] => 2
            [post_date] => 2020-01-14 12:47:00
            [year] => 2020
            [month] => 1
            [post_type] => post
        )

    [373] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10075
            [post_name] => pbm-101-webinar-how-to-slash-pbm-service-fees-up-to-50-without-changing-vendors-or-member-benefit-levels
            [post_title] => PBM 101 Webinar: How to Slash PBM Service Fees, up to 50%, Without Changing Vendors or Member Benefit Levels
            [post_author] => 2
            [post_date] => 2020-01-11 22:34:00
            [year] => 2020
            [month] => 1
            [post_type] => post
        )

    [374] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10076
            [post_name] => drawing-a-line-in-the-sand-california-looks-to-contract-directly-with-generic-drug-manufacturers
            [post_title] => Drawing a Line in the Sand California Looks to Contract Directly with Generic Drug Manufacturers
            [post_author] => 2
            [post_date] => 2020-01-10 13:42:00
            [year] => 2020
            [month] => 1
            [post_type] => post
        )

    [375] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10077
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-300
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 300)
            [post_author] => 2
            [post_date] => 2020-01-09 17:50:00
            [year] => 2020
            [month] => 1
            [post_type] => post
        )

    [376] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10078
            [post_name] => chief-economist-writes-constraining-pharmacy-benefit-managers-will-not-reduce-drug-prices
            [post_title] => Chief Economist Writes, "Constraining Pharmacy Benefit Managers Will Not Reduce Drug Prices"
            [post_author] => 2
            [post_date] => 2020-01-06 16:45:00
            [year] => 2020
            [month] => 1
            [post_type] => post
        )

    [377] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10079
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-299
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 299)
            [post_author] => 2
            [post_date] => 2020-01-04 19:40:00
            [year] => 2020
            [month] => 1
            [post_type] => post
        )

    [378] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10080
            [post_name] => reducing-wasteful-spending-in-employers-pharmacy-benefit-plans-special-report-rerun
            [post_title] => Reducing Wasteful Spending in Employers’ Pharmacy Benefit Plans; Special Report (Rerun)
            [post_author] => 2
            [post_date] => 2019-12-31 16:07:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [379] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10081
            [post_name] => wasteful-spending-check-out-the-price-tags-on-combination-prescription-drugs
            [post_title] => Wasteful Spending: Check out the price tags on combination prescription drugs
            [post_author] => 2
            [post_date] => 2019-12-30 14:53:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [380] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10082
            [post_name] => bcbs-of-tennessee-will-stop-reimbursing-providers-for-certain-specialty-drugs-typically-administered-in-a-doctors-office-or-hospital-setting
            [post_title] => BCBS of Tennessee will stop reimbursing providers for certain specialty drugs typically administered in a doctor's office or hospital setting
            [post_author] => 2
            [post_date] => 2019-12-29 17:45:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [381] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10083
            [post_name] => feds-finally-release-proposed-drug-importation-policies
            [post_title] => Feds Finally Release Proposed Drug Importation Policies
            [post_author] => 2
            [post_date] => 2019-12-28 15:29:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [382] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10084
            [post_name] => u-s-pharmacy-reimbursement-and-distribution-system-rerun
            [post_title] => U.S. Pharmacy Reimbursement and Distribution System (Rerun)
            [post_author] => 2
            [post_date] => 2019-12-27 15:56:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [383] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10085
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-298
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 298)
            [post_author] => 2
            [post_date] => 2019-12-26 19:04:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [384] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10086
            [post_name] => doctors-prescribe-more-of-a-drug-if-they-receive-money-from-a-pharma-company-tied-to-it
            [post_title] => Doctors Prescribe More of a Drug If They Receive Money from a Pharma Company Tied to It
            [post_author] => 2
            [post_date] => 2019-12-23 14:41:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [385] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10087
            [post_name] => express-scripts-to-handle-drug-rebate-negotiations-on-the-pharmacy-benefit-for-prime-therapeutics
            [post_title] => Express Scripts to handle drug rebate negotiations, on the pharmacy benefit, for Prime Therapeutics
            [post_author] => 2
            [post_date] => 2019-12-20 04:26:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [386] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10088
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-297
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 297)
            [post_author] => 2
            [post_date] => 2019-12-20 03:54:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [387] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10089
            [post_name] => researchers-find-surgery-for-blocked-arteries-is-often-unnecessary
            [post_title] => Researchers find surgery for blocked arteries is often unnecessary
            [post_author] => 2
            [post_date] => 2019-12-17 02:18:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [388] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10090
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-296
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 296)
            [post_author] => 2
            [post_date] => 2019-12-12 23:07:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [389] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10091
            [post_name] => geesh-unitedhealths-optum-paying-300-million-for-diplomat-specialty-pharmacy
            [post_title] => Geesh! UnitedHealth's Optum paying $300 million for Diplomat specialty pharmacy
            [post_author] => 2
            [post_date] => 2019-12-10 15:57:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [390] => stdClass Object
        (
            [slug] => transparentrx-tips
            [ID] => 10092
            [post_name] => specialty-generic-and-biosimilar-drug-pipeline-update
            [post_title] => Specialty Generic and Biosimilar Drug Pipeline Update
            [post_author] => 2
            [post_date] => 2019-12-10 15:19:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [391] => stdClass Object
        (
            [slug] => transparentrx-tips
            [ID] => 10095
            [post_name] => pbm-101-webinar-how-to-slash-pbm-service-fees-up-to-50-without-reducing-benefits-or-shifting-costs-to-employees-2
            [post_title] => PBM 101 Webinar: How to Slash PBM Service Fees, up to 50%, Without Reducing Benefits or Shifting Costs to Employees
            [post_author] => 2
            [post_date] => 2019-12-07 17:57:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [392] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10096
            [post_name] => generic-drug-pipeline-update
            [post_title] => Generic Drug Pipeline Update
            [post_author] => 2
            [post_date] => 2019-12-06 18:20:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [393] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10097
            [post_name] => in-2020-optum-to-provide-more-than-50-of-unitedhealths-total-company-earnings
            [post_title] => In 2020, Optum To Provide More Than 50% Of UnitedHealth’s Total Company Earnings
            [post_author] => 2
            [post_date] => 2019-12-04 17:54:00
            [year] => 2019
            [month] => 12
            [post_type] => post
        )

    [394] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10098
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-295
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 295)
            [post_author] => 2
            [post_date] => 2019-11-29 22:36:00
            [year] => 2019
            [month] => 11
            [post_type] => post
        )

    [395] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10099
            [post_name] => optumrx-overcharged-ohio-bwc-by-millions-attorney-general-says
            [post_title] => OptumRx overcharged Ohio BWC by millions, Attorney General says
            [post_author] => 2
            [post_date] => 2019-11-27 18:29:00
            [year] => 2019
            [month] => 11
            [post_type] => post
        )

    [396] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10101
            [post_name] => a-prominent-attorney-and-advocate-for-pbm-transparency-says-state-medicaid-plan-hemorrhaging-money
            [post_title] => A Prominent Attorney and Advocate for PBM Transparency Says State Medicaid Plan Hemorrhaging Money
            [post_author] => 2
            [post_date] => 2019-11-22 14:58:00
            [year] => 2019
            [month] => 11
            [post_type] => post
        )

    [397] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10102
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-294
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 294)
            [post_author] => 2
            [post_date] => 2019-11-21 17:27:00
            [year] => 2019
            [month] => 11
            [post_type] => post
        )

    [398] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10104
            [post_name] => american-college-of-physicians-position-paper-recommendations-for-pbms-to-stem-the-escalating-costs-of-prescription-drugs
            [post_title] => American College of Physicians Position Paper: Recommendations for PBMs to Stem the Escalating Costs of Prescription Drugs
            [post_author] => 2
            [post_date] => 2019-11-20 13:19:00
            [year] => 2019
            [month] => 11
            [post_type] => post
        )

    [399] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10105
            [post_name] => california-is-carving-out-pharmacy-benefits
            [post_title] => California is Carving Out Pharmacy Benefits
            [post_author] => 2
            [post_date] => 2019-11-18 16:51:00
            [year] => 2019
            [month] => 11
            [post_type] => post
        )

    [400] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10106
            [post_name] => aarp-has-released-a-new-rx-price-watch-report
            [post_title] => AARP has released a new Rx Price Watch report
            [post_author] => 2
            [post_date] => 2019-11-16 16:30:00
            [year] => 2019
            [month] => 11
            [post_type] => post
        )

    [401] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10107
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-293
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 293)
            [post_author] => 2
            [post_date] => 2019-11-15 13:23:00
            [year] => 2019
            [month] => 11
            [post_type] => post
        )

    [402] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10108
            [post_name] => holy-cow-diplomat-pharmacy-is-a-shell-of-its-former-self
            [post_title] => Holy cow! Diplomat Pharmacy is a shell of its former self
            [post_author] => 2
            [post_date] => 2019-11-14 15:09:00
            [year] => 2019
            [month] => 11
            [post_type] => post
        )

    [403] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10112
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-292
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 292)
            [post_author] => 2
            [post_date] => 2019-11-07 18:46:00
            [year] => 2019
            [month] => 11
            [post_type] => post
        )

    [404] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10113
            [post_name] => benefits-alert-chronological-timeline-of-prescription-drug-copay-accumulator-programs
            [post_title] => Benefits Alert: Chronological Timeline of Prescription Drug Copay Accumulator Programs
            [post_author] => 2
            [post_date] => 2019-11-05 12:31:00
            [year] => 2019
            [month] => 11
            [post_type] => post
        )

    [405] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10114
            [post_name] => infusing-radical-transparency-into-pbm-contracts
            [post_title] => Infusing Radical Transparency into PBM Contracts
            [post_author] => 2
            [post_date] => 2019-11-04 18:17:00
            [year] => 2019
            [month] => 11
            [post_type] => post
        )

    [406] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10115
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-291
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 291)
            [post_author] => 2
            [post_date] => 2019-11-01 20:20:00
            [year] => 2019
            [month] => 11
            [post_type] => post
        )

    [407] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10116
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-290
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 290)
            [post_author] => 2
            [post_date] => 2019-10-25 12:22:00
            [year] => 2019
            [month] => 10
            [post_type] => post
        )

    [408] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10117
            [post_name] => new-york-firefighters-association-cracks-down-on-non-fiduciary-pharmacy-benefit-managers
            [post_title] => New York Firefighters Association Cracks Down on Non-Fiduciary Pharmacy Benefit Managers
            [post_author] => 2
            [post_date] => 2019-10-23 18:48:00
            [year] => 2019
            [month] => 10
            [post_type] => post
        )

    [409] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10118
            [post_name] => prime-therapeutics-study-number-of-drug-super-spenders-grew-63-in-3-years
            [post_title] => Prime Therapeutics Study: Number of 'Drug Super Spenders' Grew 63% In 3 Years
            [post_author] => 2
            [post_date] => 2019-10-22 15:28:00
            [year] => 2019
            [month] => 10
            [post_type] => post
        )

    [410] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10119
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-289
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 289)
            [post_author] => 2
            [post_date] => 2019-10-18 19:58:00
            [year] => 2019
            [month] => 10
            [post_type] => post
        )

    [411] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10120
            [post_name] => wasteful-spending-in-healthcare-estimated-at-760b-to-935b
            [post_title] => Wasteful Spending in Healthcare Estimated at $760B to $935B
            [post_author] => 2
            [post_date] => 2019-10-17 19:08:00
            [year] => 2019
            [month] => 10
            [post_type] => post
        )

    [412] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10121
            [post_name] => michigan-wants-to-save-40-million-by-cutting-non-fiduciary-pbms-out-of-medicaid
            [post_title] => Michigan wants to save $40 million by cutting non-fiduciary PBMs out of Medicaid
            [post_author] => 2
            [post_date] => 2019-10-14 20:15:00
            [year] => 2019
            [month] => 10
            [post_type] => post
        )

    [413] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10122
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-288
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 288)
            [post_author] => 2
            [post_date] => 2019-10-11 16:42:00
            [year] => 2019
            [month] => 10
            [post_type] => post
        )

    [414] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10124
            [post_name] => courts-look-closely-at-the-contractual-relationship-between-plan-sponsor-and-pbm
            [post_title] => Courts Look Closely at the Contractual Relationship Between Plan Sponsor and PBM
            [post_author] => 2
            [post_date] => 2019-10-10 15:03:00
            [year] => 2019
            [month] => 10
            [post_type] => post
        )

    [415] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10126
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-287
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 287)
            [post_author] => 2
            [post_date] => 2019-10-03 19:17:00
            [year] => 2019
            [month] => 10
            [post_type] => post
        )

    [416] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10127
            [post_name] => new-prescription-drug-pricing-system-reins-in-non-fiduciary-pharmacy-benefit-managers
            [post_title] => New prescription drug pricing system reins in non-fiduciary pharmacy benefit managers
            [post_author] => 2
            [post_date] => 2019-10-01 17:41:00
            [year] => 2019
            [month] => 10
            [post_type] => post
        )

    [417] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10128
            [post_name] => milton-friedmans-shareholder-theory-is-wrong-afterall
            [post_title] => Milton Friedman's Shareholder Theory Is Wrong Afterall
            [post_author] => 2
            [post_date] => 2019-09-30 18:43:00
            [year] => 2019
            [month] => 9
            [post_type] => post
        )

    [418] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10129
            [post_name] => how-to-assess-the-value-of-cell-and-gene-therapies-icers-founder
            [post_title] => How to Assess the Value of Cell and Gene Therapies: ICER's Founder
            [post_author] => 2
            [post_date] => 2019-09-27 22:42:00
            [year] => 2019
            [month] => 9
            [post_type] => post
        )

    [419] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10130
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-286
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 286)
            [post_author] => 2
            [post_date] => 2019-09-26 21:33:00
            [year] => 2019
            [month] => 9
            [post_type] => post
        )

    [420] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10131
            [post_name] => can-formulary-management-bring-specialty-drug-spend-back-down-to-earth
            [post_title] => Can Formulary Management Bring Specialty Drug Spend Back Down to Earth?
            [post_author] => 2
            [post_date] => 2019-09-25 14:47:00
            [year] => 2019
            [month] => 9
            [post_type] => post
        )

    [421] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10132
            [post_name] => aarp-rx-price-watch-report-shows-prescription-drug-prices-increase-by-double-the-rate-of-inflation
            [post_title] => AARP Rx Price Watch Report Shows Prescription Drug Prices Increase by Double the Rate of Inflation
            [post_author] => 2
            [post_date] => 2019-09-23 17:14:00
            [year] => 2019
            [month] => 9
            [post_type] => post
        )

    [422] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10133
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-285
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 285)
            [post_author] => 2
            [post_date] => 2019-09-19 21:18:00
            [year] => 2019
            [month] => 9
            [post_type] => post
        )

    [423] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10134
            [post_name] => special-report-reducing-wasteful-spending-in-employers-pharmacy-benefit-plans
            [post_title] => Special Report: Reducing Wasteful Spending in Employers’ Pharmacy Benefit Plans
            [post_author] => 2
            [post_date] => 2019-09-18 13:49:00
            [year] => 2019
            [month] => 9
            [post_type] => post
        )

    [424] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10135
            [post_name] => oncologists-getting-6-of-drug-price-is-financial-conflict
            [post_title] => Oncologists Getting 6% of Drug Price Is 'Financial Conflict'
            [post_author] => 2
            [post_date] => 2019-09-17 12:41:00
            [year] => 2019
            [month] => 9
            [post_type] => post
        )

    [425] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10136
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-284
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 284)
            [post_author] => 2
            [post_date] => 2019-09-12 13:41:00
            [year] => 2019
            [month] => 9
            [post_type] => post
        )

    [426] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10138
            [post_name] => site-of-care-management-administering-specialty-drugs-outside-hospitals-could-save-4-billion
            [post_title] => Site of Care Management: Administering specialty drugs outside hospitals could save $4 billion
            [post_author] => 2
            [post_date] => 2019-09-09 16:09:00
            [year] => 2019
            [month] => 9
            [post_type] => post
        )

    [427] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10141
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-283
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 283)
            [post_author] => 2
            [post_date] => 2019-09-05 16:48:00
            [year] => 2019
            [month] => 9
            [post_type] => post
        )

    [428] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10142
            [post_name] => opinion-editorial-a-reckoning-is-coming-for-non-fiduciary-pbms
            [post_title] => Opinion Editorial: A reckoning is coming for non-fiduciary PBMs
            [post_author] => 2
            [post_date] => 2019-09-04 14:24:00
            [year] => 2019
            [month] => 9
            [post_type] => post
        )

    [429] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10143
            [post_name] => pension-funds-sue-insulin-manufacturer-for-1-75-billion-over-alleged-collusion
            [post_title] => Pension Funds Sue Insulin Manufacturer for $1.75 Billion over Alleged Collusion
            [post_author] => 2
            [post_date] => 2019-08-30 12:59:00
            [year] => 2019
            [month] => 8
            [post_type] => post
        )

    [430] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10144
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-282
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 282)
            [post_author] => 2
            [post_date] => 2019-08-29 13:14:00
            [year] => 2019
            [month] => 8
            [post_type] => post
        )

    [431] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10145
            [post_name] => pbm-101-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels
            [post_title] => PBM 101 Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2019-08-28 19:27:00
            [year] => 2019
            [month] => 8
            [post_type] => post
        )

    [432] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10146
            [post_name] => targeted-medication-reviews-tmrs-critical-success-factor-for-medication-therapy-management
            [post_title] => Targeted Medication Reviews (TMRs) Critical Success Factor for Medication Therapy Management
            [post_author] => 2
            [post_date] => 2019-08-27 17:51:00
            [year] => 2019
            [month] => 8
            [post_type] => post
        )

    [433] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10147
            [post_name] => op-ed-pbms-are-driving-up-costs-and-lowering-quality-care-in-america
            [post_title] => Op-ed: PBMs are Driving Up Costs and Lowering Quality Care in America
            [post_author] => 2
            [post_date] => 2019-08-26 15:00:00
            [year] => 2019
            [month] => 8
            [post_type] => post
        )

    [434] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10149
            [post_name] => self-funded-employers-spend-40-of-costs-on-less-than-1-of-prescriptions
            [post_title] => Self-funded employers spend 40% of costs on less than 1% of prescriptions
            [post_author] => 2
            [post_date] => 2019-08-23 13:00:00
            [year] => 2019
            [month] => 8
            [post_type] => post
        )

    [435] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10151
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-281
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 281)
            [post_author] => 2
            [post_date] => 2019-08-22 08:57:00
            [year] => 2019
            [month] => 8
            [post_type] => post
        )

    [436] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10152
            [post_name] => how-an-stand-alone-pbm-uses-patient-engagement-to-improve-cost-and-patient-outcomes
            [post_title] => How an Stand-alone PBM Uses Patient Engagement to Improve Cost and Patient Outcomes
            [post_author] => 2
            [post_date] => 2019-08-21 17:38:00
            [year] => 2019
            [month] => 8
            [post_type] => post
        )

    [437] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10153
            [post_name] => medicare-and-its-beneficiaries-could-have-saved-an-estimated-17-7-billion-if-older-generics-were-prescribed-study-finds
            [post_title] => Medicare and its beneficiaries could have saved an estimated $17.7 billion if older generics were prescribed, study finds
            [post_author] => 2
            [post_date] => 2019-08-20 13:02:00
            [year] => 2019
            [month] => 8
            [post_type] => post
        )

    [438] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10154
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-280
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 280)
            [post_author] => 2
            [post_date] => 2019-08-19 19:17:00
            [year] => 2019
            [month] => 8
            [post_type] => post
        )

    [439] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10156
            [post_name] => plan-sponsors-laser-focused-on-high-cost-claims
            [post_title] => Plan Sponsors Laser Focused on High-Cost Claims
            [post_author] => 2
            [post_date] => 2019-08-18 12:44:00
            [year] => 2019
            [month] => 8
            [post_type] => post
        )

    [440] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10157
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-279
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 279)
            [post_author] => 2
            [post_date] => 2019-08-09 22:48:00
            [year] => 2019
            [month] => 8
            [post_type] => post
        )

    [441] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10162
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-278
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 278)
            [post_author] => 2
            [post_date] => 2019-08-01 14:40:00
            [year] => 2019
            [month] => 8
            [post_type] => post
        )

    [442] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10163
            [post_name] => trump-administration-opens-pathway-on-drug-imports-from-canada
            [post_title] => Trump Administration ‘Opens Pathway’ on Drug Imports From Canada
            [post_author] => 2
            [post_date] => 2019-07-31 18:14:00
            [year] => 2019
            [month] => 7
            [post_type] => post
        )

    [443] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10164
            [post_name] => impact-of-a-co-pay-accumulator-adjustment-program-on-specialty-drug-adherence
            [post_title] => Impact of a Co-pay Accumulator Adjustment Program on Specialty Drug Adherence
            [post_author] => 2
            [post_date] => 2019-07-30 21:22:00
            [year] => 2019
            [month] => 7
            [post_type] => post
        )

    [444] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10166
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-277
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 277)
            [post_author] => 2
            [post_date] => 2019-07-25 12:08:00
            [year] => 2019
            [month] => 7
            [post_type] => post
        )

    [445] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10167
            [post_name] => flow-of-the-specialty-drug-dollar-a-business-process-model-with-notation
            [post_title] => Flow of the Specialty Drug Dollar: A Business Process Model with Notation
            [post_author] => 2
            [post_date] => 2019-07-23 16:09:00
            [year] => 2019
            [month] => 7
            [post_type] => post
        )

    [446] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10169
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-276
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 276)
            [post_author] => 2
            [post_date] => 2019-07-18 15:54:00
            [year] => 2019
            [month] => 7
            [post_type] => post
        )

    [447] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10170
            [post_name] => dir-fees-in-medicare-part-d-grew-by-45000-between-2010-and-2017
            [post_title] => DIR fees in Medicare Part D grew by 45,000% between 2010 and 2017
            [post_author] => 2
            [post_date] => 2019-07-16 15:26:00
            [year] => 2019
            [month] => 7
            [post_type] => post
        )

    [448] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10171
            [post_name] => the-white-house-yanks-proposed-drug-rebate-overhaul
            [post_title] => The White House Yanks Proposed Drug Rebate Overhaul
            [post_author] => 2
            [post_date] => 2019-07-11 16:40:00
            [year] => 2019
            [month] => 7
            [post_type] => post
        )

    [449] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10172
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-275
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 275)
            [post_author] => 2
            [post_date] => 2019-07-11 13:48:00
            [year] => 2019
            [month] => 7
            [post_type] => post
        )

    [450] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10173
            [post_name] => largest-pharmacy-benefits-manager-in-the-u-s-accused-of-costing-the-new-york-city-transit-authority-tens-of-millions-of-dollars
            [post_title] => Largest pharmacy benefits manager in the U.S. accused of costing the New York City Transit Authority tens of millions of dollars
            [post_author] => 2
            [post_date] => 2019-07-10 17:27:00
            [year] => 2019
            [month] => 7
            [post_type] => post
        )

    [451] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10174
            [post_name] => court-declines-to-enforce-indemnification-provision-against-negligent-pharmacy-benefits-manager
            [post_title] => Court Declines to Enforce Indemnification Provision Against Negligent Pharmacy Benefits Manager
            [post_author] => 2
            [post_date] => 2019-07-08 17:59:00
            [year] => 2019
            [month] => 7
            [post_type] => post
        )

    [452] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10175
            [post_name] => unitedhealths-pbm-unit-optum-tops-100-billion-in-revenues-for-the-first-time
            [post_title] => UnitedHealth's PBM unit, Optum, tops $100 billion in revenues for the first time
            [post_author] => 2
            [post_date] => 2019-07-05 13:45:00
            [year] => 2019
            [month] => 7
            [post_type] => post
        )

    [453] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10176
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-274
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 274)
            [post_author] => 2
            [post_date] => 2019-07-04 13:48:00
            [year] => 2019
            [month] => 7
            [post_type] => post
        )

    [454] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10177
            [post_name] => states-attempt-to-curb-pharmacy-benefit-manager-service-fees-mostly-futile
            [post_title] => State's attempt to curb pharmacy benefit manager service fees mostly futile
            [post_author] => 2
            [post_date] => 2019-07-01 15:29:00
            [year] => 2019
            [month] => 7
            [post_type] => post
        )

    [455] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10178
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-273
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 273)
            [post_author] => 2
            [post_date] => 2019-06-28 13:32:00
            [year] => 2019
            [month] => 6
            [post_type] => post
        )

    [456] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10179
            [post_name] => help-is-on-the-way-federal-lawsuit-accuses-generic-drug-makers-of-using-code-to-fix-price-increases
            [post_title] => Help is on the way: Federal lawsuit accuses generic drug makers of using "code" to fix price increases
            [post_author] => 2
            [post_date] => 2019-06-27 15:52:00
            [year] => 2019
            [month] => 6
            [post_type] => post
        )

    [457] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10180
            [post_name] => aarp-report-specialty-drug-prices-soar-to-nearly-79000-per-year
            [post_title] => AARP Report: Specialty Drug Prices Soar to Nearly $79,000 per Year
            [post_author] => 2
            [post_date] => 2019-06-26 15:58:00
            [year] => 2019
            [month] => 6
            [post_type] => post
        )

    [458] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10181
            [post_name] => another-opaque-pbm-contract-bites-the-dust
            [post_title] => Another opaque PBM contract bites the dust
            [post_author] => 2
            [post_date] => 2019-06-21 13:25:00
            [year] => 2019
            [month] => 6
            [post_type] => post
        )

    [459] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10182
            [post_name] => could-proposed-rebate-rule-be-a-once-in-a-generation-opportunity-to-reset-our-system-to-work-better
            [post_title] => Could proposed rebate rule be a once-in-a-generation opportunity to reset our system to work better?
            [post_author] => 2
            [post_date] => 2019-06-18 23:06:00
            [year] => 2019
            [month] => 6
            [post_type] => post
        )

    [460] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10183
            [post_name] => ohio-cancels-bad-pbm-contracts-and-quickly-gets-a-better-deal
            [post_title] => Ohio Cancels Bad PBM Contracts and Quickly Gets a Better Deal
            [post_author] => 2
            [post_date] => 2019-06-15 02:07:00
            [year] => 2019
            [month] => 6
            [post_type] => post
        )

    [461] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10184
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-272
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 272)
            [post_author] => 2
            [post_date] => 2019-06-13 21:48:00
            [year] => 2019
            [month] => 6
            [post_type] => post
        )

    [462] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10185
            [post_name] => massachusetts-health-policy-commission-report-non-fiduciary-pbms-are-driving-up-health-care-costs
            [post_title] => Massachusetts Health Policy Commission report: Non-fiduciary PBMs are driving up health care costs
            [post_author] => 2
            [post_date] => 2019-06-07 15:40:00
            [year] => 2019
            [month] => 6
            [post_type] => post
        )

    [463] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10186
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-271
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 271)
            [post_author] => 2
            [post_date] => 2019-06-06 16:38:00
            [year] => 2019
            [month] => 6
            [post_type] => post
        )

    [464] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10187
            [post_name] => the-big-payback-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels
            [post_title] => "The Big Payback" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2019-06-04 18:08:00
            [year] => 2019
            [month] => 6
            [post_type] => post
        )

    [465] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10188
            [post_name] => cvss-push-into-your-doctors-office
            [post_title] => CVS's Push Into Your Doctor's Office
            [post_author] => 2
            [post_date] => 2019-06-03 22:02:00
            [year] => 2019
            [month] => 6
            [post_type] => post
        )

    [466] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10189
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-270
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 270)
            [post_author] => 2
            [post_date] => 2019-05-31 03:11:00
            [year] => 2019
            [month] => 5
            [post_type] => post
        )

    [467] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10190
            [post_name] => good-options-to-help-self-insured-employers-improve-pbm-contracting-efficiency
            [post_title] => Good Options To Help Self-Insured Employers Improve PBM Contracting Efficiency
            [post_author] => 2
            [post_date] => 2019-05-29 23:24:00
            [year] => 2019
            [month] => 5
            [post_type] => post
        )

    [468] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10191
            [post_name] => kentucky-report-opening-the-black-box-reveals-non-fiduciary-pbms-took-home-123-million-from-spread-pricing
            [post_title] => Kentucky Report:  "Opening the Black Box" Reveals Non-Fiduciary PBMs Took Home $123 Million From Spread Pricing
            [post_author] => 2
            [post_date] => 2019-05-28 12:42:00
            [year] => 2019
            [month] => 5
            [post_type] => post
        )

    [469] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10192
            [post_name] => sweeping-health-care-legislation-proposal-calls-for-disclosure-of-perks-and-fees-paid-to-health-benefits-brokers
            [post_title] => Sweeping Health Care Legislation Proposal Calls for Disclosure of Perks and Fees Paid to Health Benefits Brokers
            [post_author] => 2
            [post_date] => 2019-05-27 14:40:00
            [year] => 2019
            [month] => 5
            [post_type] => post
        )

    [470] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10193
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-269
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 269)
            [post_author] => 2
            [post_date] => 2019-05-23 14:02:00
            [year] => 2019
            [month] => 5
            [post_type] => post
        )

    [471] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10194
            [post_name] => elimination-of-pbm-gag-clauses-allow-independent-pharmacies-to-save-patients-money-on-prescription-drugs
            [post_title] => Elimination of PBM Gag Clauses Allow Independent Pharmacies to Save Patients Money on Prescription Drugs
            [post_author] => 2
            [post_date] => 2019-05-22 13:25:00
            [year] => 2019
            [month] => 5
            [post_type] => post
        )

    [472] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10195
            [post_name] => top-7-reasons-the-pbm-industry-is-ripe-for-disruption
            [post_title] => Top 7 Reasons the PBM Industry is Ripe for Disruption
            [post_author] => 2
            [post_date] => 2019-05-20 17:12:00
            [year] => 2019
            [month] => 5
            [post_type] => post
        )

    [473] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10196
            [post_name] => heres-one-reason-why-prescription-drug-prices-are-so-high-the-fix-is-in
            [post_title] => Here's one reason why prescription drug prices are so high: the fix is in!
            [post_author] => 2
            [post_date] => 2019-05-13 13:52:00
            [year] => 2019
            [month] => 5
            [post_type] => post
        )

    [474] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10197
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-268
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 268)
            [post_author] => 2
            [post_date] => 2019-05-09 17:17:00
            [year] => 2019
            [month] => 5
            [post_type] => post
        )

    [475] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10198
            [post_name] => the-big-payback-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-2
            [post_title] => "The Big Payback" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2019-05-08 19:49:00
            [year] => 2019
            [month] => 5
            [post_type] => post
        )

    [476] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10199
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-267
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 267)
            [post_author] => 2
            [post_date] => 2019-05-02 14:38:00
            [year] => 2019
            [month] => 5
            [post_type] => post
        )

    [477] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10200
            [post_name] => copay-accumulator-programs-now-allowed-by-cms-to-encourage-switch-to-generic-drugs
            [post_title] => Copay Accumulator Programs Now Allowed by CMS to Encourage Switch to Generic Drugs
            [post_author] => 2
            [post_date] => 2019-04-30 17:06:00
            [year] => 2019
            [month] => 4
            [post_type] => post
        )

    [478] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10201
            [post_name] => ohios-attorney-general-calls-for-pbms-to-operate-as-fiduciaries
            [post_title] => Ohio's Attorney General Calls for PBMs to Operate as Fiduciaries
            [post_author] => 2
            [post_date] => 2019-04-29 16:55:00
            [year] => 2019
            [month] => 4
            [post_type] => post
        )

    [479] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10202
            [post_name] => are-specialty-drug-pricing-spreads-the-new-money-pit-vis-a-vis-rebates
            [post_title] => Are specialty drug pricing spreads the new money pit vis-a-vis rebates?
            [post_author] => 2
            [post_date] => 2019-04-26 14:45:00
            [year] => 2019
            [month] => 4
            [post_type] => post
        )

    [480] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10203
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-266
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 266)
            [post_author] => 2
            [post_date] => 2019-04-25 20:15:00
            [year] => 2019
            [month] => 4
            [post_type] => post
        )

    [481] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10204
            [post_name] => short-fills-eliminate-medication-waste-and-reduces-costs
            [post_title] => Short fills eliminate medication waste and reduces costs
            [post_author] => 2
            [post_date] => 2019-04-22 15:13:00
            [year] => 2019
            [month] => 4
            [post_type] => post
        )

    [482] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10205
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-265
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 265)
            [post_author] => 2
            [post_date] => 2019-04-18 12:57:00
            [year] => 2019
            [month] => 4
            [post_type] => post
        )

    [483] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10206
            [post_name] => cross-walk-hcpcs-codes-to-ndc-codes-for-granular-medical-benefit-drug-claim-mbdc-information
            [post_title] => Cross-walk HCPCS codes to NDC codes for granular medical benefit drug claim (MBDC) information
            [post_author] => 2
            [post_date] => 2019-04-17 16:30:00
            [year] => 2019
            [month] => 4
            [post_type] => post
        )

    [484] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10207
            [post_name] => bureau-of-securities-releases-rule-to-impose-fiduciary-duty-on-brokers
            [post_title] => Bureau of Securities Releases Rule to Impose Fiduciary Duty on Brokers
            [post_author] => 2
            [post_date] => 2019-04-16 17:53:00
            [year] => 2019
            [month] => 4
            [post_type] => post
        )

    [485] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10208
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-264
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 264)
            [post_author] => 2
            [post_date] => 2019-04-04 20:49:00
            [year] => 2019
            [month] => 4
            [post_type] => post
        )

    [486] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10209
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2019-04-03 19:57:00
            [year] => 2019
            [month] => 4
            [post_type] => post
        )

    [487] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10211
            [post_name] => electronic-prior-authorizations-epa-save-plan-sponsors-time-and-money
            [post_title] => Electronic Prior Authorizations (ePA) Save Plan Sponsors Time and Money
            [post_author] => 2
            [post_date] => 2019-03-31 13:36:00
            [year] => 2019
            [month] => 3
            [post_type] => post
        )

    [488] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10212
            [post_name] => understanding-the-complexity-of-dir-fees
            [post_title] => Understanding the Complexity of DIR Fees
            [post_author] => 2
            [post_date] => 2019-03-30 22:48:00
            [year] => 2019
            [month] => 3
            [post_type] => post
        )

    [489] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 10213
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-263
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 263)
            [post_author] => 2
            [post_date] => 2019-03-28 13:21:00
            [year] => 2019
            [month] => 3
            [post_type] => post
        )

    [490] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10214
            [post_name] => robbing-peter-to-pay-paul-co-pay-accumulator-programs-could-be-doing-more-harm-than-good
            [post_title] => Robbing Peter to Pay Paul: Co-Pay Accumulator Programs Could be Doing More Harm Than Good
            [post_author] => 2
            [post_date] => 2019-03-27 15:31:00
            [year] => 2019
            [month] => 3
            [post_type] => post
        )

    [491] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10215
            [post_name] => smaller-independent-pharmacies-consistently-offer-cheaper-options-than-chain-pharmacies
            [post_title] => Smaller independent pharmacies consistently offer cheaper options than chain pharmacies
            [post_author] => 2
            [post_date] => 2019-03-26 15:26:00
            [year] => 2019
            [month] => 3
            [post_type] => post
        )

    [492] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10216
            [post_name] => dont-look-now-but-things-are-getting-even-more-complicated-point-of-sale-discounts-rebates-to-consumers-as-part-of-employer-sponsored-plan-design
            [post_title] => Don't look now but things are getting even more complicated: Point-of-sale discounts (rebates) to consumers as part of employer-sponsored plan design
            [post_author] => 2
            [post_date] => 2019-03-25 15:03:00
            [year] => 2019
            [month] => 3
            [post_type] => post
        )

    [493] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10217
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-262
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 262)
            [post_author] => 2
            [post_date] => 2019-03-24 15:36:00
            [year] => 2019
            [month] => 3
            [post_type] => post
        )

    [494] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10218
            [post_name] => a-lack-of-competition-leads-to-brand-drug-price-increases
            [post_title] => A Lack of Competition Leads to Brand Drug Price Increases
            [post_author] => 2
            [post_date] => 2019-03-21 23:01:00
            [year] => 2019
            [month] => 3
            [post_type] => post
        )

    [495] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10219
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-261
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 261)
            [post_author] => 2
            [post_date] => 2019-03-14 20:00:00
            [year] => 2019
            [month] => 3
            [post_type] => post
        )

    [496] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10220
            [post_name] => uncovering-hidden-specialty-drug-spend-outside-of-the-pharmacy-benefit
            [post_title] => Uncovering Hidden Specialty Drug Spend Outside of the Pharmacy Benefit
            [post_author] => 1
            [post_date] => 2019-03-11 17:32:00
            [year] => 2019
            [month] => 3
            [post_type] => post
        )

    [497] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10221
            [post_name] => eli-lilly-and-company-to-offer-generic-insulin-at-50-off-brand-name-humalog
            [post_title] => Eli Lilly and Company to Offer Generic Insulin at 50% Off Brand Name Humalog
            [post_author] => 2
            [post_date] => 2019-03-06 19:11:00
            [year] => 2019
            [month] => 3
            [post_type] => post
        )

    [498] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10222
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-2
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2019-03-05 18:12:00
            [year] => 2019
            [month] => 3
            [post_type] => post
        )

    [499] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10223
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-260
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 260)
            [post_author] => 2
            [post_date] => 2019-03-01 18:51:00
            [year] => 2019
            [month] => 3
            [post_type] => post
        )

    [500] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10224
            [post_name] => how-to-save-1-6-million-bucks-5-tips-for-cutting-specialty-pharmacy-costs
            [post_title] => How to Save $1.6 Million Bucks:  5 Tips for Cutting Specialty Pharmacy Costs
            [post_author] => 2
            [post_date] => 2019-02-25 19:33:00
            [year] => 2019
            [month] => 2
            [post_type] => post
        )

    [501] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10225
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-259
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 259)
            [post_author] => 2
            [post_date] => 2019-02-21 14:13:00
            [year] => 2019
            [month] => 2
            [post_type] => post
        )

    [502] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10226
            [post_name] => how-self-funded-employers-leave-employees-holding-the-bag-the-copay-clawback-phenomenon
            [post_title] => How Self-Funded Employers Leave Employees Holding the Bag: The Copay Clawback Phenomenon:
            [post_author] => 2
            [post_date] => 2019-02-19 15:42:00
            [year] => 2019
            [month] => 2
            [post_type] => post
        )

    [503] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10227
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-258
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 258)
            [post_author] => 2
            [post_date] => 2019-02-15 14:51:00
            [year] => 2019
            [month] => 2
            [post_type] => post
        )

    [504] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10228
            [post_name] => a-closer-look-into-the-popular-pricing-benchmark-average-wholesale-price-awp
            [post_title] => A Closer Look into the Popular Pricing Benchmark: Average Wholesale Price (AWP)
            [post_author] => 1
            [post_date] => 2019-02-14 16:31:00
            [year] => 2019
            [month] => 2
            [post_type] => post
        )

    [505] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10229
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-257
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 257)
            [post_author] => 2
            [post_date] => 2019-02-08 01:29:00
            [year] => 2019
            [month] => 2
            [post_type] => post
        )

    [506] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10230
            [post_name] => ohios-state-auditor-just-released-its-full-report-on-pbm-transparency-and-you-wont-believe-your-eyes
            [post_title] => Ohio's State Auditor Just Released its Full Report on PBM Transparency and You Won't Believe Your Eyes
            [post_author] => 2
            [post_date] => 2019-02-06 15:11:00
            [year] => 2019
            [month] => 2
            [post_type] => post
        )

    [507] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10231
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-256
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 256)
            [post_author] => 2
            [post_date] => 2019-01-31 14:08:00
            [year] => 2019
            [month] => 1
            [post_type] => post
        )

    [508] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10232
            [post_name] => big-pharma-is-slow-to-allow-health-outcomes-to-dictate-pricing-at-least-for-now
            [post_title] => Big Pharma is Slow to Allow Health Outcomes to Dictate Pricing -- At Least For Now
            [post_author] => 2
            [post_date] => 2019-01-30 22:01:00
            [year] => 2019
            [month] => 1
            [post_type] => post
        )

    [509] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10233
            [post_name] => outcomes-based-contracting-for-prescription-drugs-is-set-to-accelerate
            [post_title] => Outcomes-Based Contracting for Prescription Drugs is Set to Accelerate
            [post_author] => 2
            [post_date] => 2019-01-29 15:03:00
            [year] => 2019
            [month] => 1
            [post_type] => post
        )

    [510] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10234
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-255
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 255)
            [post_author] => 2
            [post_date] => 2019-01-24 17:13:00
            [year] => 2019
            [month] => 1
            [post_type] => post
        )

    [511] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10235
            [post_name] => access-to-drug-cost-data-before-leaving-the-doctors-office
            [post_title] => Access to Drug Cost Data Before Leaving the Doctor’s Office
            [post_author] => 1
            [post_date] => 2019-01-23 13:50:00
            [year] => 2019
            [month] => 1
            [post_type] => post
        )

    [512] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10236
            [post_name] => employers-are-sticking-it-to-employees-with-rebates-for-a-couple-of-dollars-in-savings
            [post_title] => Employers are Sticking it to Employees, with Rebates, for a Couple of Dollars in Savings
            [post_author] => 2
            [post_date] => 2019-01-21 14:21:00
            [year] => 2019
            [month] => 1
            [post_type] => post
        )

    [513] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10237
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-254
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 254)
            [post_author] => 2
            [post_date] => 2019-01-17 13:40:00
            [year] => 2019
            [month] => 1
            [post_type] => post
        )

    [514] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10238
            [post_name] => cvs-makes-dubious-case-for-rebates-impact-on-drug-prices
            [post_title] => CVS makes dubious case for rebates’ impact on drug prices
            [post_author] => 2
            [post_date] => 2019-01-14 17:38:00
            [year] => 2019
            [month] => 1
            [post_type] => post
        )

    [515] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10239
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-253
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 253)
            [post_author] => 2
            [post_date] => 2019-01-11 13:24:00
            [year] => 2019
            [month] => 1
            [post_type] => post
        )

    [516] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10240
            [post_name] => turns-out-cvss-new-guaranteed-net-cost-pricing-model-is-more-of-the-same-that-is-bait-and-switch
            [post_title] => Turns out CVS's "New" Guaranteed Net Cost Pricing Model is More of the Same - That is Bait and Switch
            [post_author] => 2
            [post_date] => 2019-01-10 19:41:00
            [year] => 2019
            [month] => 1
            [post_type] => post
        )

    [517] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10241
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-252
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 252)
            [post_author] => 2
            [post_date] => 2019-01-03 19:10:00
            [year] => 2019
            [month] => 1
            [post_type] => post
        )

    [518] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10242
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-3
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2019-01-02 14:16:00
            [year] => 2019
            [month] => 1
            [post_type] => post
        )

    [519] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 10243
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-251
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 251)
            [post_author] => 2
            [post_date] => 2018-12-28 20:55:00
            [year] => 2018
            [month] => 12
            [post_type] => post
        )

    [520] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10244
            [post_name] => are-biosimilars-the-future-of-specialty-pharmacy
            [post_title] => Are Biosimilars the Future of Specialty Pharmacy?
            [post_author] => 2
            [post_date] => 2018-12-27 18:51:00
            [year] => 2018
            [month] => 12
            [post_type] => post
        )

    [521] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 10245
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-250
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 250)
            [post_author] => 2
            [post_date] => 2018-12-20 14:32:00
            [year] => 2018
            [month] => 12
            [post_type] => post
        )

    [522] => stdClass Object
        (
            [slug] => radical-transparency
            [ID] => 10246
            [post_name] => pennsylvanias-auditor-general-demands-pbm-contracting-transparency
            [post_title] => Pennsylvania's Auditor General Demands PBM Contracting Transparency
            [post_author] => 2
            [post_date] => 2018-12-18 18:12:00
            [year] => 2018
            [month] => 12
            [post_type] => post
        )

    [523] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 10247
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-249
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 249)
            [post_author] => 2
            [post_date] => 2018-12-14 02:41:00
            [year] => 2018
            [month] => 12
            [post_type] => post
        )

    [524] => stdClass Object
        (
            [slug] => evaluate-pbm-performance
            [ID] => 10248
            [post_name] => ninety-two-percent-of-self-insured-companies-lack-a-formalized-pharmacy-benefits-management-process
            [post_title] => Ninety-Two Percent of Self-Insured Companies Lack a Formalized Pharmacy Benefits Management Process
            [post_author] => 2
            [post_date] => 2018-12-09 20:27:00
            [year] => 2018
            [month] => 12
            [post_type] => post
        )

    [525] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10249
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-248
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 248)
            [post_author] => 2
            [post_date] => 2018-12-06 16:12:00
            [year] => 2018
            [month] => 12
            [post_type] => post
        )

    [526] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10250
            [post_name] => cvs-health-launches-new-guaranteed-net-cost-pricing-model
            [post_title] => CVS Health launches "New" Guaranteed Net Cost Pricing Model
            [post_author] => 2
            [post_date] => 2018-12-05 16:49:00
            [year] => 2018
            [month] => 12
            [post_type] => post
        )

    [527] => stdClass Object
        (
            [slug] => webinar
            [ID] => 10251
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-4
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2018-12-04 18:21:00
            [year] => 2018
            [month] => 12
            [post_type] => post
        )

    [528] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10252
            [post_name] => union-takes-to-task-pharmaceutical-manufacturer-on-a-6000000-per-year-specialty-drug
            [post_title] => Union takes to task pharmaceutical manufacturer on a $6,000,000 per year specialty drug
            [post_author] => 2
            [post_date] => 2018-12-03 13:47:00
            [year] => 2018
            [month] => 12
            [post_type] => post
        )

    [529] => stdClass Object
        (
            [slug] => reference-based-drug-pricing
            [ID] => 10253
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-247
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 247)
            [post_author] => 2
            [post_date] => 2018-11-29 12:55:00
            [year] => 2018
            [month] => 11
            [post_type] => post
        )

    [530] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10254
            [post_name] => 4-key-factors-employers-must-consider-when-evaluating-specialty-pharmacy-performance
            [post_title] => 4 Key Factors Employers Must Consider When Evaluating Specialty Pharmacy Performance
            [post_author] => 2
            [post_date] => 2018-11-29 00:38:00
            [year] => 2018
            [month] => 11
            [post_type] => post
        )

    [531] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10255
            [post_name] => state-settles-500k-dispute-with-a-big-three-pharmacy-benefits-manager
            [post_title] => State Settles $500k Dispute with a Big Three Pharmacy Benefits Manager
            [post_author] => 2
            [post_date] => 2018-11-26 19:17:00
            [year] => 2018
            [month] => 11
            [post_type] => post
        )

    [532] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10256
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-246
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 246)
            [post_author] => 2
            [post_date] => 2018-11-21 19:42:00
            [year] => 2018
            [month] => 11
            [post_type] => post
        )

    [533] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10257
            [post_name] => express-scripts-announces-new-formulary-that-favors-lower-cost-generics
            [post_title] => Express Scripts announces "new" formulary that favors lower-cost generics
            [post_author] => 2
            [post_date] => 2018-11-19 20:23:00
            [year] => 2018
            [month] => 11
            [post_type] => post
        )

    [534] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10258
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-245
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 245)
            [post_author] => 2
            [post_date] => 2018-11-15 13:11:00
            [year] => 2018
            [month] => 11
            [post_type] => post
        )

    [535] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10259
            [post_name] => achievement-is-significant-but-comes-with-a-huge-price-tag-new-regulation-requires-regulatory-oversight-of-pharmacy-benefit-managers-pbms
            [post_title] => Achievement is Significant But Comes with a Huge Price Tag: New Regulation Requires Regulatory Oversight of Pharmacy Benefit Managers (“PBMs”)
            [post_author] => 2
            [post_date] => 2018-11-14 15:20:00
            [year] => 2018
            [month] => 11
            [post_type] => post
        )

    [536] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10260
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-244
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 244)
            [post_author] => 2
            [post_date] => 2018-11-08 13:49:00
            [year] => 2018
            [month] => 11
            [post_type] => post
        )

    [537] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10261
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-5
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2018-11-07 12:44:00
            [year] => 2018
            [month] => 11
            [post_type] => post
        )

    [538] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10262
            [post_name] => unless-your-company-has-money-to-burn-dont-ignore-these-7-pbm-contract-pitfalls
            [post_title] => Unless Your Company Has Money to Burn Don't Ignore These 7 PBM Contract Pitfalls
            [post_author] => 2
            [post_date] => 2018-11-06 15:03:00
            [year] => 2018
            [month] => 11
            [post_type] => post
        )

    [539] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10263
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-243
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 243)
            [post_author] => 2
            [post_date] => 2018-11-01 13:11:00
            [year] => 2018
            [month] => 11
            [post_type] => post
        )

    [540] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10264
            [post_name] => most-employers-60-arent-tracking-wasteful-healthcare-spending
            [post_title] => Most employers (60%) aren't tracking wasteful healthcare spending
            [post_author] => 2
            [post_date] => 2018-10-30 14:10:00
            [year] => 2018
            [month] => 10
            [post_type] => post
        )

    [541] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10265
            [post_name] => pepsico-and-exxonmobil-team-up-with-express-scripts-to-create-pharmacy-benefit-design-for-radical-transparency-and-greater-performance-accountability
            [post_title] => PepsiCo and ExxonMobil Team Up with Express Scripts to Create Pharmacy Benefit Design for Radical Transparency and Greater Performance Accountability
            [post_author] => 2
            [post_date] => 2018-10-26 13:18:00
            [year] => 2018
            [month] => 10
            [post_type] => post
        )

    [542] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10266
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-242
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 242)
            [post_author] => 2
            [post_date] => 2018-10-25 13:37:00
            [year] => 2018
            [month] => 10
            [post_type] => post
        )

    [543] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10267
            [post_name] => unitedhealth-has-bought-another-billion-dollar-pharmacy-business
            [post_title] => UnitedHealth has bought another billion-dollar pharmacy business
            [post_author] => 2
            [post_date] => 2018-10-23 13:14:00
            [year] => 2018
            [month] => 10
            [post_type] => post
        )

    [544] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10268
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-241
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 241)
            [post_author] => 2
            [post_date] => 2018-10-18 19:10:00
            [year] => 2018
            [month] => 10
            [post_type] => post
        )

    [545] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10269
            [post_name] => another-big-pbm-has-confirmed-its-primary-objective-isnt-to-contain-prescription-drug-costs
            [post_title] => Another big PBM has confirmed it's primary objective isn't to contain prescription drug costs
            [post_author] => 2
            [post_date] => 2018-10-15 13:13:00
            [year] => 2018
            [month] => 10
            [post_type] => post
        )

    [546] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10270
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-240
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 240)
            [post_author] => 2
            [post_date] => 2018-10-11 12:52:00
            [year] => 2018
            [month] => 10
            [post_type] => post
        )

    [547] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10271
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-239
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 239)
            [post_author] => 2
            [post_date] => 2018-10-04 12:09:00
            [year] => 2018
            [month] => 10
            [post_type] => post
        )

    [548] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10272
            [post_name] => a-tough-negotiator-proves-employers-can-bargain-down-health-care-prices
            [post_title] => A Tough Negotiator Proves Employers Can Bargain Down Health Care Prices
            [post_author] => 2
            [post_date] => 2018-10-03 18:28:00
            [year] => 2018
            [month] => 10
            [post_type] => post
        )

    [549] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10273
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-6
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2018-10-02 12:47:00
            [year] => 2018
            [month] => 10
            [post_type] => post
        )

    [550] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10274
            [post_name] => abolishing-drug-rebates-may-push-consumer-drug-costs-higher
            [post_title] => Abolishing Drug Rebates May Push Consumer Drug Costs Higher
            [post_author] => 2
            [post_date] => 2018-09-28 16:21:00
            [year] => 2018
            [month] => 9
            [post_type] => post
        )

    [551] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10275
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-238
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 238)
            [post_author] => 2
            [post_date] => 2018-09-27 17:14:00
            [year] => 2018
            [month] => 9
            [post_type] => post
        )

    [552] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10276
            [post_name] => gilead-to-launch-generic-versions-of-its-hepatitis-drugs
            [post_title] => Gilead to launch generic versions of its hepatitis drugs
            [post_author] => 2
            [post_date] => 2018-09-26 20:42:00
            [year] => 2018
            [month] => 9
            [post_type] => post
        )

    [553] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10277
            [post_name] => fiduciary-rule-revival-should-it-apply-to-pharmacy-benefits-managers
            [post_title] => Fiduciary rule revival: Should it apply to pharmacy benefits managers?
            [post_author] => 2
            [post_date] => 2018-09-25 19:54:00
            [year] => 2018
            [month] => 9
            [post_type] => post
        )

    [554] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10278
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-237
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 237)
            [post_author] => 2
            [post_date] => 2018-09-20 14:27:00
            [year] => 2018
            [month] => 9
            [post_type] => post
        )

    [555] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10279
            [post_name] => why-third-party-payers-are-gobbling-up-pbms
            [post_title] => Why third-party payers are gobbling up PBMs
            [post_author] => 2
            [post_date] => 2018-09-18 19:52:00
            [year] => 2018
            [month] => 9
            [post_type] => post
        )

    [556] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10280
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-236
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 236)
            [post_author] => 2
            [post_date] => 2018-09-13 15:17:00
            [year] => 2018
            [month] => 9
            [post_type] => post
        )

    [557] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10281
            [post_name] => the-marriott-rewards-program-and-non-fiduciary-pbms-have-a-lot-in-common
            [post_title] => The Marriott Rewards Program and Non-Fiduciary PBMs have a lot in common
            [post_author] => 2
            [post_date] => 2018-09-12 14:38:00
            [year] => 2018
            [month] => 9
            [post_type] => post
        )

    [558] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10282
            [post_name] => the-secret-drug-pricing-system-middlemen-use-to-rake-in-millions
            [post_title] => The Secret Drug Pricing System Middlemen Use to Rake in Millions
            [post_author] => 2
            [post_date] => 2018-09-11 15:05:00
            [year] => 2018
            [month] => 9
            [post_type] => post
        )

    [559] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10283
            [post_name] => health-plan-with-495000-covered-lives-says-prescription-medications-account-for-one-in-four-dollars-spent
            [post_title] => Health Plan with 495,000 Covered Lives Says Prescription Medications Account For One in Four Dollars Spent
            [post_author] => 2
            [post_date] => 2018-09-10 14:23:00
            [year] => 2018
            [month] => 9
            [post_type] => post
        )

    [560] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10284
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-235
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 235)
            [post_author] => 2
            [post_date] => 2018-09-06 14:53:00
            [year] => 2018
            [month] => 9
            [post_type] => post
        )

    [561] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10285
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-7
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2018-09-04 12:22:00
            [year] => 2018
            [month] => 9
            [post_type] => post
        )

    [562] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10286
            [post_name] => bcbs-of-tennessee-prescription-drugs-have-become-the-single-leading-cost-driver
            [post_title] => BCBS of Tennessee: Prescription Drugs Have Become the Single Leading Cost Driver
            [post_author] => 2
            [post_date] => 2018-08-31 13:42:00
            [year] => 2018
            [month] => 8
            [post_type] => post
        )

    [563] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10287
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-234
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 234)
            [post_author] => 2
            [post_date] => 2018-08-30 12:56:00
            [year] => 2018
            [month] => 8
            [post_type] => post
        )

    [564] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10288
            [post_name] => is-consolidation-in-health-care-good-for-employers
            [post_title] => Is consolidation in health care good for employers?
            [post_author] => 2
            [post_date] => 2018-08-29 13:13:00
            [year] => 2018
            [month] => 8
            [post_type] => post
        )

    [565] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10289
            [post_name] => three-ways-to-avoid-bankrupting-costs-for-medical-spend-j-code-drugs
            [post_title] => Three Ways to Avoid Bankrupting Costs for Medical Spend J Code Drugs
            [post_author] => 2
            [post_date] => 2018-08-28 15:03:00
            [year] => 2018
            [month] => 8
            [post_type] => post
        )

    [566] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10290
            [post_name] => large-pbm-is-staking-out-million-dollar-gene-therapies
            [post_title] => Large PBM is staking out million-dollar gene therapies
            [post_author] => 2
            [post_date] => 2018-08-27 20:51:00
            [year] => 2018
            [month] => 8
            [post_type] => post
        )

    [567] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10291
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-233
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 233)
            [post_author] => 2
            [post_date] => 2018-08-23 16:04:00
            [year] => 2018
            [month] => 8
            [post_type] => post
        )

    [568] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10292
            [post_name] => auditors-report-pharmacy-benefit-managers-take-fees-of-31-on-generic-drugs-worth-208m-in-one-year-period
            [post_title] => Auditor’s Report: Pharmacy Benefit Managers Take Fees of 31% on Generic Drugs Worth $208M in One-Year Period
            [post_author] => 2
            [post_date] => 2018-08-22 13:31:00
            [year] => 2018
            [month] => 8
            [post_type] => post
        )

    [569] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10293
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-232
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 232)
            [post_author] => 2
            [post_date] => 2018-08-16 18:16:00
            [year] => 2018
            [month] => 8
            [post_type] => post
        )

    [570] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10294
            [post_name] => ohio-medicaid-pulls-the-plug-on-contracts-with-two-big-pbms-over-spread-pricing
            [post_title] => Ohio Medicaid pulls the plug on contracts with two big PBMs over ‘spread’ pricing
            [post_author] => 2
            [post_date] => 2018-08-15 17:12:00
            [year] => 2018
            [month] => 8
            [post_type] => post
        )

    [571] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10295
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-231
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 231)
            [post_author] => 2
            [post_date] => 2018-08-10 22:26:00
            [year] => 2018
            [month] => 8
            [post_type] => post
        )

    [572] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10296
            [post_name] => secret-discounts-paid-by-drugmakers-to-pharmacy-benefit-managers-are-going-away-so-now-what
            [post_title] => Secret discounts paid by drugmakers to pharmacy benefit managers are going away so now what?
            [post_author] => 2
            [post_date] => 2018-08-08 17:03:00
            [year] => 2018
            [month] => 8
            [post_type] => post
        )

    [573] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10297
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-8
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2018-08-07 12:41:00
            [year] => 2018
            [month] => 8
            [post_type] => post
        )

    [574] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10298
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-230
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 230)
            [post_author] => 2
            [post_date] => 2018-08-02 16:07:00
            [year] => 2018
            [month] => 8
            [post_type] => post
        )

    [575] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10299
            [post_name] => fda-biosimilar-plan-offers-employers-saving-strategy-solution
            [post_title] => FDA Biosimilar Plan Offers Employers Saving Strategy Solution
            [post_author] => 2
            [post_date] => 2018-07-31 12:46:00
            [year] => 2018
            [month] => 7
            [post_type] => post
        )

    [576] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10300
            [post_name] => meet-the-rebate-the-new-villain-of-high-drug-prices
            [post_title] => Meet the Rebate, the New Villain of High Drug Prices
            [post_author] => 2
            [post_date] => 2018-07-30 20:57:00
            [year] => 2018
            [month] => 7
            [post_type] => post
        )

    [577] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10301
            [post_name] => million-dollar-medical-claims-increase-87-percent-from-2014-2017-sun-life-report
            [post_title] => Million-dollar+ medical claims increase 87 percent from 2014-2017: Sun Life report
            [post_author] => 2
            [post_date] => 2018-07-27 22:46:00
            [year] => 2018
            [month] => 7
            [post_type] => post
        )

    [578] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10302
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-229
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 229)
            [post_author] => 2
            [post_date] => 2018-07-26 17:42:00
            [year] => 2018
            [month] => 7
            [post_type] => post
        )

    [579] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10303
            [post_name] => the-bezos-buffett-dimon-health-care-venture-eliminate-the-middlemen
            [post_title] => The Bezos-Buffett-Dimon health care venture: Eliminate the middlemen
            [post_author] => 2
            [post_date] => 2018-07-24 12:08:00
            [year] => 2018
            [month] => 7
            [post_type] => post
        )

    [580] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10304
            [post_name] => department-of-health-and-human-services-hhs-blueprint-to-lower-drug-prices-and-reduce-out-of-pocket-costs
            [post_title] => Department of Health and Human Services (HHS) Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs
            [post_author] => 2
            [post_date] => 2018-07-23 12:43:00
            [year] => 2018
            [month] => 7
            [post_type] => post
        )

    [581] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10305
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-228
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 228)
            [post_author] => 2
            [post_date] => 2018-07-19 16:10:00
            [year] => 2018
            [month] => 7
            [post_type] => post
        )

    [582] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10306
            [post_name] => amazons-pillpack-deal-puts-pbms-advisers-on-notice
            [post_title] => Amazon’s PillPack deal puts PBMs, advisers on notice
            [post_author] => 2
            [post_date] => 2018-07-18 12:42:00
            [year] => 2018
            [month] => 7
            [post_type] => post
        )

    [583] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10307
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-227
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 227)
            [post_author] => 2
            [post_date] => 2018-07-16 20:12:00
            [year] => 2018
            [month] => 7
            [post_type] => post
        )

    [584] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10308
            [post_name] => ifebp-provides-tips-on-managing-specialty-drugs
            [post_title] => IFEBP provides tips on managing specialty drugs
            [post_author] => 2
            [post_date] => 2018-07-12 21:25:00
            [year] => 2018
            [month] => 7
            [post_type] => post
        )

    [585] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10309
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-226
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 226)
            [post_author] => 2
            [post_date] => 2018-07-05 14:55:00
            [year] => 2018
            [month] => 7
            [post_type] => post
        )

    [586] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10310
            [post_name] => clawbacks-settling-the-score-with-non-fiduciary-pharmacy-benefit-managers
            [post_title] => Clawbacks: Settling the score with non-fiduciary pharmacy benefit managers
            [post_author] => 2
            [post_date] => 2018-07-03 14:04:00
            [year] => 2018
            [month] => 7
            [post_type] => post
        )

    [587] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10311
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-225
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 225)
            [post_author] => 2
            [post_date] => 2018-06-28 12:15:00
            [year] => 2018
            [month] => 6
            [post_type] => post
        )

    [588] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10312
            [post_name] => what-is-a-fair-share-pharmacy-middlemen-made-223-7m-from-ohio-medicaid
            [post_title] => What is a fair share? Pharmacy middlemen made $223.7M from Ohio Medicaid
            [post_author] => 2
            [post_date] => 2018-06-26 14:38:00
            [year] => 2018
            [month] => 6
            [post_type] => post
        )

    [589] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10313
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-224
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 224)
            [post_author] => 2
            [post_date] => 2018-06-25 14:31:00
            [year] => 2018
            [month] => 6
            [post_type] => post
        )

    [590] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10314
            [post_name] => dereliction-of-fiduciary-duties-by-cfos-and-hr-execs-triggering-department-of-labor-investigations
            [post_title] => Dereliction of Fiduciary Duties by CFOs and HR Execs Triggering Department of Labor Investigations
            [post_author] => 2
            [post_date] => 2018-06-20 19:37:00
            [year] => 2018
            [month] => 6
            [post_type] => post
        )

    [591] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10315
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-223
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 223)
            [post_author] => 2
            [post_date] => 2018-06-14 15:36:00
            [year] => 2018
            [month] => 6
            [post_type] => post
        )

    [592] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10316
            [post_name] => 3-strategies-for-reducing-pharmacy-costs
            [post_title] => 3 strategies for reducing pharmacy costs
            [post_author] => 2
            [post_date] => 2018-06-13 14:28:00
            [year] => 2018
            [month] => 6
            [post_type] => post
        )

    [593] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10317
            [post_name] => state-rx-law-cut-down-on-appeal-benefits-manager-group-prevails-in-federal-panel-ruling
            [post_title] => State Rx law cut down on appeal; benefits manager group prevails in federal panel ruling
            [post_author] => 2
            [post_date] => 2018-06-10 15:05:00
            [year] => 2018
            [month] => 6
            [post_type] => post
        )

    [594] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10318
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-222
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 222)
            [post_author] => 2
            [post_date] => 2018-06-07 12:17:00
            [year] => 2018
            [month] => 6
            [post_type] => post
        )

    [595] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10319
            [post_name] => mergers-between-health-insurers-and-pharmacy-benefit-managers-could-be-bad-for-your-health
            [post_title] => Mergers between health insurers and pharmacy benefit managers could be bad for your health
            [post_author] => 2
            [post_date] => 2018-06-06 13:28:00
            [year] => 2018
            [month] => 6
            [post_type] => post
        )

    [596] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10320
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-9
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2018-06-04 21:16:00
            [year] => 2018
            [month] => 6
            [post_type] => post
        )

    [597] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10321
            [post_name] => why-cvs-loves-obamacare
            [post_title] => Why CVS Loves ObamaCare
            [post_author] => 2
            [post_date] => 2018-06-01 15:24:00
            [year] => 2018
            [month] => 6
            [post_type] => post
        )

    [598] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10322
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-221
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 221)
            [post_author] => 2
            [post_date] => 2018-05-31 14:18:00
            [year] => 2018
            [month] => 5
            [post_type] => post
        )

    [599] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10323
            [post_name] => amgen-abbvie-ahead-of-the-crowd-in-fighting-payers-latest-assault-on-copay-coupons
            [post_title] => Amgen, AbbVie 'ahead of the crowd' in fighting payers' latest assault on copay coupons
            [post_author] => 2
            [post_date] => 2018-05-29 22:45:00
            [year] => 2018
            [month] => 5
            [post_type] => post
        )

    [600] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10324
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-220
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 220)
            [post_author] => 2
            [post_date] => 2018-05-24 12:16:00
            [year] => 2018
            [month] => 5
            [post_type] => post
        )

    [601] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10325
            [post_name] => trumps-drug-blueprint-could-alter-pbm-contracting
            [post_title] => Trump’s Drug Blueprint Could Alter PBM Contracting
            [post_author] => 2
            [post_date] => 2018-05-23 14:18:00
            [year] => 2018
            [month] => 5
            [post_type] => post
        )

    [602] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10326
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-219
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 219)
            [post_author] => 2
            [post_date] => 2018-05-18 11:23:00
            [year] => 2018
            [month] => 5
            [post_type] => post
        )

    [603] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10327
            [post_name] => appellate-court-kills-optums-6-7b-pharmacy-benefits-management-contract-orders-rebid
            [post_title] => Appellate court kills Optum's $6.7B pharmacy benefits management contract; orders rebid
            [post_author] => 2
            [post_date] => 2018-05-15 12:54:00
            [year] => 2018
            [month] => 5
            [post_type] => post
        )

    [604] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10328
            [post_name] => from-14000-to-8000-overnight-with-almost-no-restrictions-cholesterol-drug-has-potential-to-break-self-insured-employers-bank
            [post_title] => From $14000 to $8000 Overnight with Almost No Restrictions; Cholesterol Drug has Potential to Break Self-Insured Employers' Bank
            [post_author] => 2
            [post_date] => 2018-05-14 12:48:00
            [year] => 2018
            [month] => 5
            [post_type] => post
        )

    [605] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10329
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-218
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 218)
            [post_author] => 2
            [post_date] => 2018-05-10 18:26:00
            [year] => 2018
            [month] => 5
            [post_type] => post
        )

    [606] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10330
            [post_name] => longtime-chief-of-pharmacy-benefit-manager-trade-group-to-step-down
            [post_title] => Longtime chief of pharmacy benefit manager trade group to step down
            [post_author] => 2
            [post_date] => 2018-05-07 17:52:00
            [year] => 2018
            [month] => 5
            [post_type] => post
        )

    [607] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10331
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-217
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 217)
            [post_author] => 2
            [post_date] => 2018-05-03 11:36:00
            [year] => 2018
            [month] => 5
            [post_type] => post
        )

    [608] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10332
            [post_name] => esi-reachs-deal-on-struggling-cholesterol-drug-with-a-list-price-over-8000
            [post_title] => ESI Reachs Deal on Struggling Cholesterol Drug with a List Price Over $8000
            [post_author] => 2
            [post_date] => 2018-05-02 17:11:00
            [year] => 2018
            [month] => 5
            [post_type] => post
        )

    [609] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10333
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-10
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2018-05-01 12:51:00
            [year] => 2018
            [month] => 5
            [post_type] => post
        )

    [610] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10334
            [post_name] => therapeutic-interchange-how-it-could-affect-patients-and-plan-sponsors
            [post_title] => Therapeutic Interchange: How It Could Affect Patients and Plan Sponsors
            [post_author] => 2
            [post_date] => 2018-04-30 18:43:00
            [year] => 2018
            [month] => 4
            [post_type] => post
        )

    [611] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10335
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-216
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 216)
            [post_author] => 2
            [post_date] => 2018-04-26 21:26:00
            [year] => 2018
            [month] => 4
            [post_type] => post
        )

    [612] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10336
            [post_name] => the-role-of-pbms-in-the-drug-supply-chain-and-why-it-matters-to-employers
            [post_title] => The role of PBMs in the drug supply chain — and why it matters to employers
            [post_author] => 2
            [post_date] => 2018-04-25 20:30:00
            [year] => 2018
            [month] => 4
            [post_type] => post
        )

    [613] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10337
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-215
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 215)
            [post_author] => 2
            [post_date] => 2018-04-19 14:20:00
            [year] => 2018
            [month] => 4
            [post_type] => post
        )

    [614] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10338
            [post_name] => amazon-about-face-on-drug-sales-not-surprising-to-walgreens-and-cvs
            [post_title] => Amazon About-Face On Drug Sales Not Surprising To Walgreens And CVS
            [post_author] => 2
            [post_date] => 2018-04-17 17:36:00
            [year] => 2018
            [month] => 4
            [post_type] => post
        )

    [615] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10339
            [post_name] => the-price-of-non-optimized-medication-therapy
            [post_title] => The Price of Non-Optimized Medication Therapy
            [post_author] => 2
            [post_date] => 2018-04-16 13:06:00
            [year] => 2018
            [month] => 4
            [post_type] => post
        )

    [616] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10340
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-214
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 214)
            [post_author] => 2
            [post_date] => 2018-04-12 12:54:00
            [year] => 2018
            [month] => 4
            [post_type] => post
        )

    [617] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10341
            [post_name] => two-generic-medications-become-one-cash-cow-drug
            [post_title] => Two Generic Medications Become One Cash Cow Drug
            [post_author] => 2
            [post_date] => 2018-04-10 13:26:00
            [year] => 2018
            [month] => 4
            [post_type] => post
        )

    [618] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10342
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-11
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2018-04-08 17:11:00
            [year] => 2018
            [month] => 4
            [post_type] => post
        )

    [619] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10343
            [post_name] => when-left-to-their-own-accord-non-fiduciary-pbms-will-act-in-their-own-self-interest
            [post_title] => When left to their own accord, non-fiduciary PBMs will act in their own self-interest
            [post_author] => 2
            [post_date] => 2018-04-06 17:45:00
            [year] => 2018
            [month] => 4
            [post_type] => post
        )

    [620] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10344
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-213
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 213)
            [post_author] => 2
            [post_date] => 2018-04-05 11:50:00
            [year] => 2018
            [month] => 4
            [post_type] => post
        )

    [621] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10345
            [post_name] => newer-specialty-drugs-require-payers-to-revise-coverage-strategies
            [post_title] => Newer Specialty Drugs Require Payers to Revise Coverage Strategies
            [post_author] => 2
            [post_date] => 2018-04-04 16:53:00
            [year] => 2018
            [month] => 4
            [post_type] => post
        )

    [622] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10346
            [post_name] => standing-pat-cant-be-a-long-term-strategy-for-self-insured-employers
            [post_title] => Standing pat can't be a long-term strategy for self-insured employers
            [post_author] => 2
            [post_date] => 2018-04-03 11:51:00
            [year] => 2018
            [month] => 4
            [post_type] => post
        )

    [623] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10347
            [post_name] => whats-your-decision-flow-process
            [post_title] => What's your decision flow process?
            [post_author] => 2
            [post_date] => 2018-03-30 17:59:00
            [year] => 2018
            [month] => 3
            [post_type] => post
        )

    [624] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10348
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-212
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 212)
            [post_author] => 2
            [post_date] => 2018-03-29 13:44:00
            [year] => 2018
            [month] => 3
            [post_type] => post
        )

    [625] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10349
            [post_name] => clinical-reviews-an-underused-way-to-save-big-on-pharmacy-benefits
            [post_title] => Clinical Reviews | An underused way to save big on pharmacy benefits
            [post_author] => 2
            [post_date] => 2018-03-28 15:12:00
            [year] => 2018
            [month] => 3
            [post_type] => post
        )

    [626] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10350
            [post_name] => u-s-spending-on-drugs-will-grow-faster-than-on-other-health-care-services-over-the-next-decade
            [post_title] => U.S. spending on drugs will grow faster than on other health-care services over the next decade
            [post_author] => 2
            [post_date] => 2018-03-27 11:36:00
            [year] => 2018
            [month] => 3
            [post_type] => post
        )

    [627] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10351
            [post_name] => 10-steps-to-improving-your-companys-pharmacy-benefit-management-results
            [post_title] => 10 Steps to Improving Your Company's Pharmacy Benefit Management Results
            [post_author] => 2
            [post_date] => 2018-03-25 17:07:00
            [year] => 2018
            [month] => 3
            [post_type] => post
        )

    [628] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10352
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-211
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 211)
            [post_author] => 2
            [post_date] => 2018-03-22 18:07:00
            [year] => 2018
            [month] => 3
            [post_type] => post
        )

    [629] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10353
            [post_name] => fiduciary-pbms-emerge-as-response-to-consolidation-of-rx-dispensing-concern-over-conficts-of-interest-and-need-for-deeper-clinical-expertise
            [post_title] => Fiduciary PBMs emerge as response to consolidation of Rx dispensing, concern over conficts of interest and need for deeper clinical expertise
            [post_author] => 2
            [post_date] => 2018-03-20 14:39:00
            [year] => 2018
            [month] => 3
            [post_type] => post
        )

    [630] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10354
            [post_name] => generic-hepatitis-c-drugs-begin-to-emerge
            [post_title] => Generic Hepatitis C Drugs Begin to Emerge
            [post_author] => 2
            [post_date] => 2018-03-16 12:35:00
            [year] => 2018
            [month] => 3
            [post_type] => post
        )

    [631] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10355
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-210
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 210)
            [post_author] => 2
            [post_date] => 2018-03-15 15:41:00
            [year] => 2018
            [month] => 3
            [post_type] => post
        )

    [632] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10356
            [post_name] => 6-pillars-of-pharmacy-benefit-plan-design
            [post_title] => 6 Pillars of Pharmacy Benefit Plan Design
            [post_author] => 2
            [post_date] => 2018-03-13 14:23:00
            [year] => 2018
            [month] => 3
            [post_type] => post
        )

    [633] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10357
            [post_name] => a-costly-pbm-trick-set-lower-copays-for-expensive-brand-name-drugs-than-for-generics
            [post_title] => A costly PBM trick: set lower copays for expensive brand-name drugs than for generics
            [post_author] => 2
            [post_date] => 2018-03-12 15:05:00
            [year] => 2018
            [month] => 3
            [post_type] => post
        )

    [634] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10358
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-209
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 209)
            [post_author] => 2
            [post_date] => 2018-03-08 17:05:00
            [year] => 2018
            [month] => 3
            [post_type] => post
        )

    [635] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10359
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-12
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2018-03-06 13:53:00
            [year] => 2018
            [month] => 3
            [post_type] => post
        )

    [636] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10360
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-208
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 208)
            [post_author] => 2
            [post_date] => 2018-03-01 15:25:00
            [year] => 2018
            [month] => 3
            [post_type] => post
        )

    [637] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10361
            [post_name] => hidden-profits-in-the-prescription-drug-supply-chain
            [post_title] => Hidden Profits In the Prescription Drug Supply Chain
            [post_author] => 2
            [post_date] => 2018-02-28 19:17:00
            [year] => 2018
            [month] => 2
            [post_type] => post
        )

    [638] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10362
            [post_name] => 7-techniques-to-blunt-specialty-drug-costs-hardly-any-self-insured-employer-is-doing-right-or-at-all
            [post_title] => 7 techniques to blunt specialty drug costs hardly any self-insured employer is doing right or at all
            [post_author] => 2
            [post_date] => 2018-02-27 14:04:00
            [year] => 2018
            [month] => 2
            [post_type] => post
        )

    [639] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10363
            [post_name] => what-might-the-amazon-berkshire-and-jp-morgan-health-care-joint-venture-actually-do
            [post_title] => What might the Amazon, Berkshire and JP Morgan health care joint venture actually do?
            [post_author] => 2
            [post_date] => 2018-02-26 18:32:00
            [year] => 2018
            [month] => 2
            [post_type] => post
        )

    [640] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10364
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-207
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 207)
            [post_author] => 2
            [post_date] => 2018-02-22 13:50:00
            [year] => 2018
            [month] => 2
            [post_type] => post
        )

    [641] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10365
            [post_name] => prescription-drug-coupons-a-one-size-fits-all-policy-approach-doesnt-fit-the-evidence
            [post_title] => Prescription Drug Coupons: A One-Size-Fits-All Policy Approach Doesn’t Fit The Evidence
            [post_author] => 2
            [post_date] => 2018-02-19 14:47:00
            [year] => 2018
            [month] => 2
            [post_type] => post
        )

    [642] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10366
            [post_name] => biosimilars-are-not-generic-versions-of-expensive-biologic-medicines
            [post_title] => Biosimilars Are Not "Generic" Versions Of Expensive Biologic Medicines
            [post_author] => 2
            [post_date] => 2018-02-17 19:35:00
            [year] => 2018
            [month] => 2
            [post_type] => post
        )

    [643] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10367
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-206
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 206)
            [post_author] => 2
            [post_date] => 2018-02-15 21:19:00
            [year] => 2018
            [month] => 2
            [post_type] => post
        )

    [644] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10368
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-205
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 205)
            [post_author] => 2
            [post_date] => 2018-02-08 13:25:00
            [year] => 2018
            [month] => 2
            [post_type] => post
        )

    [645] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10369
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-13
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2018-02-07 22:23:00
            [year] => 2018
            [month] => 2
            [post_type] => post
        )

    [646] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10370
            [post_name] => top-8-specialty-drug-categories-driving-spending-in-2018
            [post_title] => Top 8 Specialty Drug Categories Driving Spending in 2018
            [post_author] => 2
            [post_date] => 2018-02-06 15:08:00
            [year] => 2018
            [month] => 2
            [post_type] => post
        )

    [647] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10371
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-204
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 204)
            [post_author] => 2
            [post_date] => 2018-02-01 18:07:00
            [year] => 2018
            [month] => 2
            [post_type] => post
        )

    [648] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10372
            [post_name] => lawmakers-seek-transparency-in-340b-program
            [post_title] => Lawmakers Seek Transparency in 340B Program
            [post_author] => 2
            [post_date] => 2018-01-31 13:28:00
            [year] => 2018
            [month] => 1
            [post_type] => post
        )

    [649] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10373
            [post_name] => fda-approved-record-breaking-number-of-generics-in-2017
            [post_title] => FDA Approved Record-Breaking Number of Generics in 2017
            [post_author] => 2
            [post_date] => 2018-01-30 14:21:00
            [year] => 2018
            [month] => 1
            [post_type] => post
        )

    [650] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10374
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-203
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 203)
            [post_author] => 2
            [post_date] => 2018-01-25 14:45:00
            [year] => 2018
            [month] => 1
            [post_type] => post
        )

    [651] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10375
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-202
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 202)
            [post_author] => 2
            [post_date] => 2018-01-18 13:55:00
            [year] => 2018
            [month] => 1
            [post_type] => post
        )

    [652] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10376
            [post_name] => why-pharmaceutical-companies-under-attack-for-drug-prices-started-an-industry-war
            [post_title] => Why pharmaceutical companies, under attack for drug prices, started an industry war
            [post_author] => 2
            [post_date] => 2018-01-17 17:44:00
            [year] => 2018
            [month] => 1
            [post_type] => post
        )

    [653] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10377
            [post_name] => health-care-deals-could-make-you-healthier-but-may-not-save-you-money
            [post_title] => Health care deals could make you healthier but may not save you money
            [post_author] => 2
            [post_date] => 2018-01-15 13:09:00
            [year] => 2018
            [month] => 1
            [post_type] => post
        )

    [654] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10378
            [post_name] => maryland-group-challenges-pharmacist-gag-clause-on-drug-costs
            [post_title] => Maryland Group Challenges Pharmacist Gag Clause on Drug Costs
            [post_author] => 2
            [post_date] => 2018-01-12 14:44:00
            [year] => 2018
            [month] => 1
            [post_type] => post
        )

    [655] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10379
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-201
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 201)
            [post_author] => 2
            [post_date] => 2018-01-11 13:26:00
            [year] => 2018
            [month] => 1
            [post_type] => post
        )

    [656] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10380
            [post_name] => the-death-of-objectivity
            [post_title] => The Death of Objectivity
            [post_author] => 2
            [post_date] => 2018-01-10 18:23:00
            [year] => 2018
            [month] => 1
            [post_type] => post
        )

    [657] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10381
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-14
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2018-01-05 19:23:00
            [year] => 2018
            [month] => 1
            [post_type] => post
        )

    [658] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10382
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-200
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 200)
            [post_author] => 2
            [post_date] => 2018-01-04 14:14:00
            [year] => 2018
            [month] => 1
            [post_type] => post
        )

    [659] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10383
            [post_name] => drug-prices-rise-as-big-pharma-profit-soars
            [post_title] => Drug prices rise as big pharma profit soars
            [post_author] => 2
            [post_date] => 2018-01-03 14:04:00
            [year] => 2018
            [month] => 1
            [post_type] => post
        )

    [660] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10384
            [post_name] => more-transparency-on-generic-drug-acquisition-cost-data-could-save-4-billion
            [post_title] => More transparency on generic drug acquisition cost data could save $4 billion
            [post_author] => 2
            [post_date] => 2018-01-02 17:16:00
            [year] => 2018
            [month] => 1
            [post_type] => post
        )

    [661] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10385
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-199
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 199)
            [post_author] => 2
            [post_date] => 2017-12-28 16:26:00
            [year] => 2017
            [month] => 12
            [post_type] => post
        )

    [662] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10386
            [post_name] => cvs-aetna-merger-is-a-robber-barons-dream-come-true
            [post_title] => CVS-Aetna merger is a robber baron's dream come true
            [post_author] => 2
            [post_date] => 2017-12-26 15:57:00
            [year] => 2017
            [month] => 12
            [post_type] => post
        )

    [663] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10387
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-198
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 198)
            [post_author] => 2
            [post_date] => 2017-12-22 02:29:00
            [year] => 2017
            [month] => 12
            [post_type] => post
        )

    [664] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10388
            [post_name] => cvs-aetna-merger-will-influence-employers-benefits-decisions-aon
            [post_title] => CVS-Aetna Merger Will Influence Employers’ Benefits Decisions: Aon
            [post_author] => 2
            [post_date] => 2017-12-19 17:25:00
            [year] => 2017
            [month] => 12
            [post_type] => post
        )

    [665] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10389
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-197
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 197)
            [post_author] => 2
            [post_date] => 2017-12-14 15:55:00
            [year] => 2017
            [month] => 12
            [post_type] => post
        )

    [666] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10390
            [post_name] => consultants-warn-change-or-get-out-of-the-way-next-year
            [post_title] => Consultants warn 'change or get out of the way' next year
            [post_author] => 2
            [post_date] => 2017-12-14 02:16:00
            [year] => 2017
            [month] => 12
            [post_type] => post
        )

    [667] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10391
            [post_name] => prescription-drugs-may-cost-more-with-insurance-than-without-it
            [post_title] => Prescription Drugs May Cost More With Insurance Than Without It
            [post_author] => 2
            [post_date] => 2017-12-11 13:31:00
            [year] => 2017
            [month] => 12
            [post_type] => post
        )

    [668] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10392
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-196
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 196)
            [post_author] => 2
            [post_date] => 2017-12-07 12:25:00
            [year] => 2017
            [month] => 12
            [post_type] => post
        )

    [669] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10393
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-15
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2017-12-06 12:52:00
            [year] => 2017
            [month] => 12
            [post_type] => post
        )

    [670] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10394
            [post_name] => cvs-buying-aetna-in-deal-valued-at-69-billion
            [post_title] => CVS buying Aetna in deal valued at $69 billion
            [post_author] => 2
            [post_date] => 2017-12-04 14:29:00
            [year] => 2017
            [month] => 12
            [post_type] => post
        )

    [671] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10395
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-195
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 195)
            [post_author] => 2
            [post_date] => 2017-11-30 14:46:00
            [year] => 2017
            [month] => 11
            [post_type] => post
        )

    [672] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10396
            [post_name] => non-fiduciary-pharmacy-benefit-managers-the-sopranos-of-the-pharmaceutical-industry
            [post_title] => Non-Fiduciary Pharmacy Benefit Managers: The Sopranos of the Pharmaceutical Industry
            [post_author] => 2
            [post_date] => 2017-11-27 18:38:00
            [year] => 2017
            [month] => 11
            [post_type] => post
        )

    [673] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10397
            [post_name] => specialty-drugs-paid-under-medical-benefit-circumvent-cost-control-measures
            [post_title] => Specialty Drugs Paid Under Medical Benefit Circumvent Cost Control Measures
            [post_author] => 2
            [post_date] => 2017-11-24 13:57:00
            [year] => 2017
            [month] => 11
            [post_type] => post
        )

    [674] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10398
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-194
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 194)
            [post_author] => 2
            [post_date] => 2017-11-22 16:18:00
            [year] => 2017
            [month] => 11
            [post_type] => post
        )

    [675] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10399
            [post_name] => optumrx-is-now-caught-up-in-the-court-battle-between-anthem-and-express-scripts
            [post_title] => OptumRx is now caught up in the court battle between Anthem and Express Scripts
            [post_author] => 2
            [post_date] => 2017-11-21 14:54:00
            [year] => 2017
            [month] => 11
            [post_type] => post
        )

    [676] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10400
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-193
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 193)
            [post_author] => 2
            [post_date] => 2017-11-16 17:27:00
            [year] => 2017
            [month] => 11
            [post_type] => post
        )

    [677] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10401
            [post_name] => reverse-auction-helps-new-jersey-save-1-6-billion-on-prescription-drugs
            [post_title] => Reverse Auction Helps New Jersey Save $1.6 Billion on Prescription Drugs
            [post_author] => 2
            [post_date] => 2017-11-14 13:12:00
            [year] => 2017
            [month] => 11
            [post_type] => post
        )

    [678] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10402
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-16
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2017-11-10 16:52:00
            [year] => 2017
            [month] => 11
            [post_type] => post
        )

    [679] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10403
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-192
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 192)
            [post_author] => 2
            [post_date] => 2017-11-09 13:36:00
            [year] => 2017
            [month] => 11
            [post_type] => post
        )

    [680] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10404
            [post_name] => controversy-heats-up-over-pharmacy-benefit-manager-dir-fees
            [post_title] => Controversy heats up over pharmacy benefit manager DIR fees
            [post_author] => 2
            [post_date] => 2017-11-08 21:51:00
            [year] => 2017
            [month] => 11
            [post_type] => post
        )

    [681] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10405
            [post_name] => pbm-service-fees-the-one-topic-which-rarely-comes-up-during-contract-negotiations
            [post_title] => PBM Service Fees: The One Topic Which Rarely Comes Up During Contract Negotiations
            [post_author] => 2
            [post_date] => 2017-11-07 15:18:00
            [year] => 2017
            [month] => 11
            [post_type] => post
        )

    [682] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10406
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-191
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 191)
            [post_author] => 2
            [post_date] => 2017-11-02 12:41:00
            [year] => 2017
            [month] => 11
            [post_type] => post
        )

    [683] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10407
            [post_name] => only-30-of-employers-get-pharmacy-benefit-manager-contracts
            [post_title] => Only 30% of Employers Get Pharmacy Benefit Manager Contracts
            [post_author] => 2
            [post_date] => 2017-10-31 13:30:00
            [year] => 2017
            [month] => 10
            [post_type] => post
        )

    [684] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10408
            [post_name] => taking-a-more-active-role-the-main-ingredient-for-controlling-prescription-drug-costs
            [post_title] => Taking a More Active Role: The Main Ingredient for Controlling Prescription Drug Costs
            [post_author] => 2
            [post_date] => 2017-10-30 11:46:00
            [year] => 2017
            [month] => 10
            [post_type] => post
        )

    [685] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10409
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-190
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 190)
            [post_author] => 2
            [post_date] => 2017-10-26 13:48:00
            [year] => 2017
            [month] => 10
            [post_type] => post
        )

    [686] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10410
            [post_name] => the-top-200-prescription-and-non-prescription-drugs-by-volume-of-2017
            [post_title] => The Top 200 Prescription and Non-Prescription Drugs, by volume, of 2017
            [post_author] => 2
            [post_date] => 2017-10-25 13:48:00
            [year] => 2017
            [month] => 10
            [post_type] => post
        )

    [687] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10411
            [post_name] => anthem-cvs-health-sign-5-year-deal-for-a-new-pbm-dealing-a-blow-to-express-scripts
            [post_title] => Anthem, CVS Health sign 5-year deal for a new PBM dealing a blow to Express Scripts
            [post_author] => 2
            [post_date] => 2017-10-24 18:47:00
            [year] => 2017
            [month] => 10
            [post_type] => post
        )

    [688] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10412
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-189
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 189)
            [post_author] => 2
            [post_date] => 2017-10-19 14:51:00
            [year] => 2017
            [month] => 10
            [post_type] => post
        )

    [689] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10413
            [post_name] => formulary-management-dont-allow-the-fox-to-guard-the-henhouse
            [post_title] => Formulary Management: Don't Allow the Fox to Guard the Henhouse
            [post_author] => 2
            [post_date] => 2017-10-16 13:13:00
            [year] => 2017
            [month] => 10
            [post_type] => post
        )

    [690] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10414
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-188
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 188)
            [post_author] => 2
            [post_date] => 2017-10-12 12:53:00
            [year] => 2017
            [month] => 10
            [post_type] => post
        )

    [691] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10415
            [post_name] => the-spread-and-im-not-talking-about-miracle-whip
            [post_title] => The Spread and I'm not talking about Miracle Whip
            [post_author] => 2
            [post_date] => 2017-10-10 21:40:00
            [year] => 2017
            [month] => 10
            [post_type] => post
        )

    [692] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10416
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-17
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2017-10-06 17:11:00
            [year] => 2017
            [month] => 10
            [post_type] => post
        )

    [693] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10417
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-187
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 187)
            [post_author] => 2
            [post_date] => 2017-10-05 14:13:00
            [year] => 2017
            [month] => 10
            [post_type] => post
        )

    [694] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10418
            [post_name] => hospital-impact-pharmacy-benefit-managers-are-a-lot-like-car-dealers
            [post_title] => Hospital Impact—Pharmacy benefit managers are a lot like car dealers
            [post_author] => 2
            [post_date] => 2017-10-03 14:07:00
            [year] => 2017
            [month] => 10
            [post_type] => post
        )

    [695] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10419
            [post_name] => impact-of-biosimilar-approvals-on-the-pharmaceutical-market
            [post_title] => Impact of Biosimilar Approvals on the Pharmaceutical Market
            [post_author] => 2
            [post_date] => 2017-09-30 21:00:00
            [year] => 2017
            [month] => 9
            [post_type] => post
        )

    [696] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10420
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-186
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 186)
            [post_author] => 2
            [post_date] => 2017-09-28 20:44:00
            [year] => 2017
            [month] => 9
            [post_type] => post
        )

    [697] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10421
            [post_name] => cost-containment-strategies-and-vendor-contracting-employers-top-health-plan-concerns
            [post_title] => Cost Containment Strategies and Vendor Contracting Employers’ Top Health Plan Concerns
            [post_author] => 2
            [post_date] => 2017-09-26 21:00:00
            [year] => 2017
            [month] => 9
            [post_type] => post
        )

    [698] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10422
            [post_name] => pfizer-files-lawsuit-against-jj-claiming-anticompetitive-practices
            [post_title] => Pfizer Files Lawsuit Against J&J, Claiming Anticompetitive Practices
            [post_author] => 2
            [post_date] => 2017-09-25 17:39:00
            [year] => 2017
            [month] => 9
            [post_type] => post
        )

    [699] => stdClass Object
        (
            [slug] => uncategorized
            [ID] => 10423
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-185
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 185)
            [post_author] => 2
            [post_date] => 2017-09-21 21:23:00
            [year] => 2017
            [month] => 9
            [post_type] => post
        )

    [700] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10424
            [post_name] => new-hep-c-pricing-model-a-game-changer-for-self-funded-employers
            [post_title] => New Hep C Pricing Model: A Game Changer for Self-Funded Employers
            [post_author] => 2
            [post_date] => 2017-09-18 14:42:00
            [year] => 2017
            [month] => 9
            [post_type] => post
        )

    [701] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10425
            [post_name] => insurers-cutting-back-on-drug-coupons-amid-concerns-over-consumer-costs
            [post_title] => Insurers cutting back on drug coupons amid concerns over consumer costs
            [post_author] => 2
            [post_date] => 2017-09-15 17:10:00
            [year] => 2017
            [month] => 9
            [post_type] => post
        )

    [702] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10426
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-184
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 184)
            [post_author] => 2
            [post_date] => 2017-09-14 13:45:00
            [year] => 2017
            [month] => 9
            [post_type] => post
        )

    [703] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10427
            [post_name] => pbms-look-to-the-future
            [post_title] => PBMs Look to the Future
            [post_author] => 2
            [post_date] => 2017-09-13 14:54:00
            [year] => 2017
            [month] => 9
            [post_type] => post
        )

    [704] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10428
            [post_name] => pbms-and-more-in-a-world-of-cost-plus-is-transparency-a-dirty-word
            [post_title] => PBM's and More: In A World of Cost Plus, Is Transparency a Dirty Word?
            [post_author] => 2
            [post_date] => 2017-09-11 16:45:00
            [year] => 2017
            [month] => 9
            [post_type] => post
        )

    [705] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10429
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-183
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 183)
            [post_author] => 2
            [post_date] => 2017-09-07 13:38:00
            [year] => 2017
            [month] => 9
            [post_type] => post
        )

    [706] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10430
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-18
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2017-09-05 16:03:00
            [year] => 2017
            [month] => 9
            [post_type] => post
        )

    [707] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10431
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-182
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 182)
            [post_author] => 2
            [post_date] => 2017-08-31 13:27:00
            [year] => 2017
            [month] => 8
            [post_type] => post
        )

    [708] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10432
            [post_name] => implementing-reference-pricing-led-to-changes-in-drug-selection-lower-spending
            [post_title] => Implementing Reference Pricing Led to Changes in Drug Selection, Lower Spending
            [post_author] => 2
            [post_date] => 2017-08-30 17:52:00
            [year] => 2017
            [month] => 8
            [post_type] => post
        )

    [709] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10433
            [post_name] => heres-how-a-non-fiduciary-pbm-controls-information-and-pricing
            [post_title] => Here's how a non-fiduciary PBM controls information and pricing
            [post_author] => 2
            [post_date] => 2017-08-28 18:55:00
            [year] => 2017
            [month] => 8
            [post_type] => post
        )

    [710] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10434
            [post_name] => take-the-generic-patients-are-told-until-they-are-not
            [post_title] => Take the Generic, Patients Are Told. Until They Are Not.
            [post_author] => 2
            [post_date] => 2017-08-25 12:46:00
            [year] => 2017
            [month] => 8
            [post_type] => post
        )

    [711] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10435
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-181
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 181)
            [post_author] => 2
            [post_date] => 2017-08-24 12:46:00
            [year] => 2017
            [month] => 8
            [post_type] => post
        )

    [712] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10436
            [post_name] => new-website-launches-to-educate-about-dir-fees
            [post_title] => New Website Launches to Educate About DIR Fees
            [post_author] => 2
            [post_date] => 2017-08-21 16:01:00
            [year] => 2017
            [month] => 8
            [post_type] => post
        )

    [713] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10437
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-180
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 180)
            [post_author] => 2
            [post_date] => 2017-08-17 21:01:00
            [year] => 2017
            [month] => 8
            [post_type] => post
        )

    [714] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10438
            [post_name] => express-scripts-profit-grows-despite-dwindling-revenue-from-anthem
            [post_title] => Express Scripts' profit grows despite dwindling revenue from Anthem
            [post_author] => 2
            [post_date] => 2017-08-15 18:00:00
            [year] => 2017
            [month] => 8
            [post_type] => post
        )

    [715] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10439
            [post_name] => lawsuit-against-cvs-could-blow-up-what-you-thought-you-knew-about-drug-prices
            [post_title] => Lawsuit against CVS could blow up what you thought you knew about drug prices
            [post_author] => 2
            [post_date] => 2017-08-11 13:02:00
            [year] => 2017
            [month] => 8
            [post_type] => post
        )

    [716] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10440
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-179
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 179)
            [post_author] => 2
            [post_date] => 2017-08-10 14:56:00
            [year] => 2017
            [month] => 8
            [post_type] => post
        )

    [717] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10441
            [post_name] => whats-your-pbm-iq-test-your-pharmacy-benefits-competency
            [post_title] => What's your PBM IQ? Test your pharmacy benefits competency.
            [post_author] => 2
            [post_date] => 2017-08-07 18:38:00
            [year] => 2017
            [month] => 8
            [post_type] => post
        )

    [718] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10442
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-178
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 178)
            [post_author] => 2
            [post_date] => 2017-08-03 23:34:00
            [year] => 2017
            [month] => 8
            [post_type] => post
        )

    [719] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10443
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-19
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2017-08-01 14:33:00
            [year] => 2017
            [month] => 8
            [post_type] => post
        )

    [720] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10444
            [post_name] => unaccountable-benefit-managers-how-pbms-put-profits-over-patients
            [post_title] => Unaccountable Benefit Managers: How PBMs Put Profits Over Patients
            [post_author] => 2
            [post_date] => 2017-07-31 16:03:00
            [year] => 2017
            [month] => 7
            [post_type] => post
        )

    [721] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10445
            [post_name] => pharmaceutical-manufacturer-drug-coupons-days-may-be-numbered
            [post_title] => Pharmaceutical manufacturer drug coupons days may be numbered
            [post_author] => 2
            [post_date] => 2017-07-28 12:38:00
            [year] => 2017
            [month] => 7
            [post_type] => post
        )

    [722] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10446
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-177
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 177)
            [post_author] => 2
            [post_date] => 2017-07-27 22:33:00
            [year] => 2017
            [month] => 7
            [post_type] => post
        )

    [723] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10447
            [post_name] => large-group-employers-are-currently-struggling-to-afford-specialty-drugs
            [post_title] => Large group employers are currently struggling to afford specialty drugs
            [post_author] => 2
            [post_date] => 2017-07-24 18:17:00
            [year] => 2017
            [month] => 7
            [post_type] => post
        )

    [724] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10448
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-176
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 176)
            [post_author] => 2
            [post_date] => 2017-07-20 11:50:00
            [year] => 2017
            [month] => 7
            [post_type] => post
        )

    [725] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10449
            [post_name] => this-story-should-terrify-the-employee-benefits-and-pbm-industries
            [post_title] => This story should terrify the employee benefits and PBM industries
            [post_author] => 2
            [post_date] => 2017-07-17 16:07:00
            [year] => 2017
            [month] => 7
            [post_type] => post
        )

    [726] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10450
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-175
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 175)
            [post_author] => 2
            [post_date] => 2017-07-13 13:52:00
            [year] => 2017
            [month] => 7
            [post_type] => post
        )

    [727] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10451
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-20
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2017-07-11 14:47:00
            [year] => 2017
            [month] => 7
            [post_type] => post
        )

    [728] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10452
            [post_name] => kaleo-fires-back-at-express-scripts-claiming-its-owed-at-least-5-3m
            [post_title] => Kaleo fires back at Express Scripts, claiming it’s owed at least $5.3M
            [post_author] => 2
            [post_date] => 2017-07-10 14:13:00
            [year] => 2017
            [month] => 7
            [post_type] => post
        )

    [729] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10453
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-174
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 174)
            [post_author] => 2
            [post_date] => 2017-07-06 15:47:00
            [year] => 2017
            [month] => 7
            [post_type] => post
        )

    [730] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10454
            [post_name] => learned-helplessness-the-biggest-reason-non-fiduciary-pbms-getaway-with-overbilling
            [post_title] => Learned Helplessness: The Biggest Reason Non-Fiduciary PBMs Getaway with Overbilling
            [post_author] => 2
            [post_date] => 2017-07-05 12:59:00
            [year] => 2017
            [month] => 7
            [post_type] => post
        )

    [731] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10455
            [post_name] => maryland-is-first-to-ban-price-gouging-on-generic-drugs-but-other-state-and-federal-initiatives-may-soon-follow
            [post_title] => Maryland Is First to Ban “Price Gouging” on Generic Drugs, but Other State and Federal Initiatives May Soon Follow
            [post_author] => 2
            [post_date] => 2017-07-03 23:39:00
            [year] => 2017
            [month] => 7
            [post_type] => post
        )

    [732] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10456
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-173
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 173)
            [post_author] => 2
            [post_date] => 2017-06-29 21:31:00
            [year] => 2017
            [month] => 6
            [post_type] => post
        )

    [733] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10457
            [post_name] => what-effect-will-anthem-express-scripts-fallout-have-on-industry
            [post_title] => What Effect Will Anthem-Express Scripts Fallout Have on Industry?
            [post_author] => 2
            [post_date] => 2017-06-28 04:26:00
            [year] => 2017
            [month] => 6
            [post_type] => post
        )

    [734] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10458
            [post_name] => video-pharmacy-benefits-manager-explained
            [post_title] => [Video] Pharmacy Benefits Manager Explained
            [post_author] => 2
            [post_date] => 2017-06-23 21:45:00
            [year] => 2017
            [month] => 6
            [post_type] => post
        )

    [735] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10459
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-172
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 172)
            [post_author] => 2
            [post_date] => 2017-06-22 15:56:00
            [year] => 2017
            [month] => 6
            [post_type] => post
        )

    [736] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10460
            [post_name] => how-price-cutting-middlemen-are-making-crucial-drugs-vastly-more-expensive
            [post_title] => How 'price-cutting' middlemen are making crucial drugs vastly more expensive
            [post_author] => 2
            [post_date] => 2017-06-16 16:49:00
            [year] => 2017
            [month] => 6
            [post_type] => post
        )

    [737] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10461
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-171
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 171)
            [post_author] => 2
            [post_date] => 2017-06-15 13:52:00
            [year] => 2017
            [month] => 6
            [post_type] => post
        )

    [738] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10462
            [post_name] => in-washington-everyone-is-for-lower-drug-prices-but-only-in-theory
            [post_title] => In Washington, everyone is for lower drug prices, but only in theory
            [post_author] => 2
            [post_date] => 2017-06-12 13:13:00
            [year] => 2017
            [month] => 6
            [post_type] => post
        )

    [739] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10463
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-21
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2017-06-09 12:27:00
            [year] => 2017
            [month] => 6
            [post_type] => post
        )

    [740] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10464
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-170
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 170)
            [post_author] => 2
            [post_date] => 2017-06-08 14:00:00
            [year] => 2017
            [month] => 6
            [post_type] => post
        )

    [741] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10465
            [post_name] => loaded-dice-how-non-fiduciary-pbms-are-winning-the-cash-and-rebate-game
            [post_title] => Loaded Dice: How Non-Fiduciary PBMs are Winning the Cash and Rebate Game
            [post_author] => 2
            [post_date] => 2017-06-07 17:20:00
            [year] => 2017
            [month] => 6
            [post_type] => post
        )

    [742] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10466
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-169
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 169)
            [post_author] => 2
            [post_date] => 2017-05-31 18:01:00
            [year] => 2017
            [month] => 5
            [post_type] => post
        )

    [743] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10467
            [post_name] => behind-the-war-between-health-insurers-and-pharmacy-benefit-managers
            [post_title] => Behind the War Between Health Insurers and Pharmacy Benefit Managers
            [post_author] => 2
            [post_date] => 2017-05-30 18:27:00
            [year] => 2017
            [month] => 5
            [post_type] => post
        )

    [744] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10468
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-168
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 168)
            [post_author] => 2
            [post_date] => 2017-05-25 14:30:00
            [year] => 2017
            [month] => 5
            [post_type] => post
        )

    [745] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10469
            [post_name] => explained-why-your-pbm-isnt-pass-through
            [post_title] => Explained: Why your PBM isn't pass-through
            [post_author] => 2
            [post_date] => 2017-05-22 16:52:00
            [year] => 2017
            [month] => 5
            [post_type] => post
        )

    [746] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10470
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-167
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 167)
            [post_author] => 2
            [post_date] => 2017-05-18 12:31:00
            [year] => 2017
            [month] => 5
            [post_type] => post
        )

    [747] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10471
            [post_name] => a-whistle-blower-tells-of-health-insurers-bilking-medicare
            [post_title] => A Whistle-Blower Tells of Health Insurers Bilking Medicare
            [post_author] => 2
            [post_date] => 2017-05-16 15:50:00
            [year] => 2017
            [month] => 5
            [post_type] => post
        )

    [748] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10472
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-166
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 166)
            [post_author] => 2
            [post_date] => 2017-05-11 13:25:00
            [year] => 2017
            [month] => 5
            [post_type] => post
        )

    [749] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10473
            [post_name] => inside-the-scorpion-room-where-drug-price-secrets-are-guarded
            [post_title] => Inside the ‘Scorpion Room’ Where Drug Price Secrets Are Guarded
            [post_author] => 2
            [post_date] => 2017-05-08 14:23:00
            [year] => 2017
            [month] => 5
            [post_type] => post
        )

    [750] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10474
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-22
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2017-05-05 13:27:00
            [year] => 2017
            [month] => 5
            [post_type] => post
        )

    [751] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10475
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-165
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 165)
            [post_author] => 2
            [post_date] => 2017-05-04 14:37:00
            [year] => 2017
            [month] => 5
            [post_type] => post
        )

    [752] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10476
            [post_name] => california-advances-pbm-transparency-law
            [post_title] => California Advances PBM “Transparency” Law
            [post_author] => 2
            [post_date] => 2017-05-02 16:01:00
            [year] => 2017
            [month] => 5
            [post_type] => post
        )

    [753] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10477
            [post_name] => how-do-manufacturer-rebates-impact-drug-prices
            [post_title] => How do manufacturer rebates impact drug prices?
            [post_author] => 2
            [post_date] => 2017-04-28 15:47:00
            [year] => 2017
            [month] => 4
            [post_type] => post
        )

    [754] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10478
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-164
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 164)
            [post_author] => 2
            [post_date] => 2017-04-27 14:00:00
            [year] => 2017
            [month] => 4
            [post_type] => post
        )

    [755] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10479
            [post_name] => anthem-express-scripts-largest-customer-will-not-renew-its-contract-with-the-pharmacy-benefit-manager
            [post_title] => Anthem, Express Scripts largest customer, will not renew its contract with the pharmacy benefit manager
            [post_author] => 2
            [post_date] => 2017-04-25 13:33:00
            [year] => 2017
            [month] => 4
            [post_type] => post
        )

    [756] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10480
            [post_name] => second-biosimilar-to-remicade-approved-by-the-fda
            [post_title] => Second biosimilar to Remicade approved by the FDA
            [post_author] => 2
            [post_date] => 2017-04-24 13:47:00
            [year] => 2017
            [month] => 4
            [post_type] => post
        )

    [757] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10481
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-163
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 163)
            [post_author] => 2
            [post_date] => 2017-04-20 12:56:00
            [year] => 2017
            [month] => 4
            [post_type] => post
        )

    [758] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10482
            [post_name] => whats-your-pbm-iq-take-our-quiz-to-find-out
            [post_title] => What's your PBM IQ? Take our quiz to find out.
            [post_author] => 2
            [post_date] => 2017-04-19 15:03:00
            [year] => 2017
            [month] => 4
            [post_type] => post
        )

    [759] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10483
            [post_name] => what-to-do-about-rising-health-care-costs
            [post_title] => What to do About Rising Health Care Costs?
            [post_author] => 2
            [post_date] => 2017-04-14 17:25:00
            [year] => 2017
            [month] => 4
            [post_type] => post
        )

    [760] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10484
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-162
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 162)
            [post_author] => 2
            [post_date] => 2017-04-13 18:31:00
            [year] => 2017
            [month] => 4
            [post_type] => post
        )

    [761] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10485
            [post_name] => new-solutions-for-curbing-runaway-drug-costs
            [post_title] => New Solutions for Curbing Runaway Drug Costs
            [post_author] => 2
            [post_date] => 2017-04-10 14:18:00
            [year] => 2017
            [month] => 4
            [post_type] => post
        )

    [762] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10486
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-161
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 161)
            [post_author] => 2
            [post_date] => 2017-04-06 18:39:00
            [year] => 2017
            [month] => 4
            [post_type] => post
        )

    [763] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10487
            [post_name] => prescription-drugs-account-for-22-of-payer-premium-spending
            [post_title] => Prescription Drugs Account for 22% of Payer Premium Spending
            [post_author] => 2
            [post_date] => 2017-04-05 22:28:00
            [year] => 2017
            [month] => 4
            [post_type] => post
        )

    [764] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10488
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-23
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2017-04-03 16:07:00
            [year] => 2017
            [month] => 4
            [post_type] => post
        )

    [765] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10489
            [post_name] => out-of-pocket-costs-based-on-drug-list-prices-a-hidden-fee
            [post_title] => Out-of-pocket costs based on drug list prices; a hidden fee
            [post_author] => 2
            [post_date] => 2017-03-31 22:21:00
            [year] => 2017
            [month] => 3
            [post_type] => post
        )

    [766] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10490
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-160
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 160)
            [post_author] => 2
            [post_date] => 2017-03-30 17:32:00
            [year] => 2017
            [month] => 3
            [post_type] => post
        )

    [767] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10491
            [post_name] => how-do-insurance-companies-decide-what-medicines-to-pay-for-and-when-to-pay-for-them
            [post_title] => How do insurance companies decide what medicines to pay for and when to pay for them?
            [post_author] => 2
            [post_date] => 2017-03-28 19:31:00
            [year] => 2017
            [month] => 3
            [post_type] => post
        )

    [768] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10492
            [post_name] => understanding-the-villain-of-big-pharma-traditional-pharmacy-benefit-managers
            [post_title] => Understanding the Villain of Big Pharma: Traditional Pharmacy Benefit Managers
            [post_author] => 2
            [post_date] => 2017-03-27 17:53:00
            [year] => 2017
            [month] => 3
            [post_type] => post
        )

    [769] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10493
            [post_name] => pharmacy-benefit-manager-back-end-fees-rise-13-billion-in-3-years
            [post_title] => Pharmacy Benefit Manager Back-end Fees Rise $13 Billion in 3 Years
            [post_author] => 2
            [post_date] => 2017-03-24 16:01:00
            [year] => 2017
            [month] => 3
            [post_type] => post
        )

    [770] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10494
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-159
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 159)
            [post_author] => 2
            [post_date] => 2017-03-23 13:59:00
            [year] => 2017
            [month] => 3
            [post_type] => post
        )

    [771] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10495
            [post_name] => the-troubles-with-pharmacy-benefit-managers
            [post_title] => The "TROUBLES" with Pharmacy Benefit Managers
            [post_author] => 2
            [post_date] => 2017-03-21 22:17:00
            [year] => 2017
            [month] => 3
            [post_type] => post
        )

    [772] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10496
            [post_name] => what-outcomes-based-contracting-means-for-drug-development-drug-pricing
            [post_title] => What Outcomes-Based Contracting Means For Drug Development & Drug Pricing
            [post_author] => 2
            [post_date] => 2017-03-20 15:11:00
            [year] => 2017
            [month] => 3
            [post_type] => post
        )

    [773] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10497
            [post_name] => reference-pricing-gross-invoice-cost-for-popular-generic-and-brand-prescription-drugs-volume-158
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Popular Generic and Brand Prescription Drugs (Volume 158)
            [post_author] => 2
            [post_date] => 2017-03-16 19:56:00
            [year] => 2017
            [month] => 3
            [post_type] => post
        )

    [774] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10498
            [post_name] => drugmaker-says-pharmacy-benefit-managers-keep-prices-high
            [post_title] => Drugmaker Says Pharmacy Benefit Managers Keep Prices High
            [post_author] => 2
            [post_date] => 2017-03-14 14:06:00
            [year] => 2017
            [month] => 3
            [post_type] => post
        )

    [775] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10499
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-157
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 157
            [post_author] => 2
            [post_date] => 2017-03-09 20:55:00
            [year] => 2017
            [month] => 3
            [post_type] => post
        )

    [776] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10500
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-24
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2017-03-08 19:02:00
            [year] => 2017
            [month] => 3
            [post_type] => post
        )

    [777] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10501
            [post_name] => drug-costs-too-high-fire-the-middleman
            [post_title] => Drug Costs Too High? Fire the Middleman
            [post_author] => 2
            [post_date] => 2017-03-06 21:03:00
            [year] => 2017
            [month] => 3
            [post_type] => post
        )

    [778] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10502
            [post_name] => fancy-pill-reminder-box-isnt-helping-patients-remember-anything
            [post_title] => Fancy Pill-Reminder Box Isn't Helping Patients Remember Anything
            [post_author] => 2
            [post_date] => 2017-03-03 12:58:00
            [year] => 2017
            [month] => 3
            [post_type] => post
        )

    [779] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10503
            [post_name] => pharmacists-sworn-to-secrecy-as-pbms-force-customers-to-overpay-for-drugs
            [post_title] => Pharmacists sworn to secrecy as PBMs force customers to overpay for drugs
            [post_author] => 2
            [post_date] => 2017-02-28 15:49:00
            [year] => 2017
            [month] => 2
            [post_type] => post
        )

    [780] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10504
            [post_name] => how-to-rein-in-the-soaring-costs-of-specialty-drugs
            [post_title] => How to Rein In the Soaring Costs of Specialty Drugs
            [post_author] => 2
            [post_date] => 2017-02-27 19:25:00
            [year] => 2017
            [month] => 2
            [post_type] => post
        )

    [781] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10505
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-156
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 156
            [post_author] => 2
            [post_date] => 2017-02-24 14:02:00
            [year] => 2017
            [month] => 2
            [post_type] => post
        )

    [782] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10506
            [post_name] => key-to-rebate-cost-savings-define-which-drugs-are-actually-eligible-for-rebates
            [post_title] => Key to rebate cost savings, define which drugs are actually eligible for rebates
            [post_author] => 2
            [post_date] => 2017-02-23 14:48:00
            [year] => 2017
            [month] => 2
            [post_type] => post
        )

    [783] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10507
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-155
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 155
            [post_author] => 2
            [post_date] => 2017-02-16 14:13:00
            [year] => 2017
            [month] => 2
            [post_type] => post
        )

    [784] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10508
            [post_name] => employers-take-extra-steps-to-curb-specialty-drug-costs
            [post_title] => Employers Take Extra Steps to Curb Specialty Drug Costs
            [post_author] => 2
            [post_date] => 2017-02-14 15:24:00
            [year] => 2017
            [month] => 2
            [post_type] => post
        )

    [785] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10509
            [post_name] => prescription-drug-pipeline-drugmaker-to-patient-explained-infographic
            [post_title] => Prescription Drug Pipeline: Drugmaker to Patient Explained [Infographic]
            [post_author] => 2
            [post_date] => 2017-02-13 13:28:00
            [year] => 2017
            [month] => 2
            [post_type] => post
        )

    [786] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10510
            [post_name] => dont-miss-webinar-how-to-slash-pbm-service-costs-up-to-50-without-changing-vendors-or-benefit-levels-25
            [post_title] => "Don't Miss" Webinar: How to Slash PBM Service Costs, up to 50%, Without Changing Vendors or Benefit Levels
            [post_author] => 2
            [post_date] => 2017-02-10 14:59:00
            [year] => 2017
            [month] => 2
            [post_type] => post
        )

    [787] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10511
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-154
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 154
            [post_author] => 2
            [post_date] => 2017-02-09 15:23:00
            [year] => 2017
            [month] => 2
            [post_type] => post
        )

    [788] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10512
            [post_name] => six-takeaways-how-are-prescription-drug-prices-set
            [post_title] => Six Takeaways: How are prescription drug prices set?
            [post_author] => 2
            [post_date] => 2017-02-06 18:03:00
            [year] => 2017
            [month] => 2
            [post_type] => post
        )

    [789] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10513
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-153
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 153
            [post_author] => 2
            [post_date] => 2017-02-02 15:13:00
            [year] => 2017
            [month] => 2
            [post_type] => post
        )

    [790] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10514
            [post_name] => pharmaceutical-companies-not-seeing-majority-of-drug-revenue
            [post_title] => Pharmaceutical Companies Not Seeing Majority of Drug Revenue
            [post_author] => 2
            [post_date] => 2017-01-29 20:27:00
            [year] => 2017
            [month] => 1
            [post_type] => post
        )

    [791] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10515
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-152
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 152
            [post_author] => 2
            [post_date] => 2017-01-26 13:36:00
            [year] => 2017
            [month] => 1
            [post_type] => post
        )

    [792] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10516
            [post_name] => diplomat-pharmacy-inc-has-published-a-new-report-on-the-state-of-specialty-pharmaceuticals
            [post_title] => Diplomat Pharmacy, Inc. has published a new report on the state of specialty pharmaceuticals
            [post_author] => 2
            [post_date] => 2017-01-25 15:09:00
            [year] => 2017
            [month] => 1
            [post_type] => post
        )

    [793] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10517
            [post_name] => secret-rebates-erode-drugmaker-revenue-industry-study-says
            [post_title] => Secret rebates erode drugmaker revenue, industry study says
            [post_author] => 2
            [post_date] => 2017-01-23 16:12:00
            [year] => 2017
            [month] => 1
            [post_type] => post
        )

    [794] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10518
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-151
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 151
            [post_author] => 2
            [post_date] => 2017-01-19 14:12:00
            [year] => 2017
            [month] => 1
            [post_type] => post
        )

    [795] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10519
            [post_name] => plan-sponsors-zero-in-on-specialty-pharmacy-costs-in-2017-benefits
            [post_title] => Plan Sponsors Zero In on Specialty Pharmacy Costs in 2017 Benefits
            [post_author] => 2
            [post_date] => 2017-01-18 14:42:00
            [year] => 2017
            [month] => 1
            [post_type] => post
        )

    [796] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10520
            [post_name] => pharmacy-benefit-manager-disclosure-law-preempted-by-federal-benefits-law-the-u-s-court-of-appeals-for-the-eighth-circuit-ruled
            [post_title] => Pharmacy Benefit Manager disclosure law preempted by federal benefits law, the U.S. Court of Appeals for the Eighth Circuit ruled
            [post_author] => 2
            [post_date] => 2017-01-15 20:38:00
            [year] => 2017
            [month] => 1
            [post_type] => post
        )

    [797] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10521
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-150
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 150
            [post_author] => 2
            [post_date] => 2017-01-12 14:41:00
            [year] => 2017
            [month] => 1
            [post_type] => post
        )

    [798] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10522
            [post_name] => the-future-of-employer-sponsored-coverage
            [post_title] => The Future of Employer-Sponsored Coverage
            [post_author] => 2
            [post_date] => 2017-01-10 16:46:00
            [year] => 2017
            [month] => 1
            [post_type] => post
        )

    [799] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10523
            [post_name] => dont-miss-webinar-tuesday-january-10-at-2pm-et
            [post_title] => "Don't Miss" webinar Tuesday January 10 at 2PM ET
            [post_author] => 2
            [post_date] => 2017-01-06 16:10:00
            [year] => 2017
            [month] => 1
            [post_type] => post
        )

    [800] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10524
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-149
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 149
            [post_author] => 2
            [post_date] => 2017-01-05 14:18:00
            [year] => 2017
            [month] => 1
            [post_type] => post
        )

    [801] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10525
            [post_name] => pharmacy-benefit-managers-could-be-in-legislative-crosshairs
            [post_title] => Pharmacy benefit managers could be in legislative crosshairs
            [post_author] => 2
            [post_date] => 2017-01-04 15:11:00
            [year] => 2017
            [month] => 1
            [post_type] => post
        )

    [802] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10526
            [post_name] => high-priced-drugs-estimates-of-annual-per-patient-expenditures-for-150-specialty-medications-report
            [post_title] => High-Priced Drugs: Estimates of Annual Per-Patient Expenditures for 150 Specialty Medications [Report]
            [post_author] => 2
            [post_date] => 2016-12-30 18:19:00
            [year] => 2016
            [month] => 12
            [post_type] => post
        )

    [803] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10527
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-148
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 148
            [post_author] => 2
            [post_date] => 2016-12-29 16:18:00
            [year] => 2016
            [month] => 12
            [post_type] => post
        )

    [804] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10528
            [post_name] => top-pharmacy-challenges-of-2017
            [post_title] => Top pharmacy challenges of 2017
            [post_author] => 2
            [post_date] => 2016-12-28 15:18:00
            [year] => 2016
            [month] => 12
            [post_type] => post
        )

    [805] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10529
            [post_name] => pharmacy-benefits-super-sized-minimized-or-right-sized
            [post_title] => Pharmacy benefits: Super-sized, minimized or right-sized?
            [post_author] => 2
            [post_date] => 2016-12-22 17:44:00
            [year] => 2016
            [month] => 12
            [post_type] => post
        )

    [806] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10530
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-147
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 147
            [post_author] => 2
            [post_date] => 2016-12-15 21:13:00
            [year] => 2016
            [month] => 12
            [post_type] => post
        )

    [807] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10531
            [post_name] => pay-for-performance-drug-pricing-drugmakers-asked-to-eat-costs-when-products-dont-deliver
            [post_title] => Pay-for-performance drug pricing: drugmakers asked to eat costs when products don't deliver
            [post_author] => 2
            [post_date] => 2016-12-13 15:55:00
            [year] => 2016
            [month] => 12
            [post_type] => post
        )

    [808] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10532
            [post_name] => dont-miss-webinar-tuesday-december-13-at-2pm-et
            [post_title] => "Don't Miss" webinar Tuesday December 13 at 2PM ET
            [post_author] => 2
            [post_date] => 2016-12-12 14:05:00
            [year] => 2016
            [month] => 12
            [post_type] => post
        )

    [809] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10533
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-146
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 146
            [post_author] => 2
            [post_date] => 2016-12-08 14:11:00
            [year] => 2016
            [month] => 12
            [post_type] => post
        )

    [810] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10534
            [post_name] => drugmaker-sheds-light-on-path-of-rebate-dollars
            [post_title] => Drugmaker sheds light on path of rebate dollars
            [post_author] => 2
            [post_date] => 2016-12-06 19:12:00
            [year] => 2016
            [month] => 12
            [post_type] => post
        )

    [811] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10535
            [post_name] => integrating-pharmacy-benefit-medical-benefit-cuts-costs
            [post_title] => Integrating pharmacy benefit, medical benefit cuts costs
            [post_author] => 2
            [post_date] => 2016-12-05 16:35:00
            [year] => 2016
            [month] => 12
            [post_type] => post
        )

    [812] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10536
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-145
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 145
            [post_author] => 2
            [post_date] => 2016-12-01 15:46:00
            [year] => 2016
            [month] => 12
            [post_type] => post
        )

    [813] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10537
            [post_name] => side-effects-the-new-role-of-pbms-video
            [post_title] => Side Effects: The new role of PBMs [VIDEO]
            [post_author] => 2
            [post_date] => 2016-11-28 16:30:00
            [year] => 2016
            [month] => 11
            [post_type] => post
        )

    [814] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10538
            [post_name] => a-sick-calculation-about-prescription-drugs
            [post_title] => A Sick Calculation About Prescription Drugs
            [post_author] => 2
            [post_date] => 2016-11-22 16:23:00
            [year] => 2016
            [month] => 11
            [post_type] => post
        )

    [815] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10539
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-144
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 144
            [post_author] => 2
            [post_date] => 2016-11-17 15:52:00
            [year] => 2016
            [month] => 11
            [post_type] => post
        )

    [816] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10540
            [post_name] => minnesota-department-of-health-finds-drugs-given-in-medical-settings-are-big-drivers-of-costs
            [post_title] => Minnesota Department of Health finds drugs given in medical settings are big drivers of costs
            [post_author] => 2
            [post_date] => 2016-11-14 16:58:00
            [year] => 2016
            [month] => 11
            [post_type] => post
        )

    [817] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10541
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-143
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 143
            [post_author] => 2
            [post_date] => 2016-11-10 16:25:00
            [year] => 2016
            [month] => 11
            [post_type] => post
        )

    [818] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10542
            [post_name] => claims-analysis-negotiated-pricing-between-preferred-and-non-preferred-retail-pharmacies
            [post_title] => Claims Analysis: Negotiated Pricing Between Preferred and Non-Preferred Retail Pharmacies
            [post_author] => 2
            [post_date] => 2016-11-09 19:23:00
            [year] => 2016
            [month] => 11
            [post_type] => post
        )

    [819] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10543
            [post_name] => pas-prior-authorization-work-if-done-right
            [post_title] => PAs (prior authorization) work, if done right
            [post_author] => 2
            [post_date] => 2016-11-07 21:21:00
            [year] => 2016
            [month] => 11
            [post_type] => post
        )

    [820] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10544
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-142
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 142
            [post_author] => 2
            [post_date] => 2016-11-04 13:25:00
            [year] => 2016
            [month] => 11
            [post_type] => post
        )

    [821] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10545
            [post_name] => podcast-rx-drugs-and-the-u-s-health-system-a-conversation-about-election-cycle-proposals-for-lowering-costs
            [post_title] => [Podcast] Rx Drugs and the U.S. Health System – A Conversation about Election-Cycle Proposals for Lowering Costs
            [post_author] => 2
            [post_date] => 2016-11-01 17:52:00
            [year] => 2016
            [month] => 11
            [post_type] => post
        )

    [822] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10546
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-141
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 141
            [post_author] => 2
            [post_date] => 2016-10-28 17:01:00
            [year] => 2016
            [month] => 10
            [post_type] => post
        )

    [823] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10547
            [post_name] => survey-supports-transparency-of-drug-pricing-by-pharmacy-benefit-managers
            [post_title] => Survey supports transparency of drug pricing by pharmacy benefit managers
            [post_author] => 2
            [post_date] => 2016-10-26 14:38:00
            [year] => 2016
            [month] => 10
            [post_type] => post
        )

    [824] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10548
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-140
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 140
            [post_author] => 2
            [post_date] => 2016-10-25 14:42:00
            [year] => 2016
            [month] => 10
            [post_type] => post
        )

    [825] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10549
            [post_name] => employers-overpay-10-50-on-health-benefits-time-for-a-second-opinion
            [post_title] => Employers Overpay 10-50% on Health Benefits: Time for a Second Opinion
            [post_author] => 2
            [post_date] => 2016-10-21 16:40:00
            [year] => 2016
            [month] => 10
            [post_type] => post
        )

    [826] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10550
            [post_name] => pipeline-to-profits-how-drug-middlemen-make-money
            [post_title] => Pipeline to Profits: How Drug Middlemen Make Money
            [post_author] => 2
            [post_date] => 2016-10-17 15:40:00
            [year] => 2016
            [month] => 10
            [post_type] => post
        )

    [827] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10551
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-139
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 139
            [post_author] => 2
            [post_date] => 2016-10-13 15:27:00
            [year] => 2016
            [month] => 10
            [post_type] => post
        )

    [828] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10552
            [post_name] => insulin-costs-are-way-up-but-drugmakers-say-pbms-are-collecting-the-loot
            [post_title] => Insulin costs are way up, but drugmakers say PBMs are collecting the loot
            [post_author] => 2
            [post_date] => 2016-10-12 17:47:00
            [year] => 2016
            [month] => 10
            [post_type] => post
        )

    [829] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10553
            [post_name] => one-slide-from-my-dont-miss-webinar-tuesday-october-11-at-330-pm-et
            [post_title] => One slide from my "don't miss" webinar Tuesday October 11 at 3:30 PM ET
            [post_author] => 2
            [post_date] => 2016-10-10 17:03:00
            [year] => 2016
            [month] => 10
            [post_type] => post
        )

    [830] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10554
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-138
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 138
            [post_author] => 2
            [post_date] => 2016-10-06 20:47:00
            [year] => 2016
            [month] => 10
            [post_type] => post
        )

    [831] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10555
            [post_name] => drugmakers-point-finger-at-middlemen-for-rising-drug-prices
            [post_title] => Drugmakers Point Finger at Middlemen for Rising Drug Prices
            [post_author] => 2
            [post_date] => 2016-10-04 18:52:00
            [year] => 2016
            [month] => 10
            [post_type] => post
        )

    [832] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10556
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-137
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 137
            [post_author] => 2
            [post_date] => 2016-09-30 12:51:00
            [year] => 2016
            [month] => 9
            [post_type] => post
        )

    [833] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10557
            [post_name] => can-pay-for-performance-control-high-drug-prices
            [post_title] => Can 'Pay for Performance' Control High Drug Prices?
            [post_author] => 2
            [post_date] => 2016-09-28 15:33:00
            [year] => 2016
            [month] => 9
            [post_type] => post
        )

    [834] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10558
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-136
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 136
            [post_author] => 2
            [post_date] => 2016-09-22 13:58:00
            [year] => 2016
            [month] => 9
            [post_type] => post
        )

    [835] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10559
            [post_name] => video-pbms-bigger-doesnt-mean-better
            [post_title] => [Video] PBMs | Bigger Doesn't Mean Better
            [post_author] => 2
            [post_date] => 2016-09-20 19:15:00
            [year] => 2016
            [month] => 9
            [post_type] => post
        )

    [836] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10560
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-135
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 135
            [post_author] => 2
            [post_date] => 2016-09-15 13:23:00
            [year] => 2016
            [month] => 9
            [post_type] => post
        )

    [837] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10561
            [post_name] => chicken-soup-for-the-self-funded-employer-foolproof-pbm-contracts
            [post_title] => Chicken Soup for the Self-Funded Employer: Foolproof PBM Contracts
            [post_author] => 2
            [post_date] => 2016-09-13 16:56:00
            [year] => 2016
            [month] => 9
            [post_type] => post
        )

    [838] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10562
            [post_name] => one-slide-from-my-dont-miss-webinar-tuesday-september-13-at-300-pm-et
            [post_title] => One slide from my "don't miss" webinar Tuesday September 13 at 3:00 PM ET
            [post_author] => 2
            [post_date] => 2016-09-09 15:02:00
            [year] => 2016
            [month] => 9
            [post_type] => post
        )

    [839] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10563
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-134
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 134
            [post_author] => 2
            [post_date] => 2016-09-08 14:41:00
            [year] => 2016
            [month] => 9
            [post_type] => post
        )

    [840] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10564
            [post_name] => podcast-rx-drugs-and-the-u-s-health-system-a-conversation-about-drug-prices
            [post_title] => [Podcast] Rx Drugs and the U.S. Health System – A Conversation About Drug Prices
            [post_author] => 2
            [post_date] => 2016-09-06 14:40:00
            [year] => 2016
            [month] => 9
            [post_type] => post
        )

    [841] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10565
            [post_name] => gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-133
            [post_title] => "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs - Volume 133
            [post_author] => 2
            [post_date] => 2016-09-02 15:54:00
            [year] => 2016
            [month] => 9
            [post_type] => post
        )

    [842] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10566
            [post_name] => the-co-pay-card-debate-simmers-as-payers-push-back
            [post_title] => The co-pay card debate simmers, as payers push back
            [post_author] => 2
            [post_date] => 2016-09-01 17:29:00
            [year] => 2016
            [month] => 9
            [post_type] => post
        )

    [843] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10567
            [post_name] => reference-pricing-actual-acquisition-cost-aac-for-top-selling-generic-and-brand-prescription-drugs-volume-132
            [post_title] => Reference Pricing: Actual Acquisition Cost (AAC) for Top Selling Generic and Brand Prescription Drugs - Volume 132
            [post_author] => 2
            [post_date] => 2016-08-26 16:50:00
            [year] => 2016
            [month] => 8
            [post_type] => post
        )

    [844] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10568
            [post_name] => hand-caught-in-cookie-jar-united-healthcare-changing-drug-overpayment-program
            [post_title] => Hand caught in cookie jar, United Healthcare changing drug overpayment program
            [post_author] => 2
            [post_date] => 2016-08-25 15:37:00
            [year] => 2016
            [month] => 8
            [post_type] => post
        )

    [845] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10569
            [post_name] => new-report-identifies-most-expensive-specialty-drugs
            [post_title] => New Report Identifies Most Expensive Specialty Drugs
            [post_author] => 2
            [post_date] => 2016-08-23 14:36:00
            [year] => 2016
            [month] => 8
            [post_type] => post
        )

    [846] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10570
            [post_name] => who-is-getting-rich-from-the-price-of-prescription-drugs
            [post_title] => Who is getting rich from the price of prescription drugs?
            [post_author] => 2
            [post_date] => 2016-08-22 19:31:00
            [year] => 2016
            [month] => 8
            [post_type] => post
        )

    [847] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10571
            [post_name] => reference-pricing-invoice-cost-gross-for-top-selling-generic-and-brand-prescription-drugs-volume-131
            [post_title] => Reference Pricing: Invoice Cost (Gross) for Top Selling Generic and Brand Prescription Drugs - Volume 131
            [post_author] => 2
            [post_date] => 2016-08-18 16:08:00
            [year] => 2016
            [month] => 8
            [post_type] => post
        )

    [848] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10572
            [post_name] => solutions-for-reducing-patient-cost-sharing-for-prescription-medications
            [post_title] => Solutions for Reducing Patient Cost Sharing for Prescription Medications
            [post_author] => 2
            [post_date] => 2016-08-17 17:33:00
            [year] => 2016
            [month] => 8
            [post_type] => post
        )

    [849] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10573
            [post_name] => should-drug-prices-be-tied-to-patient-outcomes
            [post_title] => Should drug prices be tied to patient outcomes?
            [post_author] => 2
            [post_date] => 2016-08-15 13:08:00
            [year] => 2016
            [month] => 8
            [post_type] => post
        )

    [850] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10574
            [post_name] => reference-pricing-invoice-cost-gross-for-top-selling-generic-and-brand-prescription-drugs-volume-130
            [post_title] => Reference Pricing: Invoice Cost (Gross) for Top Selling Generic and Brand Prescription Drugs - Volume 130
            [post_author] => 2
            [post_date] => 2016-08-12 13:48:00
            [year] => 2016
            [month] => 8
            [post_type] => post
        )

    [851] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10575
            [post_name] => in-office-dispensing-a-better-value
            [post_title] => In-Office Dispensing: A Better Value?
            [post_author] => 2
            [post_date] => 2016-08-11 15:28:00
            [year] => 2016
            [month] => 8
            [post_type] => post
        )

    [852] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10576
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-129
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 129)
            [post_author] => 2
            [post_date] => 2016-08-05 15:26:00
            [year] => 2016
            [month] => 8
            [post_type] => post
        )

    [853] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10577
            [post_name] => big-companies-form-an-alliance-to-find-ways-to-reduce-pharmacy-costs
            [post_title] => Big companies form an alliance to find ways to reduce pharmacy costs
            [post_author] => 2
            [post_date] => 2016-08-04 15:54:00
            [year] => 2016
            [month] => 8
            [post_type] => post
        )

    [854] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10578
            [post_name] => a-path-forward-for-lowering-prescription-drug-prices
            [post_title] => A Path Forward for Lowering Prescription Drug Prices
            [post_author] => 2
            [post_date] => 2016-08-02 15:00:00
            [year] => 2016
            [month] => 8
            [post_type] => post
        )

    [855] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10579
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-128
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 128)
            [post_author] => 2
            [post_date] => 2016-07-28 23:43:00
            [year] => 2016
            [month] => 7
            [post_type] => post
        )

    [856] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10580
            [post_name] => employers-falling-short-on-managing-healthcare-costs
            [post_title] => Employers falling short on managing healthcare costs
            [post_author] => 2
            [post_date] => 2016-07-25 14:54:00
            [year] => 2016
            [month] => 7
            [post_type] => post
        )

    [857] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10581
            [post_name] => reference-pricing-gross-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-127
            [post_title] => Reference Pricing: "Gross" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 127)
            [post_author] => 2
            [post_date] => 2016-07-21 14:56:00
            [year] => 2016
            [month] => 7
            [post_type] => post
        )

    [858] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10582
            [post_name] => anthem-express-scripts-dispute-comes-down-to-pricing-as-should-all-pbm-service-agreements
            [post_title] => Anthem, Express Scripts dispute comes down to pricing...as should all PBM service agreements
            [post_author] => 2
            [post_date] => 2016-07-19 13:35:00
            [year] => 2016
            [month] => 7
            [post_type] => post
        )

    [859] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10583
            [post_name] => back-billing-an-opaque-process-which-significantly-increases-plan-sponsors-pharmacy-costs
            [post_title] => Back-billing: an opaque process which significantly increases plan sponsors' pharmacy costs
            [post_author] => 2
            [post_date] => 2016-07-15 14:21:00
            [year] => 2016
            [month] => 7
            [post_type] => post
        )

    [860] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10584
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-126
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 126)
            [post_author] => 2
            [post_date] => 2016-07-14 13:45:00
            [year] => 2016
            [month] => 7
            [post_type] => post
        )

    [861] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10585
            [post_name] => 10-essential-facts-about-medicare-and-prescription-drug-spending
            [post_title] => 10 Essential Facts About Medicare and Prescription Drug Spending
            [post_author] => 2
            [post_date] => 2016-07-12 15:40:00
            [year] => 2016
            [month] => 7
            [post_type] => post
        )

    [862] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10586
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-125
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 125)
            [post_author] => 2
            [post_date] => 2016-07-07 13:58:00
            [year] => 2016
            [month] => 7
            [post_type] => post
        )

    [863] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10587
            [post_name] => hold-middlemens-feet-to-the-fire-to-cauterize-specialty-drug-spending
            [post_title] => Hold middlemen's feet to the fire to cauterize specialty drug spending
            [post_author] => 2
            [post_date] => 2016-07-06 21:22:00
            [year] => 2016
            [month] => 7
            [post_type] => post
        )

    [864] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10588
            [post_name] => decoding-big-pharmas-secret-drug-pricing-practices
            [post_title] => Decoding Big Pharma’s Secret Drug Pricing Practices
            [post_author] => 2
            [post_date] => 2016-07-05 22:46:00
            [year] => 2016
            [month] => 7
            [post_type] => post
        )

    [865] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10589
            [post_name] => express-scripts-anthem-face-erisa-lawsuit-over-drug-pricing
            [post_title] => Express Scripts, Anthem Face ERISA Lawsuit Over Drug Pricing
            [post_author] => 2
            [post_date] => 2016-06-29 20:28:00
            [year] => 2016
            [month] => 6
            [post_type] => post
        )

    [866] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10590
            [post_name] => workplaces-fight-skyrocketing-prescription-drug-costs
            [post_title] => Workplaces Fight Skyrocketing Prescription Drug Costs
            [post_author] => 2
            [post_date] => 2016-06-28 13:41:00
            [year] => 2016
            [month] => 6
            [post_type] => post
        )

    [867] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10591
            [post_name] => review-vs-audit-a-comparison-of-services-performed-by-pharmacy-benefit-management-consultants
            [post_title] => Review vs Audit: A Comparison of Services Performed by Pharmacy Benefit Management Consultants
            [post_author] => 2
            [post_date] => 2016-06-27 13:57:00
            [year] => 2016
            [month] => 6
            [post_type] => post
        )

    [868] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10592
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-124
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 124)
            [post_author] => 2
            [post_date] => 2016-06-24 13:07:00
            [year] => 2016
            [month] => 6
            [post_type] => post
        )

    [869] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10593
            [post_name] => the-7-habits-of-highly-effective-benefits-professionals
            [post_title] => The 7 Habits Of Highly Effective Benefits Professionals
            [post_author] => 2
            [post_date] => 2016-06-17 15:20:00
            [year] => 2016
            [month] => 6
            [post_type] => post
        )

    [870] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10594
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-123
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 123)
            [post_author] => 2
            [post_date] => 2016-06-16 22:06:00
            [year] => 2016
            [month] => 6
            [post_type] => post
        )

    [871] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10595
            [post_name] => drug-companies-fight-generics-with-coupons
            [post_title] => Drug companies fight generics with coupons
            [post_author] => 2
            [post_date] => 2016-06-14 14:31:00
            [year] => 2016
            [month] => 6
            [post_type] => post
        )

    [872] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10596
            [post_name] => pharmacy-benefit-managers-offer-a-commodity-do-not-treat-them-as-differentiated-services
            [post_title] => Pharmacy Benefit Managers offer a commodity. Do not treat them as differentiated services.
            [post_author] => 2
            [post_date] => 2016-06-13 15:35:00
            [year] => 2016
            [month] => 6
            [post_type] => post
        )

    [873] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10597
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-122
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 122)
            [post_author] => 2
            [post_date] => 2016-06-09 16:19:00
            [year] => 2016
            [month] => 6
            [post_type] => post
        )

    [874] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10598
            [post_name] => uhc-administered-self-insured-health-plan-att-sued-in-federal-court-for-embezzlement-self-dealing-in-medical-claims-overpayment-offset-dispute
            [post_title] => UHC administered self-insured health plan, AT&T, sued in federal court for embezzlement, self-dealing in medical claims overpayment offset dispute
            [post_author] => 2
            [post_date] => 2016-06-06 17:41:00
            [year] => 2016
            [month] => 6
            [post_type] => post
        )

    [875] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10599
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-121
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 121)
            [post_author] => 2
            [post_date] => 2016-06-02 21:55:00
            [year] => 2016
            [month] => 6
            [post_type] => post
        )

    [876] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10600
            [post_name] => concerns-persist-about-the-340b-discount-program
            [post_title] => Concerns Persist about the 340B Discount Program
            [post_author] => 2
            [post_date] => 2016-06-01 14:59:00
            [year] => 2016
            [month] => 6
            [post_type] => post
        )

    [877] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10601
            [post_name] => specialty-pharmacy-spending-continues-to-grow
            [post_title] => Specialty Pharmacy Spending Continues to Grow
            [post_author] => 2
            [post_date] => 2016-05-31 20:44:00
            [year] => 2016
            [month] => 5
            [post_type] => post
        )

    [878] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10602
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-120
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 120)
            [post_author] => 2
            [post_date] => 2016-05-27 16:46:00
            [year] => 2016
            [month] => 5
            [post_type] => post
        )

    [879] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10603
            [post_name] => 1-number-from-cvs-health-that-blew-me-away
            [post_title] => 1 Number From CVS Health That Blew Me Away
            [post_author] => 2
            [post_date] => 2016-05-26 14:38:00
            [year] => 2016
            [month] => 5
            [post_type] => post
        )

    [880] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10604
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-119
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 119)
            [post_author] => 2
            [post_date] => 2016-05-19 19:20:00
            [year] => 2016
            [month] => 5
            [post_type] => post
        )

    [881] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10605
            [post_name] => high-cost-or-high-value-specialty-pharmaceuticals-add-to-employers-health-care-costs
            [post_title] => High cost or high value? Specialty pharmaceuticals add to employers' health care costs
            [post_author] => 2
            [post_date] => 2016-05-16 16:31:00
            [year] => 2016
            [month] => 5
            [post_type] => post
        )

    [882] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10606
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-118
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 118)
            [post_author] => 2
            [post_date] => 2016-05-12 14:37:00
            [year] => 2016
            [month] => 5
            [post_type] => post
        )

    [883] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10607
            [post_name] => u-s-investigates-drugmaker-contracts-with-pharmacy-benefit-managers
            [post_title] => U.S. Investigates Drugmaker Contracts With Pharmacy Benefit Managers
            [post_author] => 2
            [post_date] => 2016-05-11 22:04:00
            [year] => 2016
            [month] => 5
            [post_type] => post
        )

    [884] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10608
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-117
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 117)
            [post_author] => 2
            [post_date] => 2016-05-06 13:11:00
            [year] => 2016
            [month] => 5
            [post_type] => post
        )

    [885] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10609
            [post_name] => video-why-your-pbms-business-model-matters
            [post_title] => [VIDEO] Why Your PBM's Business Model Matters
            [post_author] => 2
            [post_date] => 2016-05-05 22:29:00
            [year] => 2016
            [month] => 5
            [post_type] => post
        )

    [886] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10610
            [post_name] => high-cost-specialty-drugs-predictions-for-the-future
            [post_title] => High-cost specialty drugs; predictions for the future
            [post_author] => 2
            [post_date] => 2016-05-03 14:49:00
            [year] => 2016
            [month] => 5
            [post_type] => post
        )

    [887] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10611
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-116
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 116)
            [post_author] => 2
            [post_date] => 2016-04-28 17:36:00
            [year] => 2016
            [month] => 4
            [post_type] => post
        )

    [888] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10612
            [post_name] => express-scripts-generates-top-line-revenue-of-76-63-per-claim
            [post_title] => Express Scripts generates top-line revenue of $76.63 per claim!
            [post_author] => 2
            [post_date] => 2016-04-26 20:28:00
            [year] => 2016
            [month] => 4
            [post_type] => post
        )

    [889] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10613
            [post_name] => game-of-thrones-express-scripts-holding-company-countersues-anthem
            [post_title] => Game of Thrones:  Express Scripts Holding Company Countersues Anthem
            [post_author] => 2
            [post_date] => 2016-04-22 17:50:00
            [year] => 2016
            [month] => 4
            [post_type] => post
        )

    [890] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10614
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-115
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 115)
            [post_author] => 2
            [post_date] => 2016-04-21 16:21:00
            [year] => 2016
            [month] => 4
            [post_type] => post
        )

    [891] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10615
            [post_name] => shining-a-light-on-the-dark-practice-of-rx-price-gouging
            [post_title] => Shining a Light on the Dark Practice of Rx Price Gouging
            [post_author] => 2
            [post_date] => 2016-04-19 16:39:00
            [year] => 2016
            [month] => 4
            [post_type] => post
        )

    [892] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10616
            [post_name] => center-for-medicare-and-medicaid-services-new-plan-to-curb-medicare-prescription-drug-price-inflation
            [post_title] => Center for Medicare and Medicaid Services New Plan to Curb Medicare Prescription Drug Price Inflation
            [post_author] => 2
            [post_date] => 2016-04-18 17:09:00
            [year] => 2016
            [month] => 4
            [post_type] => post
        )

    [893] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10617
            [post_name] => national-drug-spend-310b-in-2015-and-projected-to-double-by-2020
            [post_title] => National Drug Spend | $310B in 2015 and projected to double by 2020
            [post_author] => 2
            [post_date] => 2016-04-15 15:50:00
            [year] => 2016
            [month] => 4
            [post_type] => post
        )

    [894] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10618
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-114
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 114)
            [post_author] => 2
            [post_date] => 2016-04-14 13:38:00
            [year] => 2016
            [month] => 4
            [post_type] => post
        )

    [895] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10619
            [post_name] => recent-trends-in-prescription-drug-costs
            [post_title] => Recent Trends in Prescription Drug Costs
            [post_author] => 2
            [post_date] => 2016-04-11 13:22:00
            [year] => 2016
            [month] => 4
            [post_type] => post
        )

    [896] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10620
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-113
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 113)
            [post_author] => 2
            [post_date] => 2016-04-06 18:07:00
            [year] => 2016
            [month] => 4
            [post_type] => post
        )

    [897] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10621
            [post_name] => optumrx-and-walgreens-to-partner-on-90-day-prescriptions
            [post_title] => OptumRx and Walgreens to partner on 90-day prescriptions
            [post_author] => 2
            [post_date] => 2016-04-05 17:02:00
            [year] => 2016
            [month] => 4
            [post_type] => post
        )

    [898] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10622
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-112
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 112)
            [post_author] => 2
            [post_date] => 2016-03-31 14:04:00
            [year] => 2016
            [month] => 3
            [post_type] => post
        )

    [899] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10623
            [post_name] => stemming-the-escalating-cost-of-prescription-drugs-a-position-paper-of-the-american-college-of-physicians
            [post_title] => Stemming the Escalating Cost of Prescription Drugs: A Position Paper of the American College of Physicians
            [post_author] => 2
            [post_date] => 2016-03-30 19:17:00
            [year] => 2016
            [month] => 3
            [post_type] => post
        )

    [900] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10624
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-111
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 111)
            [post_author] => 2
            [post_date] => 2016-03-24 14:06:00
            [year] => 2016
            [month] => 3
            [post_type] => post
        )

    [901] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10625
            [post_name] => unbundling-the-secrets-of-managing-drug-costs-in-the-era-of-value-based-care
            [post_title] => Unbundling the Secrets of Managing Drug Costs in the Era of Value-Based Care
            [post_author] => 2
            [post_date] => 2016-03-23 14:44:00
            [year] => 2016
            [month] => 3
            [post_type] => post
        )

    [902] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10626
            [post_name] => employers-scramble-to-keep-lid-on-climbing-specialty-drug-costs
            [post_title] => Employers scramble to keep lid on climbing specialty drug costs
            [post_author] => 2
            [post_date] => 2016-03-21 16:46:00
            [year] => 2016
            [month] => 3
            [post_type] => post
        )

    [903] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10627
            [post_name] => more-large-employers-self-funding-pharmacy-benefit-plans
            [post_title] => More Large Employers Self-funding Pharmacy Benefit Plans
            [post_author] => 2
            [post_date] => 2016-03-18 15:00:00
            [year] => 2016
            [month] => 3
            [post_type] => post
        )

    [904] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10628
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-110
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 110)
            [post_author] => 2
            [post_date] => 2016-03-17 21:32:00
            [year] => 2016
            [month] => 3
            [post_type] => post
        )

    [905] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10629
            [post_name] => surprise-proposal-medicare-wants-to-jump-on-the-value-based-prescription-drug-pricing-bandwagon
            [post_title] => Surprise proposal: Medicare wants to jump on the value-based prescription drug pricing bandwagon
            [post_author] => 2
            [post_date] => 2016-03-16 15:30:00
            [year] => 2016
            [month] => 3
            [post_type] => post
        )

    [906] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10630
            [post_name] => for-pharmacy-benefits-is-greater-choice-always-better
            [post_title] => For Pharmacy Benefits, Is Greater Choice Always Better?
            [post_author] => 2
            [post_date] => 2016-03-11 15:57:00
            [year] => 2016
            [month] => 3
            [post_type] => post
        )

    [907] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10631
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-109
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 109)
            [post_author] => 2
            [post_date] => 2016-03-10 14:57:00
            [year] => 2016
            [month] => 3
            [post_type] => post
        )

    [908] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10632
            [post_name] => employers-testing-new-ways-to-rein-in-specialty-drug-costs
            [post_title] => Employers testing new ways to rein in specialty drug costs
            [post_author] => 2
            [post_date] => 2016-03-07 17:58:00
            [year] => 2016
            [month] => 3
            [post_type] => post
        )

    [909] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10633
            [post_name] => drug-distribution-becomes-a-weapon-to-block-competition
            [post_title] => Drug distribution becomes a weapon to block competition
            [post_author] => 2
            [post_date] => 2016-03-04 14:26:00
            [year] => 2016
            [month] => 3
            [post_type] => post
        )

    [910] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10634
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-108
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 108)
            [post_author] => 2
            [post_date] => 2016-03-03 15:09:00
            [year] => 2016
            [month] => 3
            [post_type] => post
        )

    [911] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10635
            [post_name] => employers-doubling-down-on-pharmacy-costs
            [post_title] => Employers Doubling Down on Pharmacy Costs
            [post_author] => 2
            [post_date] => 2016-03-01 16:19:00
            [year] => 2016
            [month] => 3
            [post_type] => post
        )

    [912] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10636
            [post_name] => employers-take-aim-to-curb-high-cost-of-pharmacy-benefits
            [post_title] => Employers Take Aim to Curb High Cost of Pharmacy Benefits
            [post_author] => 2
            [post_date] => 2016-02-29 14:47:00
            [year] => 2016
            [month] => 2
            [post_type] => post
        )

    [913] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10637
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-107
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 107)
            [post_author] => 2
            [post_date] => 2016-02-25 21:07:00
            [year] => 2016
            [month] => 2
            [post_type] => post
        )

    [914] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10638
            [post_name] => economists-debate-fight-with-or-adapt-to-rising-drug-prices
            [post_title] => Economists Debate: Fight With or Adapt to Rising Drug Prices?
            [post_author] => 2
            [post_date] => 2016-02-23 13:54:00
            [year] => 2016
            [month] => 2
            [post_type] => post
        )

    [915] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10639
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-106
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 106)
            [post_author] => 2
            [post_date] => 2016-02-18 15:01:00
            [year] => 2016
            [month] => 2
            [post_type] => post
        )

    [916] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10640
            [post_name] => pbm-tools-play-key-role-in-managing-specialty-drug-costs
            [post_title] => PBM Tools Play Key Role in Managing Specialty Drug Costs
            [post_author] => 2
            [post_date] => 2016-02-16 15:46:00
            [year] => 2016
            [month] => 2
            [post_type] => post
        )

    [917] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10641
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-105
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 105)
            [post_author] => 2
            [post_date] => 2016-02-11 15:41:00
            [year] => 2016
            [month] => 2
            [post_type] => post
        )

    [918] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10642
            [post_name] => hospitals-launch-specialty-pharmacies-to-curb-drug-costs
            [post_title] => Hospitals launch specialty pharmacies to curb drug costs
            [post_author] => 2
            [post_date] => 2016-02-10 14:09:00
            [year] => 2016
            [month] => 2
            [post_type] => post
        )

    [919] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10643
            [post_name] => pbms-provide-policy-solutions-to-reduce-rx-costs-increase-competition
            [post_title] => PBMs Provide Policy Solutions to Reduce Rx Costs, Increase Competition
            [post_author] => 2
            [post_date] => 2016-02-08 14:28:00
            [year] => 2016
            [month] => 2
            [post_type] => post
        )

    [920] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10644
            [post_name] => ncpa-to-congress-scrutinize-pbm-corporations-as-part-of-drug-cost-review
            [post_title] => NCPA to Congress: Scrutinize PBM Corporations as Part of Drug Cost Review
            [post_author] => 2
            [post_date] => 2016-02-05 15:33:00
            [year] => 2016
            [month] => 2
            [post_type] => post
        )

    [921] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10645
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-104
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 104)
            [post_author] => 2
            [post_date] => 2016-02-04 14:06:00
            [year] => 2016
            [month] => 2
            [post_type] => post
        )

    [922] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10646
            [post_name] => new-york-requires-pbm-contracts-to-include-dispute-resolution-provisions
            [post_title] => New York requires PBM contracts to include dispute resolution provisions
            [post_author] => 2
            [post_date] => 2016-02-02 14:39:00
            [year] => 2016
            [month] => 2
            [post_type] => post
        )

    [923] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10647
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-103
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 103)
            [post_author] => 2
            [post_date] => 2016-01-28 19:08:00
            [year] => 2016
            [month] => 1
            [post_type] => post
        )

    [924] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10648
            [post_name] => employers-turn-to-deductibles-out-of-pocket-oop-limits-to-manage-prescription-drug-costs
            [post_title] => Employers Turn to Deductibles, Out-of-Pocket (OOP) Limits to Manage Prescription Drug Costs
            [post_author] => 2
            [post_date] => 2016-01-25 15:21:00
            [year] => 2016
            [month] => 1
            [post_type] => post
        )

    [925] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10649
            [post_name] => despite-obamacare-prescription-drug-discount-cards-are-still-relevant
            [post_title] => Despite Obamacare, prescription drug discount cards are still relevant
            [post_author] => 2
            [post_date] => 2016-01-22 14:43:00
            [year] => 2016
            [month] => 1
            [post_type] => post
        )

    [926] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10650
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-102
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 102)
            [post_author] => 2
            [post_date] => 2016-01-21 15:09:00
            [year] => 2016
            [month] => 1
            [post_type] => post
        )

    [927] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10651
            [post_name] => with-coupon-programs-drug-industry-hides-ballooning-costs-of-expensive-new-medicines
            [post_title] => With coupon programs, drug industry hides ballooning costs of expensive new medicines
            [post_author] => 2
            [post_date] => 2016-01-18 15:16:00
            [year] => 2016
            [month] => 1
            [post_type] => post
        )

    [928] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10652
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-101
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 101)
            [post_author] => 2
            [post_date] => 2016-01-14 16:28:00
            [year] => 2016
            [month] => 1
            [post_type] => post
        )

    [929] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10653
            [post_name] => anthem-seeks-3b-more-in-drug-savings-from-express-scripts
            [post_title] => Anthem seeks $3B more in drug savings from Express Scripts
            [post_author] => 2
            [post_date] => 2016-01-13 19:10:00
            [year] => 2016
            [month] => 1
            [post_type] => post
        )

    [930] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10654
            [post_name] => prescription-drug-launch-forecast-2016
            [post_title] => Prescription Drug Launch Forecast - 2016
            [post_author] => 2
            [post_date] => 2016-01-11 17:45:00
            [year] => 2016
            [month] => 1
            [post_type] => post
        )

    [931] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10655
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-100
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 100)
            [post_author] => 2
            [post_date] => 2016-01-09 00:10:00
            [year] => 2016
            [month] => 1
            [post_type] => post
        )

    [932] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10656
            [post_name] => how-pfizer-set-the-cost-of-its-new-drug-at-9850-a-month
            [post_title] => How Pfizer set the cost of its new drug at $9,850 a month
            [post_author] => 2
            [post_date] => 2016-01-05 16:21:00
            [year] => 2016
            [month] => 1
            [post_type] => post
        )

    [933] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10657
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-99
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 99)
            [post_author] => 2
            [post_date] => 2016-01-02 21:17:00
            [year] => 2016
            [month] => 1
            [post_type] => post
        )

    [934] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10658
            [post_name] => drug-prices-are-too-damn-high-heres-how-to-fix-them
            [post_title] => Drug Prices Are Too Damn High. Here’s How to Fix Them
            [post_author] => 2
            [post_date] => 2015-12-28 15:15:00
            [year] => 2015
            [month] => 12
            [post_type] => post
        )

    [935] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10659
            [post_name] => employers-battle-drug-costs
            [post_title] => Employers Battle Drug Costs
            [post_author] => 2
            [post_date] => 2015-12-21 14:13:00
            [year] => 2015
            [month] => 12
            [post_type] => post
        )

    [936] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10660
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-98
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 98)
            [post_author] => 2
            [post_date] => 2015-12-17 13:36:00
            [year] => 2015
            [month] => 12
            [post_type] => post
        )

    [937] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10661
            [post_name] => who-has-the-power-to-cut-drug-prices-employers
            [post_title] => Who Has the Power to Cut Drug Prices? Employers.
            [post_author] => 2
            [post_date] => 2015-12-15 15:47:00
            [year] => 2015
            [month] => 12
            [post_type] => post
        )

    [938] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10662
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-97
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 97)
            [post_author] => 2
            [post_date] => 2015-12-10 16:25:00
            [year] => 2015
            [month] => 12
            [post_type] => post
        )

    [939] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10663
            [post_name] => prescription-drug-spending-for-state-employees-runs-wild-despite-cost-saving-efforts
            [post_title] => Prescription Drug Spending For State Employees Runs Wild, Despite Cost-Saving Efforts
            [post_author] => 2
            [post_date] => 2015-12-07 16:11:00
            [year] => 2015
            [month] => 12
            [post_type] => post
        )

    [940] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10664
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-96
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 96)
            [post_author] => 2
            [post_date] => 2015-12-03 14:42:00
            [year] => 2015
            [month] => 12
            [post_type] => post
        )

    [941] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10665
            [post_name] => specialty-drugs-in-the-pipeline-4-heavily-impacted-diseases
            [post_title] => Specialty drugs in the pipeline: 4 heavily impacted diseases
            [post_author] => 2
            [post_date] => 2015-11-30 15:04:00
            [year] => 2015
            [month] => 11
            [post_type] => post
        )

    [942] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10666
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-95
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 95)
            [post_author] => 2
            [post_date] => 2015-11-27 22:34:00
            [year] => 2015
            [month] => 11
            [post_type] => post
        )

    [943] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10667
            [post_name] => amgen-agrees-to-pay-for-performance-deal-with-harvard-pilgrim-health-care-plan
            [post_title] => Amgen Agrees to Pay-for-Performance Deal With Harvard Pilgrim Health Care Plan
            [post_author] => 2
            [post_date] => 2015-11-23 15:33:00
            [year] => 2015
            [month] => 11
            [post_type] => post
        )

    [944] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10668
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-94
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 94)
            [post_author] => 2
            [post_date] => 2015-11-19 21:22:00
            [year] => 2015
            [month] => 11
            [post_type] => post
        )

    [945] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10669
            [post_name] => payers-forget-specialty-drug-costs-generic-prices-are-crushing-our-budgets-too
            [post_title] => Payers: Forget specialty drug costs—generic prices are crushing our budgets, too
            [post_author] => 2
            [post_date] => 2015-11-16 17:44:00
            [year] => 2015
            [month] => 11
            [post_type] => post
        )

    [946] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10670
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-93
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 93)
            [post_author] => 2
            [post_date] => 2015-11-12 14:36:00
            [year] => 2015
            [month] => 11
            [post_type] => post
        )

    [947] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10671
            [post_name] => pbms-wed-with-promise-of-savings-but-reduction-in-choice-may-hurt-employers
            [post_title] => PBMs wed with promise of savings, but reduction in choice may hurt employers
            [post_author] => 2
            [post_date] => 2015-11-09 15:28:00
            [year] => 2015
            [month] => 11
            [post_type] => post
        )

    [948] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10672
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-92
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 92)
            [post_author] => 2
            [post_date] => 2015-11-05 15:44:00
            [year] => 2015
            [month] => 11
            [post_type] => post
        )

    [949] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10673
            [post_name] => how-self-funded-employers-can-tackle-double-digit-prescription-drug-cost-increases
            [post_title] => How self-funded employers can tackle double-digit prescription drug cost increases
            [post_author] => 2
            [post_date] => 2015-11-03 15:49:00
            [year] => 2015
            [month] => 11
            [post_type] => post
        )

    [950] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10674
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-91
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 91)
            [post_author] => 2
            [post_date] => 2015-10-29 20:25:00
            [year] => 2015
            [month] => 10
            [post_type] => post
        )

    [951] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10675
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-90
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 90)
            [post_author] => 2
            [post_date] => 2015-10-22 17:00:00
            [year] => 2015
            [month] => 10
            [post_type] => post
        )

    [952] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10676
            [post_name] => some-multi-source-generic-prescription-drugs-cost-roughly-as-much-as-their-brand-name-rivals-heres-why
            [post_title] => Some multi-source (generic) prescription drugs cost roughly as much as their brand name rivals: Here's why
            [post_author] => 2
            [post_date] => 2015-10-19 16:39:00
            [year] => 2015
            [month] => 10
            [post_type] => post
        )

    [953] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10677
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-89
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 89)
            [post_author] => 2
            [post_date] => 2015-10-15 13:33:00
            [year] => 2015
            [month] => 10
            [post_type] => post
        )

    [954] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10678
            [post_name] => building-the-in-house-pharmacy-benefit-three-considerations-for-the-health-system-as-plan-sponsor
            [post_title] => Building the In-house Pharmacy Benefit: Three considerations for the health system as plan sponsor
            [post_author] => 2
            [post_date] => 2015-10-13 13:14:00
            [year] => 2015
            [month] => 10
            [post_type] => post
        )

    [955] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10679
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-88
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 88)
            [post_author] => 2
            [post_date] => 2015-10-08 18:30:00
            [year] => 2015
            [month] => 10
            [post_type] => post
        )

    [956] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10680
            [post_name] => for-prescription-drug-makers-price-increases-drive-revenue
            [post_title] => For Prescription Drug Makers, Price Increases Drive Revenue
            [post_author] => 2
            [post_date] => 2015-10-07 14:03:00
            [year] => 2015
            [month] => 10
            [post_type] => post
        )

    [957] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10681
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-87
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 87)
            [post_author] => 2
            [post_date] => 2015-10-01 17:08:00
            [year] => 2015
            [month] => 10
            [post_type] => post
        )

    [958] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10682
            [post_name] => how-the-national-drug-debate-is-changing-the-pharmacy-benefit-business
            [post_title] => How the national drug debate is changing the pharmacy benefit business
            [post_author] => 2
            [post_date] => 2015-09-29 15:39:00
            [year] => 2015
            [month] => 9
            [post_type] => post
        )

    [959] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10683
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-86
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 86)
            [post_author] => 2
            [post_date] => 2015-09-24 13:01:00
            [year] => 2015
            [month] => 9
            [post_type] => post
        )

    [960] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10684
            [post_name] => can-payers-and-plan-sponsors-be-held-responsible-for-questionable-pharmacy-benefit-manager-practices
            [post_title] => Can payers and plan sponsors be held responsible for questionable pharmacy benefit manager practices?
            [post_author] => 2
            [post_date] => 2015-09-22 21:03:00
            [year] => 2015
            [month] => 9
            [post_type] => post
        )

    [961] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10685
            [post_name] => reference-pricing-net-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-85
            [post_title] => Reference Pricing: "Net" Invoice Cost for Top Selling Generic and Brand Prescription Drugs (Volume 85)
            [post_author] => 2
            [post_date] => 2015-09-17 14:52:00
            [year] => 2015
            [month] => 9
            [post_type] => post
        )

    [962] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10686
            [post_name] => studies-try-to-help-pill-regimen-adherence
            [post_title] => Studies try to help pill regimen adherence
            [post_author] => 2
            [post_date] => 2015-09-16 16:07:00
            [year] => 2015
            [month] => 9
            [post_type] => post
        )

    [963] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10687
            [post_name] => reference-pricing-net-ingredient-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-84
            [post_title] => Reference Pricing: "Net" Ingredient Cost for Top Selling Generic and Brand Prescription Drugs (Volume 84)
            [post_author] => 2
            [post_date] => 2015-09-11 19:54:00
            [year] => 2015
            [month] => 9
            [post_type] => post
        )

    [964] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10688
            [post_name] => rising-cost-of-drugs-where-do-we-go-from-here
            [post_title] => Rising Cost Of Drugs: Where Do We Go From Here?
            [post_author] => 2
            [post_date] => 2015-09-08 13:52:00
            [year] => 2015
            [month] => 9
            [post_type] => post
        )

    [965] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10689
            [post_name] => reference-pricing-net-ingredient-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-83
            [post_title] => Reference Pricing: "Net" Ingredient Cost for Top Selling Generic and Brand Prescription Drugs (Volume 83)
            [post_author] => 2
            [post_date] => 2015-09-03 15:19:00
            [year] => 2015
            [month] => 9
            [post_type] => post
        )

    [966] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10690
            [post_name] => state-in-legal-battle-over-prescription-drug-benefits
            [post_title] => State In Legal Battle Over Prescription Drug Benefits
            [post_author] => 2
            [post_date] => 2015-09-01 14:21:00
            [year] => 2015
            [month] => 9
            [post_type] => post
        )

    [967] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10691
            [post_name] => reference-pricing-net-ingredient-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-82
            [post_title] => Reference Pricing: "Net" Ingredient Cost for Top Selling Generic and Brand Prescription Drugs (Volume 82)
            [post_author] => 2
            [post_date] => 2015-08-27 16:14:00
            [year] => 2015
            [month] => 8
            [post_type] => post
        )

    [968] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10692
            [post_name] => specialty-drug-costs-prompt-employers-to-tighten-their-belts
            [post_title] => Specialty Drug Costs Prompt Employers to Tighten Their Belts
            [post_author] => 2
            [post_date] => 2015-08-24 21:41:00
            [year] => 2015
            [month] => 8
            [post_type] => post
        )

    [969] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10693
            [post_name] => reference-pricing-net-ingredient-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-81
            [post_title] => Reference Pricing: "Net" Ingredient Cost for Top Selling Generic and Brand Prescription Drugs (Volume 81)
            [post_author] => 2
            [post_date] => 2015-08-20 19:53:00
            [year] => 2015
            [month] => 8
            [post_type] => post
        )

    [970] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10694
            [post_name] => large-employers-look-to-tighten-control-of-costs-for-expensive-drugs
            [post_title] => Large Employers Look To Tighten Control Of Costs For Expensive Drugs
            [post_author] => 2
            [post_date] => 2015-08-17 12:31:00
            [year] => 2015
            [month] => 8
            [post_type] => post
        )

    [971] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10695
            [post_name] => reference-pricing-net-ingredient-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-80
            [post_title] => Reference Pricing: "Net" Ingredient Cost for Top Selling Generic and Brand Prescription Drugs (Volume 80)
            [post_author] => 2
            [post_date] => 2015-08-13 14:46:00
            [year] => 2015
            [month] => 8
            [post_type] => post
        )

    [972] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10696
            [post_name] => pharmacy-podcast-show-the-fiduciary-pbm
            [post_title] => Pharmacy Podcast Show - The Fiduciary PBM
            [post_author] => 2
            [post_date] => 2015-08-11 20:21:00
            [year] => 2015
            [month] => 8
            [post_type] => post
        )

    [973] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10697
            [post_name] => reference-pricing-net-ingredient-cost-for-top-selling-generic-and-brand-prescription-drugs-volume-79
            [post_title] => Reference Pricing: "Net" Ingredient Cost for Top Selling Generic and Brand Prescription Drugs (Volume 79)
            [post_author] => 2
            [post_date] => 2015-08-06 16:08:00
            [year] => 2015
            [month] => 8
            [post_type] => post
        )

    [974] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10698
            [post_name] => shocker-cvs-allegedly-overcharged-employers-payers-for-prescription-drugs
            [post_title] => Shocker: CVS Allegedly Overcharged Employers (Payers) for Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-08-03 19:04:00
            [year] => 2015
            [month] => 8
            [post_type] => post
        )

    [975] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10699
            [post_name] => reference-pricing-net-ingredient-cost-for-top-selling-generic-and-brand-prescription-drugs
            [post_title] => Reference Pricing: "Net" Ingredient Cost for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-07-30 13:03:00
            [year] => 2015
            [month] => 7
            [post_type] => post
        )

    [976] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10700
            [post_name] => employers-use-of-multi-tier-pharmacy-benefits-continues-to-rise
            [post_title] => Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise
            [post_author] => 2
            [post_date] => 2015-07-29 14:50:00
            [year] => 2015
            [month] => 7
            [post_type] => post
        )

    [977] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10701
            [post_name] => reference-pricing-net-ingredient-cost-for-top-selling-generic-and-brand-prescription-drugs-2
            [post_title] => Reference Pricing: "Net" Ingredient Cost for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-07-23 21:04:00
            [year] => 2015
            [month] => 7
            [post_type] => post
        )

    [978] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10702
            [post_name] => emerging-trends-in-the-specialty-drug-market
            [post_title] => Emerging Trends in the Specialty Drug Market
            [post_author] => 2
            [post_date] => 2015-07-22 16:46:00
            [year] => 2015
            [month] => 7
            [post_type] => post
        )

    [979] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10703
            [post_name] => reference-pricing-net-ingredient-cost-for-top-selling-generic-and-brand-prescription-drugs-3
            [post_title] => Reference Pricing: "Net" Ingredient Cost for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-07-16 14:19:00
            [year] => 2015
            [month] => 7
            [post_type] => post
        )

    [980] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10704
            [post_name] => will-specialty-oncology-products-follow-the-sovaldi-way
            [post_title] => Will Specialty Oncology Products Follow the Sovaldi Way?
            [post_author] => 2
            [post_date] => 2015-07-14 19:03:00
            [year] => 2015
            [month] => 7
            [post_type] => post
        )

    [981] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10705
            [post_name] => reference-pricing-net-ingredient-cost-for-top-selling-generic-and-brand-prescription-drugs-4
            [post_title] => Reference Pricing: "Net" Ingredient Cost for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-07-13 13:05:00
            [year] => 2015
            [month] => 7
            [post_type] => post
        )

    [982] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10706
            [post_name] => controlling-pharmacy-costs
            [post_title] => Controlling Pharmacy Costs
            [post_author] => 2
            [post_date] => 2015-07-10 21:15:00
            [year] => 2015
            [month] => 7
            [post_type] => post
        )

    [983] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10707
            [post_name] => reference-pricing-net-ingredient-cost-for-top-selling-generic-and-brand-prescription-drugs-5
            [post_title] => Reference Pricing: "Net" Ingredient Cost for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-07-08 13:29:00
            [year] => 2015
            [month] => 7
            [post_type] => post
        )

    [984] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10708
            [post_name] => time-to-blow-up-your-pbm-strategy-heres-how
            [post_title] => Time to Blow Up Your PBM Strategy -- Here's How
            [post_author] => 2
            [post_date] => 2015-07-06 17:24:00
            [year] => 2015
            [month] => 7
            [post_type] => post
        )

    [985] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10709
            [post_name] => reference-pricing-net-ingredient-cost-for-top-selling-generic-and-brand-prescription-drugs-6
            [post_title] => Reference Pricing: "Net" Ingredient Cost for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-06-25 13:27:00
            [year] => 2015
            [month] => 6
            [post_type] => post
        )

    [986] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10710
            [post_name] => 125-things-to-know-about-the-big-5-insurers
            [post_title] => 125 Things to Know About the 'Big 5' Insurers
            [post_author] => 2
            [post_date] => 2015-06-23 12:35:00
            [year] => 2015
            [month] => 6
            [post_type] => post
        )

    [987] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10711
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-06-18 16:33:00
            [year] => 2015
            [month] => 6
            [post_type] => post
        )

    [988] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10712
            [post_name] => the-curious-incident-of-the-44000-prescription
            [post_title] => The Curious Incident of the $44,000 Prescription
            [post_author] => 2
            [post_date] => 2015-06-16 14:01:00
            [year] => 2015
            [month] => 6
            [post_type] => post
        )

    [989] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10713
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-2
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-06-11 19:48:00
            [year] => 2015
            [month] => 6
            [post_type] => post
        )

    [990] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10714
            [post_name] => oig-highlights-anti-kickback-risks-of-drug-co-payment-coupons
            [post_title] => OIG Highlights Anti-Kickback Risks of Drug Co-payment Coupons
            [post_author] => 2
            [post_date] => 2015-06-09 12:15:00
            [year] => 2015
            [month] => 6
            [post_type] => post
        )

    [991] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10715
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-3
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-06-04 19:03:00
            [year] => 2015
            [month] => 6
            [post_type] => post
        )

    [992] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10716
            [post_name] => pharmacy-discount-cards-scam-or-savings
            [post_title] => Pharmacy Discount Cards: Scam or Savings?
            [post_author] => 2
            [post_date] => 2015-06-02 13:31:00
            [year] => 2015
            [month] => 6
            [post_type] => post
        )

    [993] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10717
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-4
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-05-28 14:51:00
            [year] => 2015
            [month] => 5
            [post_type] => post
        )

    [994] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10718
            [post_name] => new-push-ties-cost-of-drugs-to-how-well-they-work
            [post_title] => New Push Ties Cost of Drugs to How Well They Work
            [post_author] => 2
            [post_date] => 2015-05-27 17:28:00
            [year] => 2015
            [month] => 5
            [post_type] => post
        )

    [995] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10719
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-5
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-05-21 15:00:00
            [year] => 2015
            [month] => 5
            [post_type] => post
        )

    [996] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10720
            [post_name] => why-do-pharmacy-benefit-managers-pbms-overcharge-their-clients
            [post_title] => Why do pharmacy benefit managers (PBMs) overcharge their clients?
            [post_author] => 2
            [post_date] => 2015-05-20 22:04:00
            [year] => 2015
            [month] => 5
            [post_type] => post
        )

    [997] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10721
            [post_name] => price-vs-patient-access-specialtys-unsettling-conundrum
            [post_title] => Price vs Patient Access: Specialty’s Unsettling Conundrum
            [post_author] => 2
            [post_date] => 2015-05-19 14:44:00
            [year] => 2015
            [month] => 5
            [post_type] => post
        )

    [998] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10722
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-6
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-05-14 13:29:00
            [year] => 2015
            [month] => 5
            [post_type] => post
        )

    [999] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10723
            [post_name] => rare-look-a-detailed-analysis-of-an-existing-clients-old-contract-with-a-legacy-pharmacy-benefits-manager
            [post_title] => Rare Look: A Detailed Analysis of an Existing Client's Old Contract with a Legacy Pharmacy Benefits Manager
            [post_author] => 2
            [post_date] => 2015-05-12 19:09:00
            [year] => 2015
            [month] => 5
            [post_type] => post
        )

    [1000] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10724
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-7
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-05-07 14:36:00
            [year] => 2015
            [month] => 5
            [post_type] => post
        )

    [1001] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10725
            [post_name] => the-rise-of-speciality-drugs-is-your-health-plan-prepared
            [post_title] => The Rise of Speciality Drugs: Is Your Health Plan Prepared?
            [post_author] => 2
            [post_date] => 2015-05-05 20:27:00
            [year] => 2015
            [month] => 5
            [post_type] => post
        )

    [1002] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10726
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-8
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-04-23 15:07:00
            [year] => 2015
            [month] => 4
            [post_type] => post
        )

    [1003] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10727
            [post_name] => proof-the-people-pbms-hire-to-hide-cash-flow-from-employers
            [post_title] => Proof: The People PBMs Hire to Hide Cash Flow From Employers
            [post_author] => 2
            [post_date] => 2015-04-21 16:01:00
            [year] => 2015
            [month] => 4
            [post_type] => post
        )

    [1004] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10728
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-9
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-04-17 15:31:00
            [year] => 2015
            [month] => 4
            [post_type] => post
        )

    [1005] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10729
            [post_name] => 6-ways-to-lower-healthcare-spend-vis-a-vis-specialty-pharmacy
            [post_title] => 6 ways to lower healthcare spend vis-à-vis specialty pharmacy
            [post_author] => 2
            [post_date] => 2015-04-16 20:48:00
            [year] => 2015
            [month] => 4
            [post_type] => post
        )

    [1006] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10730
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-10
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-04-13 16:05:00
            [year] => 2015
            [month] => 4
            [post_type] => post
        )

    [1007] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10731
            [post_name] => 5-keys-to-managing-your-companys-pharmacy-benefit-in-a-dynamic-health-care-marketplace
            [post_title] => 5 Keys to Managing Your Company's Pharmacy Benefit in a Dynamic Health Care Marketplace
            [post_author] => 2
            [post_date] => 2015-04-09 14:40:00
            [year] => 2015
            [month] => 4
            [post_type] => post
        )

    [1008] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10732
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-11
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-04-02 17:21:00
            [year] => 2015
            [month] => 4
            [post_type] => post
        )

    [1009] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10733
            [post_name] => the-malevolence-of-all-health-care-sectors
            [post_title] => The malevolence of all health care sectors
            [post_author] => 2
            [post_date] => 2015-04-01 14:16:00
            [year] => 2015
            [month] => 4
            [post_type] => post
        )

    [1010] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10734
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-12
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-03-26 20:04:00
            [year] => 2015
            [month] => 3
            [post_type] => post
        )

    [1011] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10735
            [post_name] => should-specialty-drugs-be-shifted-from-medical-to-pharmacy-benefit
            [post_title] => Should Specialty Drugs Be Shifted From Medical to Pharmacy Benefit?
            [post_author] => 2
            [post_date] => 2015-03-24 15:22:00
            [year] => 2015
            [month] => 3
            [post_type] => post
        )

    [1012] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10736
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-13
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-03-19 17:24:00
            [year] => 2015
            [month] => 3
            [post_type] => post
        )

    [1013] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10737
            [post_name] => when-it-comes-to-new-drugs-if-providers-and-payers-snooze-they-lose
            [post_title] => When It Comes to New Drugs, If Providers and Payers Snooze, They Lose
            [post_author] => 2
            [post_date] => 2015-03-18 18:02:00
            [year] => 2015
            [month] => 3
            [post_type] => post
        )

    [1014] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10738
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-14
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-03-16 17:13:00
            [year] => 2015
            [month] => 3
            [post_type] => post
        )

    [1015] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10739
            [post_name] => video-the-challenge-of-getting-specialty-drugs-from-manufacturer-to-patient
            [post_title] => [Video] The Challenge of Getting Specialty Drugs from Manufacturer to Patient
            [post_author] => 2
            [post_date] => 2015-03-12 00:41:00
            [year] => 2015
            [month] => 3
            [post_type] => post
        )

    [1016] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10740
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-15
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-03-05 23:38:00
            [year] => 2015
            [month] => 3
            [post_type] => post
        )

    [1017] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10741
            [post_name] => the-makings-of-a-good-drug-formulary
            [post_title] => The Makings of a Good Drug Formulary
            [post_author] => 2
            [post_date] => 2015-03-03 15:51:00
            [year] => 2015
            [month] => 3
            [post_type] => post
        )

    [1018] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10742
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-16
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-02-26 16:27:00
            [year] => 2015
            [month] => 2
            [post_type] => post
        )

    [1019] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10743
            [post_name] => mild-to-aggressive-remedies-for-reducing-prescription-drug-prices
            [post_title] => Mild to aggressive; remedies for reducing prescription drug prices
            [post_author] => 2
            [post_date] => 2015-02-23 14:20:00
            [year] => 2015
            [month] => 2
            [post_type] => post
        )

    [1020] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10744
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-17
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-02-19 14:49:00
            [year] => 2015
            [month] => 2
            [post_type] => post
        )

    [1021] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10745
            [post_name] => specialty-pharmacy-the-top-10-trends-payers-should-be-following
            [post_title] => Specialty Pharmacy: The Top 10 Trends Payers Should Be Following
            [post_author] => 2
            [post_date] => 2015-02-17 16:02:00
            [year] => 2015
            [month] => 2
            [post_type] => post
        )

    [1022] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10746
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-18
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-02-12 15:34:00
            [year] => 2015
            [month] => 2
            [post_type] => post
        )

    [1023] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10747
            [post_name] => generic-drug-price-hikes-hit-pharmacists-and-payers
            [post_title] => Generic drug price hikes hit pharmacists and payers
            [post_author] => 2
            [post_date] => 2015-02-09 17:33:00
            [year] => 2015
            [month] => 2
            [post_type] => post
        )

    [1024] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10748
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-19
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-02-05 14:09:00
            [year] => 2015
            [month] => 2
            [post_type] => post
        )

    [1025] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10749
            [post_name] => infographic-the-cost-of-innovation-how-specialty-drugs-impact-healthcare
            [post_title] => [Infographic] The Cost of Innovation: How Specialty Drugs Impact Healthcare
            [post_author] => 2
            [post_date] => 2015-02-03 17:08:00
            [year] => 2015
            [month] => 2
            [post_type] => post
        )

    [1026] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10750
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-20
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-02-02 15:32:00
            [year] => 2015
            [month] => 2
            [post_type] => post
        )

    [1027] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10751
            [post_name] => top-10-trends-shaping-the-health-industry-in-2015
            [post_title] => Top 10 trends shaping the health industry in 2015
            [post_author] => 2
            [post_date] => 2015-01-27 19:33:00
            [year] => 2015
            [month] => 1
            [post_type] => post
        )

    [1028] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10752
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-21
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-01-22 15:57:00
            [year] => 2015
            [month] => 1
            [post_type] => post
        )

    [1029] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10753
            [post_name] => drug-distributors-build-strength-in-an-era-of-change
            [post_title] => Drug Distributors Build Strength In An Era Of Change
            [post_author] => 2
            [post_date] => 2015-01-20 16:20:00
            [year] => 2015
            [month] => 1
            [post_type] => post
        )

    [1030] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10754
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-22
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-01-15 15:31:00
            [year] => 2015
            [month] => 1
            [post_type] => post
        )

    [1031] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10755
            [post_name] => prevent-prescription-drug-monopolies
            [post_title] => Prevent prescription drug monopolies
            [post_author] => 2
            [post_date] => 2015-01-13 19:35:00
            [year] => 2015
            [month] => 1
            [post_type] => post
        )

    [1032] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10756
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-23
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-01-08 17:47:00
            [year] => 2015
            [month] => 1
            [post_type] => post
        )

    [1033] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10757
            [post_name] => specialty-drug-approvals-review-2014-and-a-forecast-for-2015
            [post_title] => Specialty Drug Approvals: Review 2014 and a Forecast for 2015
            [post_author] => 2
            [post_date] => 2015-01-06 17:07:00
            [year] => 2015
            [month] => 1
            [post_type] => post
        )

    [1034] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10758
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-24
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2015-01-02 15:02:00
            [year] => 2015
            [month] => 1
            [post_type] => post
        )

    [1035] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10759
            [post_name] => pbm-myth-the-request-for-proposal-rfp-binds-your-pharmacy-benefits-manager
            [post_title] => PBM Myth:  The Request For Proposal (RFP) Binds Your Pharmacy Benefits Manager
            [post_author] => 2
            [post_date] => 2014-12-29 15:24:00
            [year] => 2014
            [month] => 12
            [post_type] => post
        )

    [1036] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10760
            [post_name] => bitter-pill-drugs-work-but-drive-overall-cost
            [post_title] => Bitter Pill: Drugs Work But Drive Overall Cost
            [post_author] => 2
            [post_date] => 2014-12-22 21:40:00
            [year] => 2014
            [month] => 12
            [post_type] => post
        )

    [1037] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10761
            [post_name] => the-rising-cost-of-generic-prescription-drugs-is-even-puzzling-experts
            [post_title] => The Rising Cost of Generic Prescription Drugs is Even Puzzling Experts
            [post_author] => 2
            [post_date] => 2014-12-14 20:11:00
            [year] => 2014
            [month] => 12
            [post_type] => post
        )

    [1038] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10762
            [post_name] => pressing-for-pbm-transparency
            [post_title] => Pressing for PBM Transparency
            [post_author] => 2
            [post_date] => 2014-12-02 16:23:00
            [year] => 2014
            [month] => 12
            [post_type] => post
        )

    [1039] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10763
            [post_name] => the-growing-turf-war-over-who-can-fill-prescriptions
            [post_title] => The Growing Turf War over Who Can Fill Prescriptions
            [post_author] => 2
            [post_date] => 2014-12-01 16:44:00
            [year] => 2014
            [month] => 12
            [post_type] => post
        )

    [1040] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10764
            [post_name] => 5-strategies-for-managing-specialty-prescription-drug-costs
            [post_title] => 5 Strategies for Managing Specialty Prescription Drug Costs
            [post_author] => 2
            [post_date] => 2014-11-19 14:55:00
            [year] => 2014
            [month] => 11
            [post_type] => post
        )

    [1041] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10765
            [post_name] => illustrative-example-of-supply-chain-pricing-for-brand-name-prescription-drugs
            [post_title] => Illustrative Example of Supply Chain Pricing for Brand Name Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-11-13 16:29:00
            [year] => 2014
            [month] => 11
            [post_type] => post
        )

    [1042] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10766
            [post_name] => plan-controls-respond-to-pbm-spreads-generic-cost-spikes
            [post_title] => Plan Controls Respond to PBM Spreads, Generic Cost Spikes
            [post_author] => 2
            [post_date] => 2014-11-11 17:01:00
            [year] => 2014
            [month] => 11
            [post_type] => post
        )

    [1043] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10767
            [post_name] => we-need-more-transparency-on-the-cost-of-specialty-drugs
            [post_title] => We Need More Transparency on the Cost of Specialty Drugs
            [post_author] => 2
            [post_date] => 2014-11-06 21:06:00
            [year] => 2014
            [month] => 11
            [post_type] => post
        )

    [1044] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10768
            [post_name] => friction-between-health-plans-pharma-grows-over-specialty-drugs
            [post_title] => Friction Between Health Plans, Pharma Grows Over Specialty Drugs
            [post_author] => 2
            [post_date] => 2014-10-29 14:37:00
            [year] => 2014
            [month] => 10
            [post_type] => post
        )

    [1045] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10769
            [post_name] => pharmacy-carve-out-7-benefits-for-self-funded-or-fully-insured-employers
            [post_title] => Pharmacy Carve-Out: 7 Benefits for Self-Funded or Fully Insured Employers
            [post_author] => 2
            [post_date] => 2014-10-26 15:47:00
            [year] => 2014
            [month] => 10
            [post_type] => post
        )

    [1046] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10770
            [post_name] => repackaging-a-traditional-pharmacy-benefit-managers-black-box-tactic-video
            [post_title] => Repackaging:  A "Traditional" Pharmacy Benefit Manager's Black Box Tactic [Video]
            [post_author] => 2
            [post_date] => 2014-10-21 18:41:00
            [year] => 2014
            [month] => 10
            [post_type] => post
        )

    [1047] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10771
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-25
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-10-20 17:35:00
            [year] => 2014
            [month] => 10
            [post_type] => post
        )

    [1048] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10772
            [post_name] => national-health-expenditure-projections-2013-2023
            [post_title] => National Health Expenditure Projections 2013-2023
            [post_author] => 2
            [post_date] => 2014-10-16 19:41:00
            [year] => 2014
            [month] => 10
            [post_type] => post
        )

    [1049] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10773
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-26
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-10-13 16:06:00
            [year] => 2014
            [month] => 10
            [post_type] => post
        )

    [1050] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10774
            [post_name] => generic-drug-field-full-of-pricing-traps
            [post_title] => Generic Drug Field Full of Pricing Traps
            [post_author] => 2
            [post_date] => 2014-10-08 22:54:00
            [year] => 2014
            [month] => 10
            [post_type] => post
        )

    [1051] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10775
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-27
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-10-06 19:53:00
            [year] => 2014
            [month] => 10
            [post_type] => post
        )

    [1052] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10776
            [post_name] => can-specialty-pharmacies-ease-the-pain-of-soaring-deductibles
            [post_title] => Can Specialty Pharmacies Ease the Pain Of Soaring Deductibles?
            [post_author] => 2
            [post_date] => 2014-10-06 19:30:00
            [year] => 2014
            [month] => 10
            [post_type] => post
        )

    [1053] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10777
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-28
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-09-24 20:03:00
            [year] => 2014
            [month] => 9
            [post_type] => post
        )

    [1054] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10778
            [post_name] => states-step-in-to-regulate-drug-copays
            [post_title] => States step in to regulate drug copays
            [post_author] => 2
            [post_date] => 2014-09-22 20:46:00
            [year] => 2014
            [month] => 9
            [post_type] => post
        )

    [1055] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10779
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-29
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-09-18 14:51:00
            [year] => 2014
            [month] => 9
            [post_type] => post
        )

    [1056] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10780
            [post_name] => drug-prices-soar-as-big-pharma-targets-discount-program
            [post_title] => Drug prices soar as Big Pharma targets discount program
            [post_author] => 2
            [post_date] => 2014-09-15 20:01:00
            [year] => 2014
            [month] => 9
            [post_type] => post
        )

    [1057] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10781
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-30
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-09-12 14:33:00
            [year] => 2014
            [month] => 9
            [post_type] => post
        )

    [1058] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10782
            [post_name] => 10-things-to-know-about-specialty-drug-spending
            [post_title] => 10 Things To Know About Specialty Drug Spending
            [post_author] => 2
            [post_date] => 2014-09-08 20:48:00
            [year] => 2014
            [month] => 9
            [post_type] => post
        )

    [1059] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10783
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-31
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-09-04 17:33:00
            [year] => 2014
            [month] => 9
            [post_type] => post
        )

    [1060] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10784
            [post_name] => 2015-generic-prescription-drug-launch-forecast-updated
            [post_title] => 2015 Generic Prescription Drug Launch Forecast [UPDATED]
            [post_author] => 2
            [post_date] => 2014-09-01 16:10:00
            [year] => 2014
            [month] => 9
            [post_type] => post
        )

    [1061] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10785
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-32
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-08-28 16:01:00
            [year] => 2014
            [month] => 8
            [post_type] => post
        )

    [1062] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10786
            [post_name] => prescription-drug-tiers-cant-handle-all-budget-woes-study-shows
            [post_title] => Prescription drug tiers can't handle all budget woes, study shows
            [post_author] => 2
            [post_date] => 2014-08-26 16:38:00
            [year] => 2014
            [month] => 8
            [post_type] => post
        )

    [1063] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10787
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-33
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-08-19 19:26:00
            [year] => 2014
            [month] => 8
            [post_type] => post
        )

    [1064] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10788
            [post_name] => 2014-generic-prescription-drug-launch-forecast-updated
            [post_title] => 2014 Generic Prescription Drug Launch Forecast [UPDATED]
            [post_author] => 2
            [post_date] => 2014-08-14 18:58:00
            [year] => 2014
            [month] => 8
            [post_type] => post
        )

    [1065] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10789
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-34
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-08-05 23:20:00
            [year] => 2014
            [month] => 8
            [post_type] => post
        )

    [1066] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10790
            [post_name] => insurance-industry-consumers-join-forces-to-fight-high-prices-of-specialty-drugs
            [post_title] => Insurance Industry, Consumers Join Forces to Fight High Prices of Specialty Drugs
            [post_author] => 2
            [post_date] => 2014-08-04 18:11:00
            [year] => 2014
            [month] => 8
            [post_type] => post
        )

    [1067] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10791
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-35
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-07-30 18:22:00
            [year] => 2014
            [month] => 7
            [post_type] => post
        )

    [1068] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10792
            [post_name] => reality-check-us-consumer-drug-costs-climb-ever-higher
            [post_title] => Reality Check: US Consumer Drug Costs Climb Ever Higher
            [post_author] => 2
            [post_date] => 2014-07-28 16:59:00
            [year] => 2014
            [month] => 7
            [post_type] => post
        )

    [1069] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10793
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-36
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-07-24 16:59:00
            [year] => 2014
            [month] => 7
            [post_type] => post
        )

    [1070] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10794
            [post_name] => restrictive-formularies-a-path-to-more-affordable-drug-prices
            [post_title] => Restrictive formularies: A path to more affordable drug prices
            [post_author] => 2
            [post_date] => 2014-07-21 16:22:00
            [year] => 2014
            [month] => 7
            [post_type] => post
        )

    [1071] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10795
            [post_name] => specialty-drugs-a-proactive-approach-to-sustained-cost-containment
            [post_title] => Specialty Drugs: A Proactive Approach to Sustained Cost Containment
            [post_author] => 2
            [post_date] => 2014-07-21 16:07:00
            [year] => 2014
            [month] => 7
            [post_type] => post
        )

    [1072] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10796
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-37
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-07-15 13:32:00
            [year] => 2014
            [month] => 7
            [post_type] => post
        )

    [1073] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10797
            [post_name] => 2015-generic-prescription-drug-launch-forecast
            [post_title] => 2015 Generic Prescription Drug Launch Forecast
            [post_author] => 2
            [post_date] => 2014-07-09 15:23:00
            [year] => 2014
            [month] => 7
            [post_type] => post
        )

    [1074] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10798
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-38
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-07-06 23:44:00
            [year] => 2014
            [month] => 7
            [post_type] => post
        )

    [1075] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10799
            [post_name] => 2014-generic-prescription-drug-launch-forecast
            [post_title] => 2014 Generic Prescription Drug Launch Forecast
            [post_author] => 2
            [post_date] => 2014-06-26 14:23:00
            [year] => 2014
            [month] => 6
            [post_type] => post
        )

    [1076] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10800
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-39
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-06-23 14:37:00
            [year] => 2014
            [month] => 6
            [post_type] => post
        )

    [1077] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10801
            [post_name] => average-wholesale-price-awp-for-twelve-of-the-most-expensive-specialty-drugs
            [post_title] => Average Wholesale Price (AWP) for Twelve of the Most Expensive Specialty Drugs
            [post_author] => 2
            [post_date] => 2014-06-17 15:53:00
            [year] => 2014
            [month] => 6
            [post_type] => post
        )

    [1078] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10802
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-40
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-06-12 15:15:00
            [year] => 2014
            [month] => 6
            [post_type] => post
        )

    [1079] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10803
            [post_name] => industry-consolidation-is-impacting-pbm-customer-service
            [post_title] => Industry Consolidation Is Impacting PBM Customer Service
            [post_author] => 2
            [post_date] => 2014-06-09 12:54:00
            [year] => 2014
            [month] => 6
            [post_type] => post
        )

    [1080] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10804
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-41
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-06-06 14:04:00
            [year] => 2014
            [month] => 6
            [post_type] => post
        )

    [1081] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10805
            [post_name] => the-insurance-industry-is-picking-a-fight-with-pharmaceutical-companies-over-the-rising-cost-of-specialty-drugs
            [post_title] => The Insurance Industry is Picking a Fight with Pharmaceutical Companies Over the Rising Cost of Specialty Drugs
            [post_author] => 2
            [post_date] => 2014-06-02 12:48:00
            [year] => 2014
            [month] => 6
            [post_type] => post
        )

    [1082] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10806
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-42
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-05-28 13:33:00
            [year] => 2014
            [month] => 5
            [post_type] => post
        )

    [1083] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10807
            [post_name] => video-specialty-drug-pricing-discussion-on-nightly-business-report
            [post_title] => Video: Specialty Drug Pricing Discussion on Nightly Business Report
            [post_author] => 2
            [post_date] => 2014-05-27 13:34:00
            [year] => 2014
            [month] => 5
            [post_type] => post
        )

    [1084] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10808
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-43
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-05-19 13:14:00
            [year] => 2014
            [month] => 5
            [post_type] => post
        )

    [1085] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10809
            [post_name] => plan-sponsors-satisfaction-with-pbms-remains-relatively-unchanged
            [post_title] => Plan Sponsors' Satisfaction With PBMs Remains Relatively Unchanged
            [post_author] => 2
            [post_date] => 2014-05-13 14:01:00
            [year] => 2014
            [month] => 5
            [post_type] => post
        )

    [1086] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10810
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-44
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-05-08 19:09:00
            [year] => 2014
            [month] => 5
            [post_type] => post
        )

    [1087] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10811
            [post_name] => ims-report-specialty-medications-drive-prescription-drug-spending-increase
            [post_title] => IMS Report:  Specialty Medications Drive Prescription Drug Spending Increase
            [post_author] => 2
            [post_date] => 2014-05-02 17:16:00
            [year] => 2014
            [month] => 5
            [post_type] => post
        )

    [1088] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10812
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-45
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-04-24 12:18:00
            [year] => 2014
            [month] => 4
            [post_type] => post
        )

    [1089] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10813
            [post_name] => early-pharmacy-claims-data-from-exchange-enrollees-indicate-high-usage
            [post_title] => Early Pharmacy Claims Data from Exchange Enrollees Indicate High Usage
            [post_author] => 2
            [post_date] => 2014-04-23 15:05:00
            [year] => 2014
            [month] => 4
            [post_type] => post
        )

    [1090] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10814
            [post_name] => video-prices-soaring-for-specialty-drugs
            [post_title] => [Video]: Prices Soaring for Specialty Drugs
            [post_author] => 2
            [post_date] => 2014-04-17 14:39:00
            [year] => 2014
            [month] => 4
            [post_type] => post
        )

    [1091] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10815
            [post_name] => experts-warn-employers-to-prepare-for-high-costs-of-specialty-drugs
            [post_title] => Experts warn employers to prepare for high costs of specialty drugs
            [post_author] => 2
            [post_date] => 2014-04-13 14:48:00
            [year] => 2014
            [month] => 4
            [post_type] => post
        )

    [1092] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10816
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-46
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-04-07 13:29:00
            [year] => 2014
            [month] => 4
            [post_type] => post
        )

    [1093] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10817
            [post_name] => lawmakers-seek-more-pricing-info-from-pbms
            [post_title] => Lawmakers seek more pricing info from PBMs
            [post_author] => 2
            [post_date] => 2014-04-04 15:20:00
            [year] => 2014
            [month] => 4
            [post_type] => post
        )

    [1094] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10818
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-47
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-03-31 13:09:00
            [year] => 2014
            [month] => 3
            [post_type] => post
        )

    [1095] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10819
            [post_name] => eight-reasons-employers-overpay-for-pbm-services
            [post_title] => Eight Reasons Employers Overpay For PBM Services
            [post_author] => 2
            [post_date] => 2014-03-27 15:22:00
            [year] => 2014
            [month] => 3
            [post_type] => post
        )

    [1096] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10820
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-48
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-03-18 17:03:00
            [year] => 2014
            [month] => 3
            [post_type] => post
        )

    [1097] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10821
            [post_name] => what-is-the-true-cost-of-pbm-services
            [post_title] => What is the True Cost of PBM Services?
            [post_author] => 2
            [post_date] => 2014-03-17 17:04:00
            [year] => 2014
            [month] => 3
            [post_type] => post
        )

    [1098] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10822
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-49
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-03-10 14:20:00
            [year] => 2014
            [month] => 3
            [post_type] => post
        )

    [1099] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10823
            [post_name] => do-drug-benefit-managers-reduce-health-costs
            [post_title] => Do drug benefit managers reduce health costs?
            [post_author] => 2
            [post_date] => 2014-03-07 20:27:00
            [year] => 2014
            [month] => 3
            [post_type] => post
        )

    [1100] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10824
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-50
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-03-04 01:04:00
            [year] => 2014
            [month] => 3
            [post_type] => post
        )

    [1101] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10825
            [post_name] => cms-proposed-rules-on-medicare-part-d
            [post_title] => CMS Proposed Rules on Medicare Part D
            [post_author] => 2
            [post_date] => 2014-02-28 21:35:00
            [year] => 2014
            [month] => 2
            [post_type] => post
        )

    [1102] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10826
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-51
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-02-26 14:18:00
            [year] => 2014
            [month] => 2
            [post_type] => post
        )

    [1103] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10827
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-52
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-02-17 14:02:00
            [year] => 2014
            [month] => 2
            [post_type] => post
        )

    [1104] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10828
            [post_name] => limited-pharmacy-networks-are-changing-employer-sponsored-prescription-drug-benefits
            [post_title] => Limited Pharmacy Networks are Changing Employer Sponsored Prescription Drug Benefits
            [post_author] => 2
            [post_date] => 2014-02-12 13:53:00
            [year] => 2014
            [month] => 2
            [post_type] => post
        )

    [1105] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10829
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-53
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-02-09 21:52:00
            [year] => 2014
            [month] => 2
            [post_type] => post
        )

    [1106] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10830
            [post_name] => pharmacy-network-reimbursement-rates
            [post_title] => Pharmacy Network Reimbursement Rates
            [post_author] => 2
            [post_date] => 2014-02-06 16:45:00
            [year] => 2014
            [month] => 2
            [post_type] => post
        )

    [1107] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10831
            [post_name] => reference-pricing-pharmacy-invoice-cost-actual-for-top-selling-generic-and-brand-prescription-drugs-54
            [post_title] => Reference Pricing: Pharmacy Invoice Cost (ACTUAL) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-02-03 15:22:00
            [year] => 2014
            [month] => 2
            [post_type] => post
        )

    [1108] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10832
            [post_name] => 2014-launch-forecast-for-generic-prescription-drugs
            [post_title] => 2014 Launch Forecast for Generic Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-01-30 13:32:00
            [year] => 2014
            [month] => 1
            [post_type] => post
        )

    [1109] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10833
            [post_name] => reference-pricing-pharmacy-invoice-cost-for-top-selling-generic-and-brand-prescription-drugs
            [post_title] => Reference Pricing:  Pharmacy Invoice Cost for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-01-27 14:42:00
            [year] => 2014
            [month] => 1
            [post_type] => post
        )

    [1110] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10834
            [post_name] => the-pharmacy-benefits-manager-rfp-7-contract-tips-for-a-cost-efficient-drug-benefit-design
            [post_title] => The Pharmacy Benefits Manager RFP; 7 Contract Tips for a Cost Efficient Drug Benefit Design
            [post_author] => 2
            [post_date] => 2014-01-24 18:18:00
            [year] => 2014
            [month] => 1
            [post_type] => post
        )

    [1111] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10835
            [post_name] => pharmacy-cost-invoice-for-top-selling-brand-and-generic-prescription-drugs
            [post_title] => Pharmacy Cost [invoice] for Top Selling Brand and Generic Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-01-16 18:07:00
            [year] => 2014
            [month] => 1
            [post_type] => post
        )

    [1112] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10836
            [post_name] => pbms-and-generic-drugs-is-the-good-news-ending
            [post_title] => PBMs and generic drugs: Is the good news ending?
            [post_author] => 2
            [post_date] => 2014-01-15 00:54:00
            [year] => 2014
            [month] => 1
            [post_type] => post
        )

    [1113] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10837
            [post_name] => pharmacy-invoice-prices-actual-for-top-selling-generic-and-brand-prescription-drugs
            [post_title] => Pharmacy Invoice Prices (Actual) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2014-01-10 12:35:00
            [year] => 2014
            [month] => 1
            [post_type] => post
        )

    [1114] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10838
            [post_name] => mail-order-drug-systems-more-cost-effective-than-brick-n-mortar-pharmacies
            [post_title] => Mail order drug systems more cost effective than brick-n-mortar pharmacies
            [post_author] => 2
            [post_date] => 2014-01-09 17:36:00
            [year] => 2014
            [month] => 1
            [post_type] => post
        )

    [1115] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10839
            [post_name] => pharmacy-invoice-prices-actual-for-top-selling-generic-and-brand-prescription-drugs-2
            [post_title] => Pharmacy Invoice Prices (Actual) for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2013-12-19 12:16:00
            [year] => 2013
            [month] => 12
            [post_type] => post
        )

    [1116] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10840
            [post_name] => adviser-or-broker-which-standard-is-most-beneficial-to-plan-sponsors
            [post_title] => Adviser or Broker - which standard is most beneficial to plan sponsors?
            [post_author] => 2
            [post_date] => 2013-12-18 13:01:00
            [year] => 2013
            [month] => 12
            [post_type] => post
        )

    [1117] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10841
            [post_name] => resource-for-payers-acquisition-cost-pharmacy-invoice-for-popular-brand-generic-prescription-drugs
            [post_title] => Resource for Payers:  Acquisition Cost (pharmacy invoice) for Popular Brand & Generic Prescription Drugs
            [post_author] => 2
            [post_date] => 2013-12-12 12:31:00
            [year] => 2013
            [month] => 12
            [post_type] => post
        )

    [1118] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10842
            [post_name] => payers-know-your-prescription-drug-opportunity-costs
            [post_title] => Payers:  Know Your Prescription Drug Opportunity Costs
            [post_author] => 2
            [post_date] => 2013-12-10 14:28:00
            [year] => 2013
            [month] => 12
            [post_type] => post
        )

    [1119] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10843
            [post_name] => actual-acquisition-costs-what-pharmacy-pays-of-top-selling-generic-and-brand-prescription-drugs-for-payers
            [post_title] => "Actual" Acquisition Costs (what pharmacy pays) of Top Selling Generic and Brand Prescription Drugs: for Payers
            [post_author] => 2
            [post_date] => 2013-12-05 13:30:00
            [year] => 2013
            [month] => 12
            [post_type] => post
        )

    [1120] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10844
            [post_name] => some-patients-need-help-with-medication-adherence-from-pharmacists
            [post_title] => Some Patients Need Help with Medication Adherence from Pharmacists
            [post_author] => 2
            [post_date] => 2013-12-03 15:35:00
            [year] => 2013
            [month] => 12
            [post_type] => post
        )

    [1121] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10845
            [post_name] => prescription-drug-prices-10-definitions-all-payers-hould-know
            [post_title] => Prescription Drug Prices:  10 Definitions All Payers $hould Know
            [post_author] => 2
            [post_date] => 2013-11-27 15:08:00
            [year] => 2013
            [month] => 11
            [post_type] => post
        )

    [1122] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10846
            [post_name] => actual-acquisition-costs-what-pharmacy-pays-of-top-selling-generic-and-brand-prescription-drugs-for-payers-2
            [post_title] => "Actual" Acquisition Costs (what pharmacy pays) of Top Selling Generic and Brand Prescription Drugs: for Payers
            [post_author] => 2
            [post_date] => 2013-11-22 22:34:00
            [year] => 2013
            [month] => 11
            [post_type] => post
        )

    [1123] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10847
            [post_name] => pharmacy-benefits-eight-ways-it-may-unfold-in-2014
            [post_title] => Pharmacy Benefits:  Eight Ways it May Unfold in 2014
            [post_author] => 2
            [post_date] => 2013-11-20 21:40:00
            [year] => 2013
            [month] => 11
            [post_type] => post
        )

    [1124] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10848
            [post_name] => actual-acquisition-costs-what-pharmacy-pays-of-top-selling-generic-and-brand-prescription-drugs-for-payers-3
            [post_title] => "Actual" Acquisition Costs (what pharmacy pays) of Top Selling Generic and Brand Prescription Drugs: for Payers
            [post_author] => 2
            [post_date] => 2013-11-14 15:12:00
            [year] => 2013
            [month] => 11
            [post_type] => post
        )

    [1125] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10849
            [post_name] => the-next-big-thing-in-prescription-drugs-is-in-your-pocket
            [post_title] => The Next BIG Thing in Prescription Drugs is in Your Pocket!
            [post_author] => 2
            [post_date] => 2013-11-12 14:49:00
            [year] => 2013
            [month] => 11
            [post_type] => post
        )

    [1126] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10850
            [post_name] => actual-acquisition-costs-what-pharmacy-pays-of-top-selling-generic-and-brand-prescription-drugs-for-payers-4
            [post_title] => "Actual" Acquisition Costs (what pharmacy pays) of Top Selling Generic and Brand Prescription Drugs for Payers
            [post_author] => 2
            [post_date] => 2013-11-10 00:46:00
            [year] => 2013
            [month] => 11
            [post_type] => post
        )

    [1127] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10851
            [post_name] => hospital-helps-patients-manage-medications-even-after-hospital-stay
            [post_title] => Hospital helps patients manage medications, even after hospital stay
            [post_author] => 2
            [post_date] => 2013-11-04 12:32:00
            [year] => 2013
            [month] => 11
            [post_type] => post
        )

    [1128] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10852
            [post_name] => actual-acquisition-costs-what-pharmacy-pays-of-top-selling-generic-and-brand-prescription-drugs-for-payers-5
            [post_title] => "Actual" Acquisition Costs (what pharmacy pays) of Top Selling Generic and Brand Prescription Drugs for Payers
            [post_author] => 2
            [post_date] => 2013-10-31 15:31:00
            [year] => 2013
            [month] => 10
            [post_type] => post
        )

    [1129] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10853
            [post_name] => actual-acquisition-costs-what-pharmacy-pays-of-top-selling-generic-and-brand-prescription-drugs-for-payers-6
            [post_title] => "Actual" Acquisition Costs (what pharmacy pays) of Top Selling Generic and Brand Prescription Drugs for Payers
            [post_author] => 2
            [post_date] => 2013-10-24 11:09:00
            [year] => 2013
            [month] => 10
            [post_type] => post
        )

    [1130] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10854
            [post_name] => the-high-price-of-specialty-drugs-whining-wont-solve-the-problem
            [post_title] => The High Price of Specialty Drugs: Whining Won't Solve the Problem!
            [post_author] => 2
            [post_date] => 2013-10-22 12:31:00
            [year] => 2013
            [month] => 10
            [post_type] => post
        )

    [1131] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10855
            [post_name] => actual-acquisition-costs-what-pharmacy-pays-of-top-selling-generic-and-brand-prescription-drugs-for-payers-7
            [post_title] => "Actual" Acquisition Costs (what pharmacy pays) of Top Selling Generic and Brand Prescription Drugs for Payers
            [post_author] => 2
            [post_date] => 2013-10-17 17:16:00
            [year] => 2013
            [month] => 10
            [post_type] => post
        )

    [1132] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10856
            [post_name] => 7-steps-for-effectively-managing-costs-of-specialty-drugs
            [post_title] => 7 Steps for Effectively Managing Costs of Specialty Drugs
            [post_author] => 2
            [post_date] => 2013-10-16 01:28:00
            [year] => 2013
            [month] => 10
            [post_type] => post
        )

    [1133] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10857
            [post_name] => actual-acquisition-costs-of-top-selling-generic-and-brand-prescription-drugs-for-payers
            [post_title] => "Actual" Acquisition Costs of Top Selling Generic and Brand Prescription Drugs for Payers
            [post_author] => 2
            [post_date] => 2013-10-10 14:40:00
            [year] => 2013
            [month] => 10
            [post_type] => post
        )

    [1134] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10858
            [post_name] => moves-by-walgreens-other-employers-to-private-exchanges-create-pbm-uncertainty
            [post_title] => Moves by Walgreens, Other Employers to Private Exchanges Create PBM Uncertainty
            [post_author] => 2
            [post_date] => 2013-10-08 14:18:00
            [year] => 2013
            [month] => 10
            [post_type] => post
        )

    [1135] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10859
            [post_name] => transparentrx-thursday-acquisition-pharmacy-cost-for-top-selling-generic-and-brand-prescription-drugs
            [post_title] => TransparentRx Thursday:  Acquisition (Pharmacy) Cost for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2013-10-03 12:05:00
            [year] => 2013
            [month] => 10
            [post_type] => post
        )

    [1136] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10860
            [post_name] => as-specialty-injectable-drug-sales-grow-drug-device-collaborations-change-the-competitive-landscape
            [post_title] => As Specialty Injectable Drug Sales Grow, Drug-Device Collaborations change the Competitive Landscape
            [post_author] => 2
            [post_date] => 2013-09-30 15:21:00
            [year] => 2013
            [month] => 9
            [post_type] => post
        )

    [1137] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10861
            [post_name] => transparentrx-thursday-acquisition-pharmacy-cost-for-top-selling-generic-and-brand-prescription-drugs-2
            [post_title] => TransparentRx Thursday:  Acquisition (Pharmacy) Cost for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2013-09-25 15:28:00
            [year] => 2013
            [month] => 9
            [post_type] => post
        )

    [1138] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10862
            [post_name] => fewer-employers-plan-to-offer-retiree-prescription-drug-plans
            [post_title] => Fewer Employers Plan to Offer Retiree Prescription Drug Plans
            [post_author] => 2
            [post_date] => 2013-09-23 23:34:00
            [year] => 2013
            [month] => 9
            [post_type] => post
        )

    [1139] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10863
            [post_name] => transparentrx-thursday-acquisition-pharmacy-cost-for-top-selling-generic-and-brand-prescription-drugs-3
            [post_title] => TransparentRx Thursday:  Acquisition (Pharmacy) Cost for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2013-09-19 13:35:00
            [year] => 2013
            [month] => 9
            [post_type] => post
        )

    [1140] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10864
            [post_name] => employers-unhappy-with-their-brokers
            [post_title] => Employers Unhappy with Their Brokers
            [post_author] => 2
            [post_date] => 2013-09-17 19:19:00
            [year] => 2013
            [month] => 9
            [post_type] => post
        )

    [1141] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10865
            [post_name] => transparentrx-thursday-acquisition-pharmacy-cost-for-top-selling-generic-and-brand-prescription-drugs-4
            [post_title] => TransparentRx Thursday:  Acquisition (Pharmacy) Cost for Top Selling Generic and Brand Prescription Drugs
            [post_author] => 2
            [post_date] => 2013-09-11 13:16:00
            [year] => 2013
            [month] => 9
            [post_type] => post
        )

    [1142] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10866
            [post_name] => infographic-are-your-pharmacy-benefit-managers-goals-aligned-with-yours
            [post_title] => Infographic:  Are your Pharmacy Benefit Manager's Goals Aligned with Yours?
            [post_author] => 2
            [post_date] => 2013-09-02 21:40:00
            [year] => 2013
            [month] => 9
            [post_type] => post
        )

    [1143] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10867
            [post_name] => specialty-drug-users-may-feel-co-pay-pain
            [post_title] => Specialty Drug Users May Feel Co-pay Pain
            [post_author] => 2
            [post_date] => 2013-08-27 16:17:00
            [year] => 2013
            [month] => 8
            [post_type] => post
        )

    [1144] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10868
            [post_name] => states-scramble-to-drive-down-medicaid-drug-costs
            [post_title] => States Scramble to Drive Down Medicaid Drug Costs
            [post_author] => 2
            [post_date] => 2013-08-22 21:35:00
            [year] => 2013
            [month] => 8
            [post_type] => post
        )

    [1145] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10869
            [post_name] => without-action-a-one-way-ticket-to-rising-drug-costs
            [post_title] => Without action, a one-way ticket to rising drug costs
            [post_author] => 2
            [post_date] => 2013-08-13 22:29:00
            [year] => 2013
            [month] => 8
            [post_type] => post
        )

    [1146] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10870
            [post_name] => video-specialty-drugs-are-a-critical-focus-for-payers
            [post_title] => Video:  Specialty Drugs are a Critical Focus for Payers
            [post_author] => 2
            [post_date] => 2013-08-06 13:09:00
            [year] => 2013
            [month] => 8
            [post_type] => post
        )

    [1147] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10871
            [post_name] => mcos-shifting-control-over-office-administered-products-from-medical-to-pharmacy-benefit-particularly-affecting-rheumatoid-arthritis-therapies
            [post_title] => MCOs' Shifting Control Over Office-Administered Products from Medical to Pharmacy Benefit, Particularly Affecting Rheumatoid Arthritis Therapies
            [post_author] => 2
            [post_date] => 2013-08-01 15:11:00
            [year] => 2013
            [month] => 8
            [post_type] => post
        )

    [1148] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10872
            [post_name] => why-the-fervor-over-drug-adherence
            [post_title] => Why the Fervor Over Drug Adherence?
            [post_author] => 2
            [post_date] => 2013-07-22 15:52:00
            [year] => 2013
            [month] => 7
            [post_type] => post
        )

    [1149] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10873
            [post_name] => diabetes-drugs-will-lead-specialty-category
            [post_title] => Diabetes Drugs will Lead Specialty Category
            [post_author] => 2
            [post_date] => 2013-07-15 15:37:00
            [year] => 2013
            [month] => 7
            [post_type] => post
        )

    [1150] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10874
            [post_name] => evolving-definition-what-is-a-specialty-pharmacy
            [post_title] => Evolving Definition: What is a Specialty Pharmacy?
            [post_author] => 2
            [post_date] => 2013-07-10 16:07:00
            [year] => 2013
            [month] => 7
            [post_type] => post
        )

    [1151] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10875
            [post_name] => expiring-prescription-drug-patents-benefit-consumers
            [post_title] => Expiring Prescription Drug Patents Benefit Consumers
            [post_author] => 2
            [post_date] => 2013-07-01 17:10:00
            [year] => 2013
            [month] => 7
            [post_type] => post
        )

    [1152] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10876
            [post_name] => are-employers-the-culprits-behind-high-u-s-health-care-prices
            [post_title] => Are Employers the Culprits Behind High U.S. Health Care Prices?
            [post_author] => 2
            [post_date] => 2013-06-24 17:01:00
            [year] => 2013
            [month] => 6
            [post_type] => post
        )

    [1153] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10877
            [post_name] => medication-adherence-infographic-getting-america-to-take-its-medicine
            [post_title] => Medication Adherence Infographic: Getting America to Take Its Medicine
            [post_author] => 2
            [post_date] => 2013-06-17 18:54:00
            [year] => 2013
            [month] => 6
            [post_type] => post
        )

    [1154] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10878
            [post_name] => spending-on-specialty-medications-will-rise-67-report
            [post_title] => Spending on Specialty Medications Will Rise 67%: Report
            [post_author] => 2
            [post_date] => 2013-06-10 23:02:00
            [year] => 2013
            [month] => 6
            [post_type] => post
        )

    [1155] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10879
            [post_name] => u-s-medical-price-tag-far-higher-than-others
            [post_title] => U.S. Medical Price Tag Far Higher Than Others
            [post_author] => 2
            [post_date] => 2013-06-03 19:56:00
            [year] => 2013
            [month] => 6
            [post_type] => post
        )

    [1156] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10880
            [post_name] => ppaca-play-or-pay-decision-guide-for-employers
            [post_title] => PPACA Play-or-Pay Decision Guide for Employers
            [post_author] => 2
            [post_date] => 2013-05-28 14:46:00
            [year] => 2013
            [month] => 5
            [post_type] => post
        )

    [1157] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10881
            [post_name] => after-cms-releases-chargemaster-data-hospitals-mull-price-changes
            [post_title] => After CMS Releases Chargemaster Data, Hospitals Mull Price Changes
            [post_author] => 2
            [post_date] => 2013-05-20 17:27:00
            [year] => 2013
            [month] => 5
            [post_type] => post
        )

    [1158] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10882
            [post_name] => a-federal-agency-cms-has-requested-copies-of-our-purchase-invoices-for-wholesale-prescription-drugs
            [post_title] => A Federal Agency (CMS) has Requested Copies of our Purchase Invoices for Wholesale Prescription Drugs
            [post_author] => 2
            [post_date] => 2013-05-14 21:52:00
            [year] => 2013
            [month] => 5
            [post_type] => post
        )

    [1159] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10883
            [post_name] => new-report-shows-drugstore-lobby-agenda-raises-rx-costs-for-small-businesses-and-government-programs
            [post_title] => New Report Shows Drugstore Lobby Agenda Raises Rx Costs for Small Businesses and Government Programs
            [post_author] => 2
            [post_date] => 2013-05-07 01:56:00
            [year] => 2013
            [month] => 5
            [post_type] => post
        )

    [1160] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10884
            [post_name] => small-pharmacies-getting-squeeze-from-goliath-pbms
            [post_title] => Small Pharmacies Getting Squeeze from Goliath PBMs
            [post_author] => 2
            [post_date] => 2013-04-29 21:27:00
            [year] => 2013
            [month] => 4
            [post_type] => post
        )

    [1161] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10885
            [post_name] => insurance-commissioner-refuses-to-enforce-obamacare
            [post_title] => Insurance Commissioner Refuses to Enforce Obamacare
            [post_author] => 2
            [post_date] => 2013-04-04 17:34:00
            [year] => 2013
            [month] => 4
            [post_type] => post
        )

    [1162] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10886
            [post_name] => how-to-control-specialty-pharmacy-costs
            [post_title] => How to Control Specialty Pharmacy Costs?
            [post_author] => 2
            [post_date] => 2013-03-25 14:38:00
            [year] => 2013
            [month] => 3
            [post_type] => post
        )

    [1163] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10887
            [post_name] => the-1-way-to-cut-employer-prescription-drug-costs
            [post_title] => The #1 Way to Cut Employer Prescription Drug Costs
            [post_author] => 2
            [post_date] => 2013-03-19 17:47:00
            [year] => 2013
            [month] => 3
            [post_type] => post
        )

    [1164] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10888
            [post_name] => infographic-the-savings-potential-of-self-insuring
            [post_title] => Infographic:  The Savings Potential of Self-Insuring
            [post_author] => 2
            [post_date] => 2013-03-09 16:03:00
            [year] => 2013
            [month] => 3
            [post_type] => post
        )

    [1165] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10889
            [post_name] => pbms-all-about-the-benjamins
            [post_title] => PBMs | All about the Benjamins
            [post_author] => 2
            [post_date] => 2013-02-19 20:52:00
            [year] => 2013
            [month] => 2
            [post_type] => post
        )

    [1166] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10890
            [post_name] => state-by-state-health-insurance-exchange-decisions
            [post_title] => State-by-State Health Insurance Exchange Decisions
            [post_author] => 2
            [post_date] => 2013-02-11 15:51:00
            [year] => 2013
            [month] => 2
            [post_type] => post
        )

    [1167] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10891
            [post_name] => why-are-prescription-drugs-so-darn-expensive
            [post_title] => Why are Prescription Drugs so Darn Expensive?
            [post_author] => 2
            [post_date] => 2013-02-05 19:32:00
            [year] => 2013
            [month] => 2
            [post_type] => post
        )

    [1168] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10892
            [post_name] => the-federal-government-has-delayed-the-exchange-notification-requirement
            [post_title] => THE FEDERAL GOVERNMENT HAS DELAYED THE EXCHANGE NOTIFICATION REQUIREMENT
            [post_author] => 2
            [post_date] => 2013-01-29 15:41:00
            [year] => 2013
            [month] => 1
            [post_type] => post
        )

    [1169] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10893
            [post_name] => u-s-pharmacy-distribution-reimbursement-system
            [post_title] => U.S. Pharmacy Distribution & Reimbursement System
            [post_author] => 2
            [post_date] => 2013-01-22 14:20:00
            [year] => 2013
            [month] => 1
            [post_type] => post
        )

    [1170] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10894
            [post_name] => agencies-offer-guidance-on-ppaca-taxes-fees
            [post_title] => Agencies Offer Guidance on PPACA Taxes, Fees
            [post_author] => 2
            [post_date] => 2013-01-14 17:59:00
            [year] => 2013
            [month] => 1
            [post_type] => post
        )

    [1171] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10895
            [post_name] => what-are-affordable-care-organizations-acos
            [post_title] => What are Affordable Care Organizations (ACOs)?
            [post_author] => 2
            [post_date] => 2012-12-31 13:53:00
            [year] => 2012
            [month] => 12
            [post_type] => post
        )

    [1172] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10896
            [post_name] => an-uncertain-future-healthcare-reform-moves-forward
            [post_title] => An Uncertain Future:  Healthcare Reform Moves Forward
            [post_author] => 2
            [post_date] => 2012-12-11 15:57:00
            [year] => 2012
            [month] => 12
            [post_type] => post
        )

    [1173] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10897
            [post_name] => 9-key-questions-to-ask-your-potential-new-pbm
            [post_title] => 9 Key Questions to Ask Your Potential (new) PBM
            [post_author] => 2
            [post_date] => 2012-12-07 15:34:00
            [year] => 2012
            [month] => 12
            [post_type] => post
        )

    [1174] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10898
            [post_name] => generic-prescription-drugs-by-mail-can-be-a-bad-deal
            [post_title] => Generic Prescription Drugs by Mail can be a Bad Deal
            [post_author] => 2
            [post_date] => 2012-11-26 15:32:00
            [year] => 2012
            [month] => 11
            [post_type] => post
        )

    [1175] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10899
            [post_name] => healthcare-reform-a-peek-at-the-cost
            [post_title] => Healthcare Reform:  “A Peek at the Cost”
            [post_author] => 2
            [post_date] => 2012-11-13 19:30:00
            [year] => 2012
            [month] => 11
            [post_type] => post
        )

    [1176] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10900
            [post_name] => its-news-to-me
            [post_title] => It's News to me!
            [post_author] => 2
            [post_date] => 2012-11-05 14:59:00
            [year] => 2012
            [month] => 11
            [post_type] => post
        )

    [1177] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10901
            [post_name] => telemedicine-a-step-in-the-right-direction
            [post_title] => Telemedicine:  a Step in the Right Direction
            [post_author] => 2
            [post_date] => 2012-10-29 15:22:00
            [year] => 2012
            [month] => 10
            [post_type] => post
        )

    [1178] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10902
            [post_name] => health-insurers-and-the-classic-bait-and-switch
            [post_title] => Health Insurers and the classic "Bait and Switch"
            [post_author] => 2
            [post_date] => 2012-10-21 21:23:00
            [year] => 2012
            [month] => 10
            [post_type] => post
        )

    [1179] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10903
            [post_name] => pbms-traditional-vs-fiduciary-repricing-report-actual
            [post_title] => PBMs: Traditional vs Fiduciary Repricing Report (Actual)
            [post_author] => 2
            [post_date] => 2012-10-09 14:54:00
            [year] => 2012
            [month] => 10
            [post_type] => post
        )

    [1180] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10904
            [post_name] => get-your-hand-out-of-my-pocket
            [post_title] => Get your Hand out of my Pocket!
            [post_author] => 2
            [post_date] => 2012-10-02 18:43:00
            [year] => 2012
            [month] => 10
            [post_type] => post
        )

    [1181] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10905
            [post_name] => 5-new-ways-to-cut-employer-prescription-drug-costs
            [post_title] => 5 New Ways to Cut Employer Prescription Drug Costs
            [post_author] => 2
            [post_date] => 2012-09-21 17:33:00
            [year] => 2012
            [month] => 9
            [post_type] => post
        )

    [1182] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10906
            [post_name] => the-truth-about-prescription-drug-discount-cards
            [post_title] => The Truth about Prescription Drug Discount Cards
            [post_author] => 2
            [post_date] => 2012-09-11 14:14:00
            [year] => 2012
            [month] => 9
            [post_type] => post
        )

    [1183] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10907
            [post_name] => two-ways-to-avoid-paying-a-premium-for-pbm-services
            [post_title] => Two Ways to Avoid Paying a Premium for PBM Services
            [post_author] => 2
            [post_date] => 2012-08-28 20:07:00
            [year] => 2012
            [month] => 8
            [post_type] => post
        )

    [1184] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10908
            [post_name] => medicare-part-d-deadline-october-15
            [post_title] => Medicare Part D Deadline: October 15
            [post_author] => 2
            [post_date] => 2012-08-20 15:15:00
            [year] => 2012
            [month] => 8
            [post_type] => post
        )

    [1185] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10909
            [post_name] => ppaca-employer-healthcare-coverage-mandate
            [post_title] => PPACA:  Employer Healthcare Coverage Mandate
            [post_author] => 2
            [post_date] => 2012-08-14 19:31:00
            [year] => 2012
            [month] => 8
            [post_type] => post
        )

    [1186] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10910
            [post_name] => which-side-of-the-fence-are-you-on
            [post_title] => Which side of the Fence are you on?
            [post_author] => 2
            [post_date] => 2012-07-26 16:28:00
            [year] => 2012
            [month] => 7
            [post_type] => post
        )

    [1187] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10911
            [post_name] => healthcare-reform-full-speed-ahead
            [post_title] => Healthcare Reform - Full Speed Ahead!
            [post_author] => 2
            [post_date] => 2012-07-17 17:44:00
            [year] => 2012
            [month] => 7
            [post_type] => post
        )

    [1188] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10912
            [post_name] => hsa-vs-hra-what-are-the-differences
            [post_title] => HSA vs. HRA:  What are the Differences?
            [post_author] => 2
            [post_date] => 2012-07-09 15:37:00
            [year] => 2012
            [month] => 7
            [post_type] => post
        )

    [1189] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10913
            [post_name] => what-the-healthcare-ruling-really-means-to-employers
            [post_title] => What the Healthcare Ruling really Means to Employers
            [post_author] => 2
            [post_date] => 2012-06-29 20:38:00
            [year] => 2012
            [month] => 6
            [post_type] => post
        )

    [1190] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10914
            [post_name] => defragmentation-the-net-effect-of-healthcare-reform
            [post_title] => Defragmentation:  The Net Effect of Healthcare Reform
            [post_author] => 2
            [post_date] => 2012-06-22 17:55:00
            [year] => 2012
            [month] => 6
            [post_type] => post
        )

    [1191] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10915
            [post_name] => rent-seeking-a-traditional-pbms-pathway-to-riches
            [post_title] => Rent-Seeking:  A Traditional PBM's Pathway to Riches
            [post_author] => 2
            [post_date] => 2012-06-10 15:23:00
            [year] => 2012
            [month] => 6
            [post_type] => post
        )

    [1192] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10916
            [post_name] => the-message-out-of-express-scripts-c-suite-is-changing
            [post_title] => The Message Out of Express Script's C-suite is Changing
            [post_author] => 2
            [post_date] => 2012-05-24 00:50:00
            [year] => 2012
            [month] => 5
            [post_type] => post
        )

    [1193] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10917
            [post_name] => out-of-network-benefits-the-one-two-punch
            [post_title] => Out-of-Network Benefits, the One–Two Punch
            [post_author] => 2
            [post_date] => 2012-05-15 16:45:00
            [year] => 2012
            [month] => 5
            [post_type] => post
        )

    [1194] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10918
            [post_name] => physicians-evaluate-ppaca
            [post_title] => Physicians Evaluate PPACA
            [post_author] => 2
            [post_date] => 2012-05-10 21:31:00
            [year] => 2012
            [month] => 5
            [post_type] => post
        )

    [1195] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10919
            [post_name] => u-s-health-insurers-to-reimburse-1-3-billion
            [post_title] => U.S. Health Insurers to Reimburse $1.3 Billion
            [post_author] => 2
            [post_date] => 2012-05-01 19:43:00
            [year] => 2012
            [month] => 5
            [post_type] => post
        )

    [1196] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10920
            [post_name] => dig-deeper-dont-be-fooled-by-fancy-titles-and-terms
            [post_title] => Dig Deeper: Don't be Fooled by Fancy Titles and Terms
            [post_author] => 2
            [post_date] => 2012-04-24 18:57:00
            [year] => 2012
            [month] => 4
            [post_type] => post
        )

    [1197] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10921
            [post_name] => informed-health-care-decisions-cut-costs-saves-lives
            [post_title] => Informed Health Care Decisions Cut Costs & Saves Lives
            [post_author] => 2
            [post_date] => 2012-04-16 20:50:00
            [year] => 2012
            [month] => 4
            [post_type] => post
        )

    [1198] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10922
            [post_name] => express-scripts-medco-merger-approved-now-what
            [post_title] => Express Scripts & Medco Merger Approved, Now What?
            [post_author] => 2
            [post_date] => 2012-04-03 19:11:00
            [year] => 2012
            [month] => 4
            [post_type] => post
        )

    [1199] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10923
            [post_name] => a-cobra-exemption
            [post_title] => A Cobra Exemption...
            [post_author] => 2
            [post_date] => 2012-03-27 21:07:00
            [year] => 2012
            [month] => 3
            [post_type] => post
        )

    [1200] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10924
            [post_name] => in-a-rfp-the-whole-is-greater-than-the-sum-of-its-parts
            [post_title] => In a RFP the Whole is Greater than the Sum of its Parts
            [post_author] => 2
            [post_date] => 2012-03-20 18:18:00
            [year] => 2012
            [month] => 3
            [post_type] => post
        )

    [1201] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10925
            [post_name] => service-is-an-attitudetips-for-evaluating-brokers
            [post_title] => Service is an Attitude…Tips for Evaluating Brokers
            [post_author] => 2
            [post_date] => 2012-03-14 15:57:00
            [year] => 2012
            [month] => 3
            [post_type] => post
        )

    [1202] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10926
            [post_name] => targeted-for-termination-you-be-the-judge
            [post_title] => Targeted for Termination?  You be the Judge
            [post_author] => 2
            [post_date] => 2012-03-06 18:52:00
            [year] => 2012
            [month] => 3
            [post_type] => post
        )

    [1203] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10927
            [post_name] => pharmacy-benefits-management-glossary-of-terms
            [post_title] => Pharmacy Benefits Management Glossary of Terms
            [post_author] => 2
            [post_date] => 2012-02-29 18:55:00
            [year] => 2012
            [month] => 2
            [post_type] => post
        )

    [1204] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10928
            [post_name] => 10-questions-to-ask-your-pharmacy-benefit-manager
            [post_title] => 10 Questions to Ask your Pharmacy Benefit Manager
            [post_author] => 2
            [post_date] => 2012-02-21 16:30:00
            [year] => 2012
            [month] => 2
            [post_type] => post
        )

    [1205] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10929
            [post_name] => what-is-a-spread-certainly-not-a-topping-for-toast
            [post_title] => What is a spread? Certainly not a Topping for Toast.
            [post_author] => 2
            [post_date] => 2012-02-07 18:05:00
            [year] => 2012
            [month] => 2
            [post_type] => post
        )

    [1206] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10930
            [post_name] => hhs-high-risk-pools-remove-restrictions-and-lowers
            [post_title] => HHS High Risk Pools Remove Restrictions and Lowers...
            [post_author] => 2
            [post_date] => 2012-01-30 14:12:00
            [year] => 2012
            [month] => 1
            [post_type] => post
        )

    [1207] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10931
            [post_name] => fiduciary-an-appropriate-role-for-a-pbm
            [post_title] => Fiduciary:  An Appropriate Role for a PBM
            [post_author] => 2
            [post_date] => 2012-01-25 19:36:00
            [year] => 2012
            [month] => 1
            [post_type] => post
        )

    [1208] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10932
            [post_name] => hidden-cash-flows-and-pharmacy-benefit-managers
            [post_title] => Hidden Cash Flows and Pharmacy Benefit Managers
            [post_author] => 2
            [post_date] => 2012-01-20 02:29:00
            [year] => 2012
            [month] => 1
            [post_type] => post
        )

    [1209] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10933
            [post_name] => pharmacy-benefits-manager-pbm-traditional-vs-fiduciary
            [post_title] => Pharmacy Benefits Manager (PBM):  Traditional vs. Fiduciary
            [post_author] => 2
            [post_date] => 2012-01-09 21:23:00
            [year] => 2012
            [month] => 1
            [post_type] => post
        )

    [1210] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10934
            [post_name] => the-lovers-quarrel-walgreens-vs-express-script
            [post_title] => The Lover's Quarrel:  Walgreens vs. Express Script
            [post_author] => 2
            [post_date] => 2012-01-04 18:47:00
            [year] => 2012
            [month] => 1
            [post_type] => post
        )

    [1211] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10935
            [post_name] => ppaca-imposes-obligations-on-self-insured-health-plans
            [post_title] => PPACA: Imposes Obligations on Self-Insured Health Plans
            [post_author] => 2
            [post_date] => 2011-12-19 18:12:00
            [year] => 2011
            [month] => 12
            [post_type] => post
        )

    [1212] => stdClass Object
        (
            [slug] => transparentrx
            [ID] => 10936
            [post_name] => proposed-esi-express-scripts-inc-and-medco-health-solutions-inc-merger
            [post_title] => Proposed ESI (Express Scripts Inc.) and Medco Health Solutions Inc. Merger
            [post_author] => 2
            [post_date] => 2011-12-11 00:34:00
            [year] => 2011
            [month] => 12
            [post_type] => post
        )

)
▼2022 (113)
►2021 (128)
- ►December (11)
- ►November (14)
- ►October (13)
- ►September (10)
- ►August (11)
- ►July (11)
- ►June (10)
- ►May (12)
- ►April (9)
- ►March (11)
- ►February (9)
- ►January (7)
►2020 (137)
- ►December (14)
- ►November (10)
- ►October (12)
- ►September (11)
- ►August (11)
- ►July (12)
- ►June (11)
- ►May (11)
- ►April (12)
- ►March (13)
- ►February (8)
- ►January (12)
►2019 (141)
- ►December (16)
- ►November (13)
- ►October (10)
- ►September (12)
- ►August (13)
- ►July (13)
- ►June (11)
- ►May (11)
- ►April (10)
- ►March (13)
- ►February (7)
- ►January (12)
►2018 (142)
- ►December (10)
- ►November (11)
- ►October (10)
- ►September (12)
- ►August (13)
- ►July (12)
- ►June (11)
- ►May (12)
- ►April (13)
- ►March (14)
- ►February (11)
- ►January (13)
►2017 (141)
- ►December (10)
- ►November (12)
- ►October (12)
- ►September (12)
- ►August (13)
- ►July (12)
- ►June (10)
- ►May (11)
- ►April (12)
- ►March (14)
- ►February (11)
- ►January (12)
►2016 (132)
- ►December (11)
- ►November (9)
- ►October (10)
- ►September (11)
- ►August (12)
- ►July (10)
- ►June (12)
- ►May (10)
- ►April (11)
- ►March (14)
- ►February (11)
- ►January (11)
►2015 (101)
- ►December (7)
- ►November (9)
- ►October (8)
- ►September (9)
- ►August (8)
- ►July (10)
- ►June (8)
- ►May (9)
- ►April (8)
- ►March (8)
- ►February (9)
- ►January (8)
►2014 (80)
- ►December (5)
- ►November (4)
- ►October (9)
- ►September (8)
- ►August (6)
- ►July (8)
- ►June (7)
- ►May (6)
- ►April (6)
- ►March (7)
- ►February (7)
- ►January (7)
►2013 (56)
- ►December (6)
- ►November (7)
- ►October (8)
- ►September (7)
- ►August (5)
- ►July (4)
- ►June (4)
- ►May (4)
- ►April (2)
- ►March (3)
- ►February (3)
- ►January (3)
►2012 (40)
- ►December (3)
- ►November (3)
- ►October (4)
- ►September (2)
- ►August (3)
- ►July (3)
- ►June (3)
- ►May (4)
- ►April (3)
- ►March (4)
- ►February (3)
- ►January (5)
►2011 (2)
- ►December (2)
How Pharmacy Benefit Managers Make Money and What To Do About It [Free Webinar]

ABOUT THE AUTHOR

Subscribe to Blog

FREE RESOURCES AND EVENTS

FEATURED POST
